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Abstract
Advances in medical and surgical care of the critically ill neonates have decreased
mortality, yet a significant number of these neonates suffer from neurodevelopmental
delays and failure in school. Thus, clinicians are now focusing on prevention of
neurologic injury and improvement of neurocognitive outcome in these high-risk infants. Assessment of
cerebral oxygenation, cerebral blood volume, and the regulation of cerebral blood flow (CBF) during the
neonatal period is vital for evaluating brain health. Traditional CBF imaging methods fail, however, for both
ethical and logistical reasons. In this dissertation, I demonstrate the use of non-invasive optical modalities, i.e.,
diffuse optical spectroscopy and diffuse correlation spectroscopy, to study cerebral oxygenation and cerebral
blood flow in the critically ill neonatal population. The optical techniques utilize near-infrared (NIR) light to
probe the static and dynamic physiological properties of deep tissues. Diffuse correlation spectroscopy (DCS)
employs the transport of temporal correlation functions of diffusing light to extract relative changes in blood
flow in biological tissues. Diffuse optical spectroscopy (DOS) employs the wavelength-dependent attenuation
of NIR light to assess the concentrations of the primary chromophores in the tissue, namely oxy- and deoxy-
hemoglobin. This dissertation presents both validation and clinical applications of novel diffuse optical
spectroscopies in two specific critically ill neonatal populations: very-low birth weight preterm infants,
and infants born with complex congenital heart defects.
For validation of DCS in neonates, the blood flow index quantified by DCS is shown to correlate well with
velocity measurements in the middle cerebral artery acquired by transcranial Doppler ultrasound. In patients
with congenital heart defects DCS-measured relative changes in CBF due to hypercapnia agree strongly with
relative changes in blood flow in the jugular veins as measured by phase-encoded velocity mapping magnetic
resonance. For applications in the clinic, CO2 reactivity in patients with congenital heart defects prior to
various stages of reconstructive surgery was quantified; our initial results suggest that CO2 reactivity is not
systematically related to brain injury in this population. Additionally, the cerebral effects of various
interventions, such as blood transfusion and sodium bicarbonate infusion, were investigated. In preterm
infants, monitoring with DCS reveals a resilience of these patients to maintain constant CBF during a small
postural manipulation.
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ABSTRACT 
 
CEREBRAL HEMODYNAMICS IN HIGH-RISK NEONATES PROBED BY 
DIFFUSE OPTICAL SPECTROSCOPIES 
Erin McGuire Buckley 
Supervisor:  Arjun G. Yodh 
 
Advances in medical and surgical care of the critically ill neonates have decreased 
mortality, yet a significant number of these neonates suffer from neurodevelopmental 
delays and failure in school. Thus, clinicians are now focusing on prevention of 
neurologic injury and improvement of neurocognitive outcome in these high-risk infants.  
Assessment of cerebral oxygenation, cerebral blood volume, and the regulation of 
cerebral blood flow (CBF) during the neonatal period is vital for evaluating brain health. 
Traditional CBF imaging methods fail, however, for both ethical and logistical reasons.  
In this dissertation, I demonstrate the use of non-invasive optical modalities, i.e., diffuse 
optical spectroscopy and diffuse correlation spectroscopy, to study cerebral oxygenation 
and cerebral blood flow in the critically ill neonatal population.  The optical techniques 
utilize near-infrared (NIR) light to probe the static and dynamic physiological properties 
of deep tissues.  Diffuse correlation spectroscopy (DCS) employs the transport of 
temporal correlation functions of diffusing light to extract relative changes in blood flow in 
biological tissues. Diffuse optical spectroscopy (DOS) employs the wavelength-
 vi
dependent attenuation of NIR light to assess the concentrations of the primary 
chromophores in the tissue, namely oxy- and deoxy-hemoglobin. This dissertation 
presents both validation and clinical applications of novel diffuse optical spectroscopies 
in two specific critically ill neonatal populations: very-low birth weight preterm infants, 
and infants born with complex congenital heart defects.   
For validation of DCS in neonates, the blood flow index quantified by DCS is 
shown to correlate well with velocity measurements in the middle cerebral artery 
acquired by transcranial Doppler ultrasound.  In patients with congenital heart defects 
DCS-measured relative changes in CBF due to hypercapnia agree strongly with relative 
changes in blood flow in the jugular veins as measured by phase-encoded velocity 
mapping magnetic resonance.  For applications in the clinic, CO2 reactivity in patients 
with congenital heart defects prior to various stages of reconstructive surgery was 
quantified; our initial results suggest that CO2 reactivity is not systematically related to 
brain injury in this population.   Additionally, the cerebral effects of various interventions, 
such as blood transfusion and sodium bicarbonate infusion, were investigated.  In 
preterm infants, monitoring with DCS reveals a resilience of these patients to maintain 
constant CBF during a small postural manipulation.   
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1 Introduction 
This introductory chapter summarizes current neuromonitoring techniques available for 
use with critically ill neonates.  The chapter also highlights the need for a non-invasive 
bedside monitor of cerebral hemodynamics in high-risk neonates.  Of course, I am 
proposing (and demonstrating) that diffuse optical spectroscopies offer unique tools to fill 
important niches for monitoring newborn infants.   
1.1 Critically-Ill Neonates  
Two populations of neonates are investigated in this dissertation.  This section briefly 
summarizes the reasons these infants should be studied and it motivates the need for 
bedside monitoring of cerebral hemodynamics in these populations.  An in-depth 
discussion of these patients can be found in Chapters 5 and 6. 
1.1.1 Motivation Studies of Preterm Infants 
Between 1990 and 2005 the percentage of preterm births in the United States rose by 
20% [1].  Preterm births now account for almost half of children with cerebral palsy, as 
well as a significant portion of children with cognitive, visual, and hearing impairments.  
Three forms of acquired brain injury affect the likelihood of mortality and 
neurodevelopmental deficits in very low birth weight (< 1500 g), very preterm (< 32 
weeks gestation age) neonates: hypoxic-ischemic insult, periventricular leukomalacia 
(PVL), and intraventricular hemorrhage (IVH) [2, 3].  PVL is a specific form of necrosis of 
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the cerebral white matter adjacent to the lateral ventricles that is often associated with 
impaired motor development and is a major cause of cerebral palsy.  During the early 
stages of brain development, this region of white matter is highly susceptible to injury 
from lack of blood flow and oxygen delivery, due to the maturation stage of the 
supporting cells (oligodendrocytes) [4].  IVH refers to hemorrhaging from the germinal 
matrix, an immature bed of vascular tissue along the ventricular wall that is typically 
present only in preterm infants less than 32 weeks gestation age.  Such hemorrhages 
are caused by fluctuations in cerebral blood flow (CBF) and may induce profound 
cognitive and physical handicaps.  A continuous monitor of cerebral hemodynamics 
(both cerebral blood flow and cerebral oxygenation) at the bedside could therefore be a 
valuable supplement for gathering information about a patient’s condition [5] and for 
guiding treatment. 
1.1.2 Motivation for Studies of Neonates with Congenital Heart Defects 
Approximately 35,000 infants are diagnosed yearly with congenital heart defects (CHD) 
[6].  A third of these infants will have severe, complex cardiac lesions that will require 
surgical repair in the first few months of life. Importantly, cardiac surgery for serious 
forms of CHD in the neonatal period has progressed to the point wherein mortality is 
minimal.  However, these patients have a high risk of stroke, seizure, hemorrhages, and 
periventricular leukomalacia.  At school age, these patients are at higher risk for 
impaired cognitive and fine motor skills, learning and speech problems, attention 
deficit/hyperactivity disorder (ADHD), and potentially lower IQ than the general 
population [7-10].  Thus, clinicians are now focusing on prevention of neurologic injury 
and improvement of neurocognitive outcome in these high-risk infants.  Therefore, as 
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was the case for preterm infants, a continuous monitor of cerebral blood flow and 
cerebral oxygenation at the bedside could be a valuable supplement for gathering 
information about a patient’s condition [5] and for predicting and possibly preventing 
brain injury. 
1.2 Current Neuromonitoring Techniques for Critically-Ill Neonates 
Herein I highlight neuromonitoring techniques used most frequently in neonates: 
magnetic resonance imaging (MRI), transcranial Doppler ultrasound (TCD), positron 
emission tomography (PET), electroencephalography (EEG), radioactive tracers such as 
Xenon-133, and near-infrared spectroscopy (NIRS).  A brief overview of each technique 
is presented, and a discussion of the advantages and disadvantages of each method for 
use in neonates is given.  Table 1 summarizes the pertinent characteristics of each of 
these techniques.  For further review/reference, Wintermark et al [11] published an 
 MRI TCD PET EEG Xe-133 NIRS 
Spatial 
Resolution 
~2 mm N/A 4-6 mm N/A 
Whole 
brain 
~10 mm 
Brain 
Coverage 
Whole 
One per 
hemisphere 
Whole Whole Whole 
Few per 
hemisphere 
Cost High Low High Low Low Low 
Bedside 
(Portable) 
No Yes No Yes Yes Yes 
Ionizing 
Radiation 
No No Yes No Yes No 
Acquisition 
Time 
1-10 min 10-20 min 5-10 min < 1 ms 10-20 min 1 ms -1 s 
Continuous No No No Yes No Yes 
Parameters 
Measured 
Anatomy, 
water 
diffusion, 
CBF 
CBFV 
CBF, CBV, 
CMRO2 
Electrical 
Activity 
CBF ScO2, CBV 
Contrast 
Agent 
No No Yes No Yes No 
Table 1, Summary of the current neuromonitoring techniques employed in neonates: CBF = 
Cerebral blood flow, CBFV = cerebral blood flow velocity, CMRO2 = cerebral metabolic rate of 
oxygen extraction, ScO2 = cerebral oxygen saturation, CBV = cerebral blood volume. 
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excellent overview of the majority of these techniques as they are used in man.  The 
majority of this section is derived from this review. 
1.2.1 Magnetic Resonance Imaging (MRI) 
MRI is an invaluable tool for studying the brain.  It provides high-resolution images of 
both cerebral anatomy and perfusion.  However, MRI only reflects physiology at a 
discrete time point and cannot be used at the bedside or in the operating room for longer 
periods of assessment. 
Structural/Dynamical Neuroimaging 
MRI provides many pulse sequences capable of rendering structural images of the brain.  
Three-dimensional volumetric MRI quantifies volumes of grey matter, white matter, and 
cerebrospinal fluid, as well as total brain volume [12-14].  Extensive MRI research has 
demonstrated post-natal progression of these parameters in neonates [12, 15] (i.e., 
increases in myelination, increases in total brain volume, grey matter volume, etc.).  
Thus, volumetric MRI may be used to assess brain development of the critically ill 
neonate as compared to a cohort of healthy “normal” neonates.   
A complimentary technique to structural scans, which reveal brain anatomy and 
volume, is MR diffusion-weighted imaging (DWI) which quantifies water diffusion in the 
neonatal brain [16].  The natural progression of the average water diffusion coefficient as 
well as the relative anisotropy of water diffusion (caused by both changes in water 
content of the brain, as well as changes in tissue microstructure) is well known in healthy 
brain development.  Thus, DWI can be used as a tool to assess brain maturation, as well 
as to diagnosis brain injuries such as stroke and periventricular leukomalacia (PVL) [17].       
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In addition to water diffusion, cerebral perfusion may be assessed using dynamic 
susceptibility contrast (DSC) (see review in [18] for a detailed description of the 
technique). In DSC, an exogenous MRI tracer such as gadolinium is used to qualify 
regional cerebral blood volume based on the theory of tracer kinetics, i.e., the indicator 
dilution method [19].  DSC requires a relatively short imaging duration and the image 
processing tools are widely available.  Although the technique is not quantitative, it can 
evaluate regional differences in cerebral blood volume, which is helpful in the 
identification and classification of brain tumors.  However, its use in pediatrics has been 
limited by the need to use gadolinium contrast boluses, by the inability to make repeated 
measurements during a single session (secondary to cumulative effects), and by the 
lack of absolute quantification of blood volume [18]. 
A novel technique, arterial spin labeled perfusion MRI (ASL-pMRI), permits 
noninvasive evaluation of quantitative CBF images using electromagnetically labeled 
arterial blood water as an endogenous contrast agent [20-23]. One of the most 
significant advantages of ASL-pMRI over previous techniques is the ability to assess 
cerebral blood flow (CBF) without using intravascular contrast agents or radioactive 
labeled tracers.  Measuring CBF with ASL in neonates and infants, however, poses 
technical challenges related to their cerebrovascular physiology. First, CBF in infants is 
lower than that of older children and adults. Second, the longitudinal relaxation time of 
blood (i.e., the time it takes for magnetically labeled blood to realign with the external 
magnetic field) is relatively long [21].  This combination of factors produces 
contaminated control images, culminating in a concentration of “negative voxels” on the 
final CBF map. The percentage of negative “voxels” increases as CBF decreases, and is 
the leading contributor to noise in ASL-MRI.   
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High-risk neonates have inherently low CBF [24-26].  Imaging at high field (3.0 vs. 
1.5 Tesla), reducing the labeling volume, and improving tagging efficiency provides more 
reliable CBF maps by reducing the percentage negative voxels (SNR). Studies in normal 
neonates using ASL-pMRI have catalogued normal CBF in preterm- and term-infants 
[27], as well as age related changes throughout childhood [28]. Other studies have 
demonstrated expected physiological responses; for example, CBF increases with lower 
hemoglobin and increases predictably with hypercarbia [26]. ASL-pMRI has also been 
useful in assessing CBF in neonates who have suffered hypoxia-ischemia [29] and in 
infants and children after stroke [30]. 
1.2.2 Transcranial Doppler Ultrasound (TCD) 
Other than NIRS (discussed below), ultrasound is the most convenient form of cerebral 
hemodynamic monitoring in critically ill neonates due to its portability.  TCD measures 
cerebral blood flow velocity (CBFV) in the large cerebral arteries by monitoring the 
frequency shift of acoustic waves that scatter from moving red blood cells [31].  
Traditionally, perfusion in the middle cerebral, anterior cerebral, and/or internal carotid 
arteries is monitored to assess global brain perfusion.  The parameters measured with 
TCD include peak systolic, mean, and end diastolic velocities (i.e., PSV, MV, and EDV, 
respectively).  The angle of isonation used to measure velocities with TCD may affect 
the values of PSV and EDV; thus, a resistance index (RI) is often employed as a way to 
eliminate the effects of the angle of probe placement [32]: 
 !" !
!"#!!"#
!"#
. [1] 
RI is a unitless parameter that reflects cerebrovascular resistance.  The natural 
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progression of changes in PSV, EDV, MV, and RI after birth in healthy infants has been 
well documented [33-35].   
With additional information about the cross-sectional area (!) of the insonated 
vessel, CBFV permits calculations of arterial CBF using the formula !"# ! !"#$! !!.  
However, cerebral vessels are small in size, making their diameter difficult to measure 
[36]. To avoid this source of error, one could focus on relative changes in flow. However, 
these blood vessels can change caliber over time, leading to large errors in calculations 
of relative change, which in turn cause errors in estimates of the amount of oxygen and 
nutrients delivered to the surrounding tissue [37-39].  Additionally, TCD measures 
cerebral blood flow/blood flow velocity in the large vessels that supply perfusion to the 
brain; however, regional variations in cerebral blood flow are not accessible with TCD.   
1.2.3 Electroencephalography (EEG) 
EEG is a non-invasive technique for monitoring electrical activity (not hemodynamics) in 
brain, generated by neuronal activity.  Electrodes are secured to the scalp and the 
resultant electrical signal is monitored over time.  Although the technique requires skilled 
clinicians/technicians for interpretation of electrical activity, EEG is a relatively 
inexpensive modality capable of continuous bedside neurological monitoring. It is 
currently the gold standard for diagnosing seizures in neonates, which may be linked to 
poor neurodevelopmental outcome [40].  Additionally, the normal progression with age of 
spontaneous EEG recorded activity is well known for healthy neonates and for infants 
born prematurely [41].  This evolution of EEG activity changes dramatically over the first 
weeks of life. Thus, abnormalities in the electroencephalogram readings as compared to 
those of age-matched healthy infants may be indicative of acute or chronic brain injury 
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and/or poor neurodevelopment [42]. 
1.2.4 Positron Emission Tomography (PET) 
PET provides quantitative tomographic images of regional cerebral blood flow, regional 
cerebral blood volume, regional oxygen extraction fraction, and regional cerebral 
metabolic rate of oxygen extraction [43, 44].  The technique is quantitative (with a 
resolution of approximately 5 mm) and reproducible; however, PET requires either the 
intravenous administration or the inhalation of positron emitting radioisotopes, it exposes 
the patient to radiation, and it works only under steady-state hemodynamic conditions.  
Very little work has been done with PET in neonates [45-48], presumably due to ethical 
considerations, need for patient transport, need for anesthesia, etc.  
1.2.5 Radioactive Tracers  
A great deal of what we know about cerebral blood flow in babies comes from research 
conducted using inert gas radiopharmaceutical tracers, such as 133Xe; however, the 
technique is not typically employed in neonates in the present day due to exposure to 
ionizing radiation.  In practice, 133Xe dissolved in saline is injected into a peripheral artery 
or vein, and scintillation detector(s) are placed over the brain to monitor gamma radiation 
during 133Xe uptake and clearance.  The time trace of the count rate of gamma radiation 
can be related to cerebral blood flow via the Fick principle [32, 49-52].   
 This technique, while providing absolute measures of cerebral blood flow in a 
reliable fashion, exposes the patient to small amounts of ionizing radiation and thus 
cannot be repeated too frequently.  Additionally, the Fick principle assumes constant and 
homogeneous cerebral blood flow during the entire course of data acquisition 
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(approximately 10-15 minutes).  Thus, measurements using 133Xe may be subject to 
error if the patient’s cerebral blood flow is not in a steady-state or if the patient has 
regions of extremely heterogeneous flow [50].  
1.2.6 Near-Infrared Spectroscopy (NIRS) 
Commercially available NIRS instruments from companies, such as Hamamatsu, 
Somanetics, and NIRx Medical Technologies, are becoming prevalent as standard of 
care for cerebral monitoring in neonatal intensive care units and operating rooms across 
the country [53].  NIRS continuously monitors attenuation of continuous wave NIR light 
incident on the tissue surface.  This attenuation enables experimenters to extract 
changes in the light absorption properties of the tissue via the modified Beer-Lambert 
law (see Section 2.1.5).  Changes in the absorption coefficient of tissue (!!!) relative to 
a presumed baseline period of measurement are related to changes in chromophore 
concentrations. These concentrations are obtained using the following formula:  
 !!! ! ! !!! ! !!!, [2] 
where !! [µM • cm
-1] is the known wavelength dependent extinction coefficient of the ith 
chromophore, and !!! ![µM] is the change in the i
th chromophore concentration. The two 
main endogenous absorbers in tissue in the NIR spectral range are oxy- and deoxy-
hemoglobin (HbO2 and Hb, respectively), thus Equation 2 is typically written as 
!!! ! ! !!!"!!" ! ! !!!"!!!!"!! ! , where !!!"  and !!!"!!  are the changes in 
concentrations of tissue oxy- and deoxy-hemoglobin, respectively. After !!! is obtained 
at multiple wavelengths, quantifying hemoglobin concentration changes only requires 
solving a system of linear equations. 
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These commercially available instruments assume baseline values of oxy- and 
deoxy-hemoglobin concentrations and compute changes in tissue oxygen saturation and 
changes in cerebral blood volume.  With the help of an exogenous tracer, such as 
oxygen or indocyanine green dye, NIRS can also provide quantification of CBF 
[mL/min/100 g]. This calculation of CBF again relies on the Fick principle, which states 
that the total uptake of a tracer by tissue is proportional to the difference between the 
rates of inflow and outflow of the tracer to and from the tissue. This measurement 
provides a snapshot of regional tissue CBF in time; however, it does not provide 
continuous CBF data. Furthermore, a few assumptions must be true for this method to 
be valid: CBV, CBF, and cerebral oxygen extraction must remain constant during the 
measurement. This technique has been validated with limited success [54, 55]. The use 
of an exogenous tracer limits its use in the clinical setting, especially in high-risk 
neonates. 
Commercial NIRS devices used in the clinic are highly sensitive to stray room 
light, to surface coupling between skin and/or hair and the optical probe, and lead to 
crosstalk between calculated tissue absorption and scattering [56, 57].  In addition, 
although reliable trends in hemodynamic changes may be obtained with these devices, 
accurate calculations of relative changes in chromophore concentrations are often highly 
influenced by the aforementioned factors.  Commercial system availability is crucial for 
wider use of NIRS in the clinic, and there now exist a handful of CW NIRS devices 
approved by the Food and Drug Administration [53].  The clinical utility of these devices 
is promising but remains to be determined by large clinical trials. 
1.3 Diffuse Optical and Diffuse Correlation Spectroscopies 
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As the previous section suggests, a handful of techniques are currently used to study 
cerebral hemodynamics in neonates.  However, all of these techniques have pitfalls.  
MRI and PET are both expensive, require patient transport, and provide snapshots of 
hemodynamics in time as opposed to continuous monitoring; TCD only looks at the 
macrovasculature; EEG only provides information on electrical activity; and NIRS only 
works as a trend monitor of cerebral oxygenation (e.g., as opposed to providing 
quantitative absolute oxygenation levels or cerebral blood flow measurements).    
I believe that NIRS holds promise as an extremely valuable measurement tool in 
neonates. However, commercial systems lack the ability to provide truly quantitative 
results, and they ignore the wealth of knowledge now available about the propagation of 
light in tissue.  In this dissertation, I distinguish NIRS from Diffuse Optical Spectroscopy 
(DOS).  Like NIRS, DOS aims to investigate tissue physiology millimeters to centimeters 
below the tissue surface by using the spectral “window” of low absorption in the near-
infrared range (NIR, 700-900 nm).  However, unlike NIRS, DOS utilizes photon diffusion 
theory to extract more rigorous information about both optical absorption and scattering 
within the tissue based on light attenuation at the tissue surface.  DOS measures slow 
variations in cerebral absorption and scattering and is sensitive to absolute chromophore 
concentrations and therefore to absolute measures of cerebral oxygen saturation and 
cerebral blood volume (CBV). 
Furthermore, DOS (or NIRS) measurements can be greatly enhanced by the 
addition of an independent monitor of cerebral blood flow.  This dissertation focuses on 
the combination of DOS with a novel optical method, diffuse correlation spectroscopy 
(DCS), which measures changes in cerebral blood flow by monitoring the temporal 
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intensity autocorrelation function of diffusing light at the tissue surface.  DCS is ideal for 
the critically ill neonate population; it can be used as a continuous, noninvasive, low-risk, 
readily portable bedside monitor of relative changes in regional cortical CBF.  
Additionally, DCS can easily be combined with other modalities, such as NIRS, Doppler 
ultrasound, or electroencephalography, to enhance the information gathered by other 
techniques about the patient’s physiology. Few studies have been conducted with DCS 
on this population, largely because of the newness of the technology [58-60]. Ideally, a 
study would use a hybrid DOS and/or DCS instrument [59, 61-64] to capture both tissue 
oxygenation and blood flow changes. These two parameters combined enable 
construction of indices for measuring cerebral metabolic rate of oxygen extraction 
(CMRO2) [62, 63]. 
1.4  Summary 
Critically ill neonates are a unique population that could benefit from continuous bedside 
monitoring of cerebral hemodynamics to identify and potentially prevent detrimental 
cerebral events such as hypoxic ischemia, hemorrhage, stroke, etc.  It appears that 
diffuse optical techniques may be well suited for monitoring this unique population.  This 
dissertation will describe the theory behind diffuse optical spectroscopies in depth, it will 
discuss the instrumentation requirements for bedside monitoring, it will report on 
numerous validation studies performed on both preterm infants and on infants with 
congenital heart defects, and finally, it will highlight clinical applications of the technique 
with the ultimate goal of improving patient care and further understanding the 
complexities of the hemodynamics in the neonatal brain. 
Chapters 2 and 3 review the diffuse optical techniques, namely diffuse optical 
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spectroscopy (DOS) and diffuse correlation spectroscopy (DCS), that are applied for 
neonatal neuromonitoring in the remainder of this dissertation.  An effort is made to gear 
the theory towards that which is applicable only to these infants.  Thus, the intricacies of 
tomographic reconstructions, etc. are not included in these chapters.  These chapters 
highlight the relevant theory behind the spectroscopic measurements made on 
neonates.  Chapter 4 describes, in depth, the hybrid DOS/DCS instrumentation needed 
to make DOS/DCS measurements.   
Chapter 5 presents published validation studies of DCS in two separate pediatric 
populations, namely patients with congenital heart defects and preterm infants.  First, 
during a hypercapnia intervention in children with congenital heart defects, changes in 
cerebral blood flow measured with DCS are shown to agree well with relative changes in 
blood flow in the jugular veins.  Second, in preterm infants, I demonstrate a strong 
correlation between the absolute blood flow index quantified by DCS and blood flow 
velocity measurements.  In patients with congenital heart defects DCS relative changes 
in CBF occurring due to hypercapnia agree strongly with relative changes in blood flow 
in the jugular veins as measured by phase-encoded velocity mapping magnetic 
resonance. 
The last chapter (Chapter 6) highlights the translation of the DOS/DCS techniques 
to the intensive care unit for bedside monitoring.  I focus on a collection of data obtained 
from infants with congenital heart defects.  The chapter quantifies the cerebral effects of 
various interventions, namely hypercapnia, blood transfusion, and sodium bicarbonate 
infusion, and it also studies the evolution of cerebral oxygen saturation, total hemoglobin 
concentration, and reduced scattering coefficient before and after cardiac surgery.    
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Finally, the majority of this dissertation focuses on my work monitoring pediatric 
patients.  I note here that I have spent a significant amount of time in collaborations with 
other lab members that have led to published results.  I am co-author on other 
publications involving cerebral blood flow in adult patients with traumatic brain injury [65], 
and hypercapnia in neonates with congenital heart defects [59].  Additionally, I 
contributed heavily to the review of optical techniques in a recent review paper on 
perfusion imaging in the high-risk neonate by Goff et al [20]. 
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2 Diffuse Optical Spectroscopy  
The goal of diffuse optical spectroscopy (DOS) is to measure tissue chromophore 
concentrations (oxy-hemoglobin, deoxy-hemoglobin, water, lipids, etc.) and scattering in 
deep tissue, i.e., on depth scales on the order of centimeters below the tissue surface.  
DOS measures chromophore concentrations by taking advantage of a spectral “window” 
in the near-infrared (NIR) within which the absorption of light is quite low; in this spectral 
regime, photons experience many multiple scattering events before absorption or re-
emission at the tissue surface.  An example of the absorption spectra of the three main 
chromophores in biological tissue is seen in Figure 1.  The optical absorption coefficient, 
!! defined as the inverse of the distance a photon travels before it is likely to experience 
an absorption event (i.e., the 1/e distance), is shown on the vertical-axis and is plotted 
versus the wavelength of light for oxy-hemoglobin, deoxy-hemoglobin, and water.  It is 
evident from this figure that, outside of the NIR range of approximately 680-900 nm, the 
 
Figure 1, Sample absorption spectrum of oxy-hemoglobin, deoxy-hemoglobin, and water in 
tissue. A spectral “window” exists in the near-infrared range (highlighted in the gray box and 
enlarged above), so that scattering, rather than absorption, dominates photon propagation.  
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tissue absorption coefficient is high and light cannot penetrate deeply.  Furthermore, 
within the NIR range, shown in the inset of Figure 1, the absorption coefficient is not only 
low, but one can also observe distinct spectral features due to each chromophore. Thus, 
measurement of this absorption coefficient at multiple wavelengths can provide enough 
information so that the concentrations of the various chromophores in the tissue can be 
calculated.   
The analysis, however, must account for the fact that light undergoes a large 
number of scattering events before reaching the boundaries of the medium, and 
therefore the input photons will travel along a distribution of pathlengths from source to 
detector (as opposed to say x-ray computed tomography in which light travels straight 
through the medium).  This chapter will discuss in detail how one separates tissue 
absorption from scattering in the NIR window.  As the chapter title suggests, the focus 
here will be on spectroscopy, which aims to measure the mean bulk chromophore 
concentrations over a large tissue volume, as opposed to imaging, which attempts to 
assign this information to many volume elements within the tissue sample.   Additionally, 
the instrumentation required to make physiological spectroscopic measurements will be 
discussed.   
2.1 Photon Diffusion Equation  
NIR light propagation in a highly scattering medium such as biological tissue is well 
modeled as a random walk process.  Interference effects are usually negligible (except 
for the famous backscattering cone [66]), and the light trajectories are fairly accurately 
visualized using ray optics.  It is not necessary to deal with Maxwell’s equations.  Thus, 
the starting point for most analyses of these problems is the radiation transport equation 
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(RTE) that describes the conservation of light radiance, !!!! !! !! [67]:   
 
!
!
!! !!!!!
!"
! ! ! !! !! !! ! ! !!!! !! !! ! ! ! !! !! ! ! !! ! !! !! ! ! !! !! !!! . [3] 
Here the radiance [W/cm2/sr] is defined as the power of light per unit area traveling in a 
given direction ! within some infinitesimal volume element located around position ! at 
time ! ; !  is the speed of light in the medium; !!  is the sum of the absorption and 
scattering coefficients (!! and !!, respectively) within the volume; ! !! !! !  is the power 
per volume emitted by sources into the direction ! ; and ! !! !!  is the normalized 
differential scattering cross-section that gives the probability that light (radiance) incident 
on a volume element will scatter from the !! direction into the ! direction.  I also define 
two additional quantities of interest: the photon fluence rate, ! !! !  [W/cm2], and the 
photon flux, ! !! !  [W/cm2]. 
 ! !! ! ! ! !! !! ! !!; [4] 
 ! !! ! ! ! !! !! ! !!!. [5]   
! !! !  is the total power per area traveling radially out of an infinitesimal volume 
element located around position ! (at time !).  ! !! !  is the vector sum of the radiance 
emerging from this infinitesimal volume. 
The RTE is quite difficult to solve analytically.  Thus, in order to obtain an 
approximate analytical solution, the radiance and source terms are typically expanded in 
terms of spherical harmonics, !!! !!!, i.e., 
 ! !! !! ! ! !!! !! ! !!! !!!
!
!!!! !
!
!!! , [6] 
 18
 ! !! !! ! ! !!! !! ! !!! !!!
!
!!!! !
!
!!! , [7] 
in what is known as the PN approximation. For this dissertation, we need only concern 
ourselves with the P1 approximation, in which only the ! ! !  and ! ! !  terms are 
employed.  Within this “nearly isotropic” approximation, the radiance is well 
approximated as the sum of an isotropic photon fluence rate and a small directional 
photon flux: 
 ! !! !! ! !
!
!!
! !! ! ! !
!
!!
!!!! !! ! !. [8] 
Here ! !! !  is proportional to !!!! !! ! , and ! !! !  is proportional to the sum of the 
!!! !! !  components of !!!! !! !!  [68, 69].  This approximation is valid when the 
radiance is nearly isotropic (! ! !!!).   
Within the P1 approximation (and under several other relatively innocuous 
assumptions1), the RTE is readily simplified to the photon diffusion equation for the 
fluence rate [68, 70-72]: 
 ! ! ! ! !! !! ! ! !"!!!!! !! ! ! !" !! ! !
!" !!!
!"
 .  [9] 
Further, the fluence rate is related to the flux via Fick’s law of diffusion: 
 ! !! ! ! !
!
!
!! !! ! !  [10] 
                                                
1 For this derivation, we assume 1. source isotropy, i.e., ! !! !! ! ! !!!! !!; 2. slow temporal fluctuations of the photon 
flux, !!!! !!, i.e., the photon flux varies slowly relative to the mean time between scattering events; 3. rotational symmetry, 
i.e., the scattering cross-section, ! !! !! , depends only on the angle between the incident and outgoing scattering 
wavevectors, ! !! !! ! !! ! ! !! .  
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Here ! !! !  is now an isotropic source of photons traveling outward from a volume 
element located around position ! at time !; ! is the speed of light in the medium [cm/s]; 
!!!!!  and !!
! !!!  are the position dependent absorption coefficient and reduced 
scattering coefficients of the medium, respectively [cm-1].  ! ! ! ! !!!!
! !!! ! !!!!!! !
! !!!
! !!! is the photon diffusion coefficient [cm2/s] [73, 74].  Note that !!
! !!! is different 
than !!, i.e., !!
!
! ! !!!! ! !!.  Here, ! is the average of the cosine of the scattering 
angle for a typical scattering event, which is generally quite high for tissue (i.e., greater 
than 0.9); photons tend to scatter predominantly in the forward direction in tissue.  Thus, 
a photon undergoes many single-scattering events (characterized by the scattering 
coefficient, !! ) in tissue before its initial direction is essentially randomized 
(characterized by the reduced scattering coefficient, !!
! !!!).  The diffusion equation thus 
describes a situation wherein individual photon trajectories are random walks through 
the tissue.  A photon, on average, travels a random walk step of length, !!" ! !!!!
! , 
before its direction is randomized.  Photons diffuse through tissue in much the same way 
that ink diffuses through water.    
In diffuse optical spectroscopy (DOS), tissue is usually modeled as a 
homogeneous medium, i.e., ! ! ! !, !!
!
! ! !!
!  and !! ! ! !!.  !, !!
! , and !! are the 
average bulk optical properties of the tissue.  These optical properties, of course, will 
change with light wavelength, but they are modeled as constants in space at each 
wavelength.  Within this approximation, the diffusion equation simplifies even further, 
i.e., 
 !!!! !! ! ! !"!! !! ! ! !" !! ! !
!! !!!
!"
!.  [11] 
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Like the radiative transport equation, the photon diffusion equation is a conservation 
equation, in which the time rate of change in photon concentration in a given unit volume 
(right hand side) is equal to the number of photons emitted from the source in the 
volume (!" !! ! ) plus the photons scattered into the volume from the surroundings 
(!!!! !! ! ) less the number of photons absorbed within the volume (!"!! !! ! ). 
2.1.1 Source Types 
As seen in Figure 2, there are three classes of sources employed for diffuse optical 
spectroscopy. For all source types, data are collected at multiple wavelengths, equal to 
or exceeding the number of chromophores measured [75].  Time-resolved DOS (Figure 
2c) typically employs multiple NIR wavelength sources of sub-nanosecond pulsed light 
and measures photon arrival times of the reflected/transmitted diffuse light. This 
technique enables quantification of absolute optical properties using fits to the solution of 
the photon diffusion equation in the time-domain [76].  However, with the high 
information content of time-resolved measurements comes a high cost of 
instrumentation components, and a low duty cycle because the maximum count rate is 
on the order of 5 MHz. 
Similar information, namely, absolute absorption and scattering coefficients at 
multiple wavelengths can be obtained in the frequency domain (Figure 2b). In this 
experimental configuration, NIR light sources are sinusoidally amplitude modulated in 
the ~100 MHz range [72, 77-79]. FD systems gather similar information as the time 
domain systems, as the techniques are Fourier analogs. Although the FD systems are 
not sensitive to stray room light, it can be sensitive to unwanted light that has leaked 
from the source around the sample of interest and to surface coupling between the skin 
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and optode [80].  
Continuous wave (CW) systems measure the attenuation of constant intensity 
source light after it has diffused through the tissue. The CW setup offers a fast and 
inexpensive method for measuring relative changes in the optical properties of the 
 
Figure 2, Graphical depiction of the three types of near infrared spectroscopy measurements (a) 
continuous wave, (b) frequency domain, (c) time resolved.  The arrows on the right side of the 
figure indicate increasing data and instrumentation complexity (increasing corresponds to 
traveling “down” in the diagram) that accompany these techniques. 
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tissue; however, absorption and scattering cannot be distinguished uniquely by a single 
measurement.   
In the studies conducted within this dissertation, the frequency domain is 
employed. Thus, the remainder of this section will focus on solutions of the photon 
diffusion equation assuming an isotropic point source at the origin whose intensity is 
sinusoidally modulated at angular frequency !, i.e., ! !! ! ! !!!" ! !!!
!!"#!!!! ! !!.  
Herein, we impose the restriction that !!!! is much smaller than the typical frequency of 
the scattering events, !!!
! .  With a source of this form, the fluence rate in the sample is 
also composed of an AC and DC component, ! !! ! ! !!"!!! ! ! ! !
!!"#.  Examining 
only the AC component, the diffuse equation becomes: 
 !!!! ! ! !"!! ! ! !!!! ! ! !!"# ! !  [12] 
This equation can be re-written as: 
 !! ! !! ! ! ! !! !! ! ! ! , [13] 
where !! ! !!!" ! !!!! ! and the right hand side of the equation equals 0 for all ! ! !.  
Isolating the DC component of ! yields 
 !!!!!" ! ! !!!!!" ! ! !!!"! ! ! !,  
which simplifies to:  
 !! ! !!
!
! ! ! !! !! ! ! ! ! [14] 
where !!
!
! !!! ! ! !!!!!
! .  The remainder of this chapter will analytically solve these 
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equations to derive Helmholtz Equation-like solutions for two simple geometries relevant 
to the experiments we carry out. 
2.1.2 Infinite Geometry 
For the case of a point source located at the origin surrounded by a homogeneous 
infinite medium, the main boundary condition is that the fluence rate falls to zero as ! 
approaches infinity.  The solution to Equation 14, given these boundary conditions, is the 
well known spherical wave: 
 ! ! !
!!!
!!"
!
!!"
!
. [15] 
Actually, the solution is in the form of a damped traveling spherical wave.  This wave, 
dubbed a diffuse photon density wave (DPDW), travels with a coherent front and has 
complex wave vector ! ! !! ! !"! ! !!!! ! !"! ! .  The real and imaginary 
components of the wave vector can be written as: 
 !! !
!!!
!!
! !
!
!!!
!
! !
! !
 [16] 
 !! ! !
!!!
!!
! !
!
!!!
!
! !
! !
 [17] 
The DPDW consists of two main parts, a phase-shift term, !!!"!! !, and an attenuation 
term, !!!!! . It has position-dependent amplitude, ! ! !!!!
!!!! !!"# , and phase, 
! ! !!!.  The DPDW can thus be characterized by a wavelength, !! phase velocity, !!, 
and decay attenuation length, !!: 
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 ! ! !
!!
!!
! [18] 
 !! !
!
!!
, [19] 
 !! !
!
!!
. [20]   
Note that all of these parameters depend on !, !!, !!
! , and the speed of light in the 
medium, !!!  For typical human brain, approximate optical properties are !! ! !!! , 
!!
!
! !" at 785nm; thus, with a frequency modulated source of 70 MHz, the DPDW 
“phase” wavelength is !!" cm, which is almost 30 times greater than its attenuation 
length of 1.1 cm; the wave has a phase velocity of 2.5!107 m/s.  It has been shown that 
DPDWs behave in many (but not all) [67] ways like traditional travelling waves, i.e., they 
exhibit reflection, refraction, diffraction/scattering, dispersion, and interference 
phenomenology [81-85].  
2.1.3 Semi-Infinite Geometry 
A remission geometry in which the source and detector fibers are placed on the ! ! ! 
plane at an air-tissue interface is a more suitable (and non-invasive) model for clinical 
settings, albeit still quite simplistic.  In this case, the medium is assumed to be optically 
homogeneous and to extend infinitely in the x-y plane and the positive !-direction (see 
Figure 3); further we choose the incident beam to be located at the origin and directed in 
the positive !-direction.   
If the boundary is perfectly transmitting (i.e., the index of refraction of both media 
are matched), then the radiance must be zero when the !-direction points into the 
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medium from outside (i.e., there is no reflection of diffuse light back into the medium), 
i.e., the total incoming diffuse radiance, !!"!! ! !! !!, is: 
 !!"!! ! !! !! ! ! ! ! !! !! ! ! ! ! !! ! !!"# ! !"!#
!!!
!
! !
!!
!
 . [21] 
Substituting in the P1 approximation for ! ! ! !! !! !  and integrating, we find: 
 !!"!! ! !! !! !
! !!!!!
!
!
!!!!!!!!!
!
! !. [22] 
Then, employing Fick’s law for diffusion (Equation 10), we obtain what is known as the 
partial-current (or partial-flux) boundary condition for a perfectly transmitting boundary: 
 ! ! ! !! ! !
!
!!!
!
!"
!" !!!
. [23] 
In addition to the boundary condition, we need to characterize our source term in 
order to solve the diffusion equation for this geometry.  In a typical experiment, the 
output of a fiber or a similarly “tight” collimated beam is placed on the air/tissue interface 
(see Figure 3); a standard approach adopted by most researchers is to approximate the 
real source with an “isotropic” source at a new position located a distance !!" inside the 
 
Figure 3, Diagram of a semi-infinite geometry.  The air/homogeneous turbid medium interface 
spans the ! ! ! plane.  The positive !!-direction extends into the turbid medium.  ! is defined as 
the azimuthal angle between the !!-direction and the direction the radiance travels along (!!).   
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tissue/air boundary, where !!" ! ! !!
!  is the photon transport mean free path.  The 
validity of this assumption for most problems has been demonstrated by [86, 87].  Thus, 
within this approximation the source term takes the following form: 
 ! !! ! ! !!!" ! !!"!
!!"#!!!! ! !! ! ! !! ! ! !!"!. [24] 
The exact solution to the photon diffusion given the partial-current boundary 
condition (Equation 23) and an embedded isotropic source approximation (Equation 24) 
is non-trivial and involves an improper integral.  However, a good approximation of the 
partial-current boundary condition is the so-called extrapolated-zero boundary condition, 
which makes an estimation for where the fluence falls to zero using the partial-current 
boundary condition (Equation 23).  Let ! ! !! be the value of z for which the fluence rate 
falls to zero; notice this position should be in the “air” medium.  To determine !!, a Taylor 
series expansion near ! ! ! of the fluence rate, ! ! , is used: 
 ! ! ! !! ! ! ! ! ! !
!"
!" !!!
!!! ! !! ! !. [25] 
Using 
!!!
!
!
!"
!" !!!
! ! ! ! !  from in Equation 23 at ! ! !, we find that the fluence falls to 
zero at ! ! !! !
!!
!!!
!
.  With this new condition for where ! is zero, we can apply the 
method of images. 
As seen in Figure 4, when the fluence rate solution is a sum of the infinite 
medium solution for a source at ! ! !!" and an image source with the same magnitude 
but opposite sign at ! ! !!!!! ! !!"!, this boundary “zero“ condition at !! is satisfied.  
Thus, the solution to the diffusion equation for a perfectly transmitting boundary given 
the extrapolated-zero boundary condition is (to a good approximation): 
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 ! !! ! !
!!!"
!!"
!
!!!!!
!!
!
!
!!!!!
!!
!
!!!"
!!"
!
!"!!
!!
!
!
!"!!
!!
!
!!!, [26] 
where !! ! !
! ! !! ! !!"!
!  is the distance to the source from the detector, !! !
!! ! !! ! !!" ! !!!!
!  is the distance to the image source from the detector, !! !
!!!!!
! , and !! ! !!!! ! !"! !.  Here that the fluence rate is written as the sum of an 
AC and DC component.  
 If the index of refraction of the turbid medium is significantly different from that of 
air (!! ! !!!), as is the case with tissue (! ! !!!), Fresnel reflection of diffuse light 
traveling out towards the interface from the turbid medium near the boundary provides a 
mechanism for the radiance to return to the medium.  We can write the inward irradiance 
(!!", or the inward radiance within the turbid medium) at the boundary, in this case, as 
the integral of the radiance reflected back into the turbid medium [67]:  
 !!" ! !!"#$%#& ! ! ! !! ! !!
!
!!!
!!"# ! !"!#
!!
!
. [27] 
Here !!"#$%#& !  is the Fresnel reflection coefficient for unpolarized light that is 
 
Figure 4, Diagram of the extrapolated-zero boundary condition for a semi-infinite geometry.   
An approximate solution involves an extrapolated boundary located at!! ! !! (shown by dotted 
line) wherein the fluence rate falls to 0.  The solution for !!!! !! is arrived at via the method of 
images where the image source is positioned at ! ! !!!!! ! !!"!. 
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dependent on the angle of incidence, ! , the refracted angle, !!  (where ! !"# ! !
!! !"# !
!), and the critical angle, !! (where ! !"# !! ! !!): 
 !!"#$%#& ! !
!
!
! !"#!
!
!!! !"#!
! !"#!!!!! !"#!
!
!
!
!
! !"#!!!! !"#!
!
! !"#!!!! !"#!
!
!
! ! ! ! ! !!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !! ! ! ! !!!
 [28] 
After some manipulation we find [67]: 
 !!" ! !!"#$%#& ! ! ! !! ! !!
!
!!!
!!"# ! !"!#
!!
!
! !!
!
!
! !!
!!
!
, [29] 
Here !! is the magnitude of the photon flux in the !-direction, and !! and !! are defined 
as: 
 !! ! ! !"# ! !"# ! !!"#$%#& ! !"
!!!
!
, [30] 
 !! ! ! !"# ! !"#
!
! !!"#$%#& ! !"
!!!
!
. [31] 
Values for !!  and !!  for various index of refraction mismatches may be found in 
Haskell’s 1994 paper [67].   
As discussed in the perfectly transmitting boundary case, the inward radiance at 
the boundary can also be expressed as (see Equation 22): 
 !!"!! ! !! !! !
! !!!!!
!
!
!!!!!!!!!
!
. [32] 
Thus, by setting the two equations for the irradiance at the boundary (Equations 32 and 
27) equal to each other, we arrive at a “modified” partial-current boundary condition for 
the more realistic case of a reflecting boundary:  
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  ! ! !!
!!!!
!!!!
!!. [33] 
This boundary condition is often rewritten as: 
 ! !
!
!
!!!!""
!!!!""
!!"
!"
!"
. [34] 
Here !!""  represents the fraction of outward radiance (i.e., emittance, !!"#$$) that is 
reflected back into the medium, i.e., !!""#$ ! !!""!!"#$$ , and it is defined as !!"" !
!!! ! !!! !! ! !! ! !!!.  For a tissue/air boundary, !!"" ! !!!"# [67].   
As discussed for the perfectly transmitting boundary, the exact solution to the 
photon diffusion given the partial-current boundary condition and embedded isotropic 
source approximation is quite complex and involves an improper integral.  However, a 
good approximation of the partial-current boundary condition is the extrapolated-zero 
boundary condition, where the fluence falls to zero at ! ! !!.  To determine the location 
of !!, a Taylor series expansion of the fluence rate ! !  at ! ! ! is used: 
 ! ! ! !! ! ! ! ! ! !
!"
!" !!!
!!! ! !! ! !. [35] 
Plugging in Equation 23 for ! ! ! ! , we find that the fluence falls to zero at !! !
!
!
!!!!""
!!!!""
!!".  Again, the principle of image sources, as in simple electrostatics, provides a 
means to extract solutions in which the fluence rate will fall to zero outside the medium 
at ! ! !!.  To satisfy this extrapolated zero boundary condition, an image source of 
equal magnitude but opposite sign is placed at a distance !!!!! ! !!"! from the origin. 
Then the homogeneous semi-infinite medium solution within the extrapolated zero 
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boundary approximation is the sum of the infinite medium point source and its image 
source:  
 ! !! ! !
!!!
!!"
!
!!!!!
!!
!
!
!!!!!
!!
!
!!!"
!!"
!
!"!!
!!
!
!
!"!!
!!
!
!!!, [36] 
where !! ! !
! ! !! ! !!"!
! is the distance to the source from the detector located at !, 
!! ! !
! ! !! ! !!" ! !!!!
!  is the distance to the image source from the detector, 
!! ! !!! ! !!""! !!!
! !! ! !!""!, !! ! !!!!!
! , and !! ! !!!! ! !"! !.   
Finally, I would like to point out that the quantity we measure in experimental 
practice is the integral of the radiance !!!! !! !! over the numerical aperature of the 
detection fiber: 
 !"#"$#"%!!"#$%& ! !"!# !!"#$%#&!!!! !! !! ! ! !! !! ! ! ! ! !", [37]   
 ! !"!# !!"#$%#&!!!
!
!!
! !! ! ! !
!
!!
!!!! !! ! ! ! ! ! !". [38]   
Thus, the detected signal has contributions from both the photon fluence rate and 
photon flux.  However, since these two quantities, i.e., fluence rate and flux, are 
proportional at the boundary (required by the boundary condition), the detected signal is 
also proportional to either the fluence rate or the flux [67] with different proportionality 
constants.  Thus, determination of ! !! !  gives detected signals.   
2.1.4 Semi-Infinite Geometry in Experimental Practice  
Assuming the source and detector are placed in the same plane (see Figure 5), and the 
source-detector separation, ! , is large compared to the transport mean free path (i.e., 
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! ! !!" ), the distances to the source and image source can be approximated by 
! ! ! !
!
!!!"!!!
!  and ! ! ! !
!
!!" ! !!!
! , respectively.  Equation 36 can then be 
simplified to the following after some algebraic rearrangement and after expanding 
!
!"!!"
!
!!
! ! ! !"!!"
!
!! and!!!"!!!"!!!!!
!
!!
! ! ! !"!!!" ! !!!!
!
!!: 
 ! !! ! !
!!!
!!"
!
!!!!
!!
!!!!!!!!! ! !!
!! !
!!!
!!"
!
!"#
!!
!!!"!!!"!! ! !!
!! !!!!! [39] 
The AC component of! !  can be broken up into a real and imaginary component [79]:  
 ! ! !
!!!
!!"
!
!"#
!!
!!!" !!"!! ! !!
!
! !!!!!!"!!! , [40] 
where !!!! and ! !  are the amplitude and phase of the detected light [88, 89].  From 
this equation, we note the following linear relations:  
 !" ! ! !! ! !!!! ! !! , [41] 
 ! ! ! !!! ! !!. [42] 
 Thus, we can measure the amplitude attenuation and phase shift at multiple 
source-detector separations on the tissue surface, to extract the slopes, !!  and !! , 
respectively, of !"!!! ! !!! versus ! and ! versus !.  Rearranging the formulas for !! 
and !! to solve for !! and !!
!  of the sample, we find: 
 !! !
!
!!
!!
!!
!
!!
!!
! !!
!
!
!!
!!
!!!! . [43] 
Figure 5 demonstrates sample data taken on a solid silicon phantom with a 
frequency domain instrument operating at 110 MHz in a semi-infinite geometry.  The 
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source fiber was kept in place and the detector fiber was translated across the phantom 
in fixed increments.  Using the semi-infinite diffusion model, the optical properties of the 
phantom can be readily extracted (see Appendix 2.5 for more detailed experimental 
methods).  The calculated optical properties typically match with the expected properties 
of the phantom to within 10%. 
2.1.5 Differential Pathlength Method 
When multiple source-detector pairs are not an option for spectroscopy measurements, 
for example as a result of size limitations on the patient’s head or other instrumentation 
limitations (i.e., limited sources or detectors), then an alternative approach to data 
analysis is needed to derive information about chromophore concentrations and 
changes thereof.    
Although the Beer-Lambert law2 cannot be accurately applied to biological tissue 
                                                
2
The Beer-Lambert law provides a well-known means to measure the concentration of absorbers in optically thin, 
homogenous samples that do not scatter light: !"!
!
!!
! !!!!!  Here ! and !! are the intensities of the transmitted and 
incident light, respectively;!!! is the absorption coefficient of the sample, equal to the concentration of the absorbers 
 
Figure 5, Amplitude and phase data (solid circles) taken on a solid phantom (setup shown on 
left) emulating a semi-infinite homogeneous medium at 830nm and 5 source-detector 
separations ranging from 1.4 to 3.5 cm. The dotted lines indicate the best linear fit lines, and the 
extracted optical properties from these fits are listed in the title. 
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(due to the highly scattering nature of tissue), it turns out that a modified version of the 
Beer-Lambert law, dubbed the modified Beer-Lambert law (MBL) can be applied to 
turbid medium such as tissue [88, 90].  This modified approach accounts for the 
distribution of light pathlengths in the turbid sample caused by multiple light scattering, 
and it provides an approximate means to quantify changes in the concentration of the 
chromophores within a highly scattering medium.  
The MBL is traditionally written as3 (see detailed derivation in Appendix 2.6) 
 !"
!!" !!!!!
!!" !!!!!
! !!" !! !! ! ! !!!! !! ! !!!"" ! . [44] 
Here !!" !! !! !  is the DC intensity of the detected light at position !  and time ! , 
respectively; !!! !  is change in the absorption coefficient as a function of time 
compared to its value at ! ! !; and !!""!!! is called effective pathlength, a term that 
takes into account the increased optical pathlength photons travel on average caused by 
multiple light scattering.  !!""!!! is the mean optical pathlength a photon travels from 
source to detector; it depends on the source detector separation, the sample geometry, 
and the wavelength of light.  There are many ways to determine !!"" for a given sample 
geometry.  Experimental data [91], Monte Carlo simulations [91], and diffusion theory 
relationships [88, 90] all provide a means to determine !!"" !  For neonatal populations 
(the focus of this dissertation), population averaged values of !!""!!!  have been 
reported by several groups [75, 92-94].   
                                                                                                                                            
within the sample times the extinction coefficient of the absorber; and ! is the length the light travels.   
3
This equation is also written as !"
!!" !!!!!
!!" !!!!!
! !!" !! !! ! ! !!!! !! ! ! "# ! !!, where !!"" ! ! !"# ! !! and !"#!!! 
is known as the differential pathlength factor.   
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 The advantage in utilizing the modified Beer-Lambert law is that only a single 
source-detector separation is needed in ordered to quantify changes in the optical 
absorption coefficient over time.  However, several conditions must be met in order to 
employ the MBL for data analysis, i.e., changes in scattering are negligible, absorption 
changes are global, the tissue is homogenous, and absorption changes are small 
relative to their baseline values (!!!!!! !! !!!!! ! ! !! ! !).  Assuming these conditions 
are met, changes in the absorption coefficient at multiple wavelengths are calculated 
using: 
 !!! !! ! !
!
!!"" !
!"
!!" !!!!!
!!" !!!!!
. [45] 
2.2 Frequency Domain Instrumentation  
In frequency domain diffuse optical spectroscopy, a radio-frequency (RF) oscillator is 
typically employed to modulate the amplitude of a laser source sinusoidally in the ~100 
MHz range.  This modulated light, delivered to a sample via fiber optic cable, 
experiences both an amplitude attenuation and phase-shift in the medium.  The 
detection optics and electronics aim to quantify the amplitude attenuation (!) and phase 
shift (!) in order to reconstruct the optical properties of the sample.   
Amplitude attenuation is a relatively easy parameter to measure. Thus, the 
setups discussed herein are unique in their ability to detect phase shift.  Because the 
phase shift is highly dependent on the modulation frequency (see Figure 6), care must 
be taken when choosing an RF driving frequency.   Higher modulation frequencies yield 
a greater phase shift with varying source-detector separation, but also a smaller 
penetration depth.  For typical brain measurements of absolute optical properties, 
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separations of ! ! ! cm or greater are used, leading to an average phase shift of more 
than 20! at 70 MHz.  However, for animal studies or for shallow penetration depth 
studies in which smaller separations are used, higher frequency devices are better in 
order to maximize the phase shift over the separation range. 
There are two main phase detection schemes that will be discussed in this 
section. Homodyne detection detects amplitude and phase shift at the same RF carrier 
frequency, which drives the laser, whereas heterodyne detection converts the detected 
RF signal to a lower frequency before determination of phase shift.  Homodyne systems 
have the advantage of simplicity and lower costs, while heterodyne systems, although 
more complex, have greater phase shift accuracy.  These two techniques are discussed 
in depth in Chapter 4.   
 
Figure 6, Relationship between phase shift and modulation frequency for absorption and 
scattering properties similar to that of brain tissue.  Dotted vertical lines indicate the two 
frequencies employed in the instruments discussed in this dissertation, namely 70 and 110 
MHz.   
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2.3 Measured Parameters 
2.3.1 Chromophore Concentration 
As mentioned in Section 1.2.6, the absorption coefficient in brain tissue is mainly 
dominated by contributions from water, oxy- and deoxy-hemoglobin.  After quantifying 
concentrations of oxy- and deoxy-hemoglobin, !!"  and !!"!! , respectively, total 
hemoglobin concentration (!"] (!"# ! !!" ! !!"!!) and tissue oxygen saturation [%] 
(!"!! ! !!"!!!!"#!!""#) are easily obtained. !"# can, in turn, be related to cerebral 
blood volume [mL/100 g brain tissue] via the following formula, 
 !"# !
!"#!!"!"
!"# !!!!!!!!"
!
!
!!!"!!"#
!"#
, [46] 
where !"!" ! !!!"!!"
!
![g/moles] is the molecular weight of deoxy-hemoglobin, !"#  
[g/dL] is the large vessel deoxy-hemoglobin concentration (measured by arterial blood 
gas), ! is the large vessel-to-cerebral hematocrit ratio (0.69), and !!" is the density of 
brain tissue (1.05 g/mL in neonates) [95].  
2.3.2 Scattering 
Light scattering is caused by variations in refractive index.  The major scatterers in tissue 
are the organelles, cell nuclei, mitochondria, and red blood cells.  Assuming these 
scatterers are homogeneous, dielectric spheres with index of refraction !! and that they 
are surrounded by a medium with index of refraction !!, Mie theory can be used to 
approximate the wavelength dependence of the reduced scattering coefficient (provided 
that the light incident on each scatterer is a plane wave) [96, 97].  Although these 
assumptions are not exact for biological tissue given the wide distribution of scatterer 
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sizes (ranging from fractions of a micron to tens of microns in diameter), experimental 
measurements demonstrate that the scattering coefficient in tissue is reasonably well 
approximated by the following power-law wavelength dependence: 
 !!
! !!! ! !!!!. [47] 
Here ! is called the scattering prefactor, which is proportional to the density of the 
scattering centers and their size (! ! !!!, where N is the number density of scatterers 
and !! is the cross-sectional area of the scatterers).  The scattering power, !, depends 
on the scatterers’ size [97, 98]. Therefore, measurements of !!
!  at multiple optical 
wavelengths enable us to extract the scattering parameters !!and !  and thus gain 
insight into tissue morphology. 
2.4 DOS Summary 
This chapter summarizes the theory behind diffuse optical spectroscopy for use in 
neonatal cerebral monitoring.  In a highly scattering medium such as brain tissue, photon 
migration is modeled as a diffusive process.  The theoretical predictions provide a 
means to extract the absorption and reduced scattering coefficients of the tissue.    
2.5 APPENDIX: Calibration for Absolute Optical Properties 
In practice, translation of the source and/or detector fibers to yield multiple source-
detector separations is not practical.  The experimental probes usually consist of multiple 
source and/or detector fibers that are positioned at varying separations.  This 
configuration introduces some practical problems that must be dealt with if one desires 
high quality data.  Specifically, variations in fiber transmission and detector efficiency 
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(and also laser intensity for multi-spectral measurements) must be calibrated in order to 
generate accurate fluence rates at multiple source-detector separations.  Thus, we 
define!!! as the coupling coefficient for the !
!! source, and !! as the coupling coefficient 
for the !!! detector. Thus, the measured fluence rate at detector ! arising from source !, 
!!", is defined as 
 !!"
!"#$
! ! !! ! !! ! !
!!!"#!!!"! !!! [48] 
Here !!!!"#!!!" ! !! is the theoretical fluence rate at !!" , the distance between the !
!! 
source and !!! detector.  Note that the coupling coefficients are complex numbers that 
account for both an amplitude and phase correction to the measured fluence rate, i.e., 
!! ! ! !!
!
!
!!
!
!
 and !! ! ! !!
!
!
!!!
!
.  We further expand Equation 48 into amplitude and 
phase:  
 !!"
!"#$
! ! !!
!
! !!
!
! !
!!!"#
!!"! ! ! !!!!"
!"#$
! ! !
!
!
! ! !!
!
! ! !
!!!"#!!!"! !![49] 
Here we have assumed the measured and theoretical fluence rate are complex numbers 
with amplitude and phase, i.e., !!"
!"#$
! ! !!"
!"#$
! !
!!"
!"#$
!  and !!!!"# !!"! ! !
!
!!!"#
!!"! ! !
!
!!!"#!!!"!!!! 
To determine these source and detector coupling coefficients ( !!  and !! , 
respectively), a phantom with known optical properties is employed.  These coefficients 
may then be applied to all subsequent measurements on phantoms/tissue in order to 
extract the unknown optical properties, !! and !!
! .  This technique is susceptible to errors 
from the differences in the probe/phantom interface as compared to the tissue/probe 
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interface.  However, it has been shown to produce repeatable and accurate results [99, 
100].  
To demonstrate the calibration procedure, measurements were made on a 
phantom with known optical properties ( !! !""!" ! !!!"#!!"
!! , !!! !"!!" !
!!!"!!!!
!! , !! !"#!" ! !!!""!!"
!! , and !!
!
!""!" ! !!! , !!!
!
!"!!" ! !!!!!"
!! , 
!!
!
!"#!" ! !!!!!"
!! ) using an optical probe with one detector and four sources, 
where three light wavelengths are sent to each of the four sources (see Figure 7).  The 
semi-infinite solution to the diffusion approximation with these optical properties predicts 
that !"!!! !! ! !!! and !!!! !! will be linear functions with respect to r (see Section 2.1.3), 
and that the slopes of !"!!! !! ! !!! and !!!! !! versus !, i.e., !! and !!, are related to 
!! !  and !!
! !!!.  The theoretical prediction of amplitude and phase are indicated by 
dotted lines in Figure 7.  The variations in fiber transmission and detector efficiency (and 
also laser intensity), and hence the need for calibration, are evident from this figure, as 
the raw data (shown in solid circles) does not fall on the predicted lines.  
 
Figure 7, Amplitude and phase data taken on a solid phantom with known optical properties at 
multiple wavelengths and multiple source-detector separations.  Solid points show raw data, while 
open circles show data calibrated to match the expected values (dotted lines).  These calibration 
factors are then applied to all subsequent data. 
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Thus, we can compute the source and detector coupling coefficients (!! and !!, 
respectively) from the measured amplitude and phase (!!"
!"#$
!  and !!"
!"#$!!!) and the 
predicted amplitude and phase for the given optical properties of the phantom 
(!!!!"#!!!" ! !! and !
!!!"#!!!" ! !!) using Equations 48 and 49:   
  !!
!
! !!
!
! ! !!!
!"#$
! !
!!!"#!!!!! !! !!!!!!
!
! ! !
!
!
! ! !!!
!"#$
! ! !
!!!"#!!!!! !![50] 
 !!
!
! !!
!
! ! !!"
!"#$
! !
!!!"#!!!"! !! !!!!!!
!
! ! !
!
!
! ! !!"
!"#$
! ! !
!!!"#!!!"! !![51] 
 !!
!
! !!
!
! ! !!"
!"#$
! !
!!!"#!!!"! !! !!!!!!
!
! ! !
!
!
! ! !!"
!"#$
! ! !
!!!"#!!!"! !![52] 
 !!
!
! !!
!
! ! !!"
!"#$
! !
!!!"#!!!"! !! !!!!!!
!
! ! !
!
!
! ! !!"
!"#$
! ! !
!!!"#
!!"! ! ![53] 
Once these coupling coefficients are determined, measurements can be made on other 
samples (with unknown optical properties), and raw amplitude and phase data from 
these samples can be corrected for source and detector coupling coefficients using the 
following formulas: 
 !!! ! ! !!!
!"#$
! !!
!
! !!
!
! !!!!!!! ! ! !!!
!"#$
! ! !!
!
!
! ! !
!
!
! ! [54] 
 !!" ! ! !!"
!"#$
! !!
!
! !!
!
! !!!!!!" ! ! !!"
!"#$
! ! !!
!
!
! ! !
!
!
! ! [55] 
 !!" ! ! !!"
!"#$
! !!
!
! !!
!
! !!!!!!" ! ! !!"
!"#$
! ! !!
!
!
! ! !
!
!
! ! [56] 
 !!" ! ! !!"
!!"#
! !!
!
! !!
!
! !!!!!!" ! ! !!"
!"#$
! ! !!
!
!
! ! !
!
!
! !! [57] 
2.6 APPENDIX: Modified Beer-Lambert Law Derivation 
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The modified Beer-Lambert law (MBL) starts with the realization that the optical density 
(OD), defined as !"#!!!!, where ! is the reflectance (! ! ! !!), is a function of !!, !!
! , 
and !.  We assume that changes in the optical density over time are solely due to 
changes in !! and !!
! : 
 !!" !! ! !!
! ! !! ! ! !" !! !! ! ! ! ! !!! !! ! ! !!
!
!! ! ! ! ! !!!
!
!! ! ! !  
!!"!!!!!! ! ! !!! !!
!
!!!! ! ! !!! !!! [58] 
Using a Taylor series expansion, i.e., ! ! ! !" ! ! ! ! !! ! !" ! !!!!!! !! !!" !!, 
!" !! !! ! ! ! ! !!! !! ! ! !!
!
!! ! ! ! ! !!!
!
!! ! ! !  is expressed as: 
!" !! !! ! ! ! ! !!! !! ! ! !!
!
!! ! ! ! ! !!!
!
!! ! ! ! ! !" !! !! ! ! ! ! !!
!
!! ! !
! ! ! !
!!" !! !!!!! ! !
!
!!!!! !!
!!!
!!! !
!!" !! !!!!! ! !
!
!!!!! !!
!!!
!
!!!
!
!
!
!!
!
!
!" !! !!!!! ! !
!
!!!!! !!
!!!
!
!!!!!
!
!
!
!!
!
!
!" !! !!!!! ! !
!
!!!!! !!
!!!
!
! !!!!
! !! !
!
!!
!
!
!" !! !!!!! ! !
!
!!!!! !!
!!!!!!
!
!!!!!!
!
!!! [59] 
The modified Beer-Lambert law (MBL) approximates !!" !! ! !!
! ! !! !  with only the first 
order terms of this expansion, i.e. 
 !!" !! ! !!
! ! !! ! !
!!" !! !!!!! ! !
!
!!!!! !!
!!!
!!! !
!!" !! !!!!! ! !
!
!!!!! !!
!!!
!
!!!
!  [60] 
In most clinical experiments, it is assumed that the absorption changes are global and 
homogenous so that !!!!!! ! !!! !!!!!!!.   
As discussed in Section 2.1.5, the MBL is formulated in terms of an effective 
 42
pathlength (!!"" ) that photons travel on average before arriving at the detector as 
!!" !! ! !!
! ! !! ! ! !!!""!!!! .  !!""  depends on the source detector separation, ! , 
sample geometry, and the wavelength of light.  There are many ways to determine !!"" 
for a given sample geometry.  Experimental data [75, 90], Monte Carlo simulations [101], 
and diffusion theory relationships [90] all provide a means to determine !!"" !   
To solve for !!"" analytically, we note that Equation 60 relates !!"" to the partial 
derivative of the optical density, i.e., !!"" ! !!"#!!! !! ! ! !! ! !!!! .  This partial 
derivative can also be written in terms of a Green’s function, !!!!!! , for a given 
geometry [90]:  
 !!"" ! !
!!"
!!!
!
!
!
!"
!!!
!
!
!!!! !
! !!!! !
!!!
,   
 !!"" ! !
!
!!!! !
! !!!! !
!"
!"
!!!
.  [61] 
Here vertical lines indicate the magnitude of the Green’s function, !!is the wave vector 
(! ! !!!! ! !"! !), and !!!!!! satisfies the equation, 
 !! ! !! ! !!! ! !!!!!, [62] 
for the geometry of interest [68].   
For the case of CW light, i.e., ! ! !, with a semi-infinite geometry given the 
extrapolated zero boundary condition, the Green’s function solution is real, i.e., 
!!!!! ! !! ! !!!!! ! !!, and it is written as: 
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 ! !!! ! ! !
!
!!
!
!!!!!
!!
!
!
!!!!!
!!
, [63] 
Thus, after some algebraic manipulation, we can write the following expression for !!"" 
in terms of the baseline optical properties !!, and !!
! , and source detector separation: 
 !!"" !
!
!!!! !
! !!!! !
!"
!"
!!!
!
!!!
!
!!!!
!!!
!
!!!!!!!
!!!!!
!!!
!!!!!!!!!
!!!!!
.  [64] 
Fantini et al [88] have shown that in the limit that ! ! !!", !!"" can be simplified to:  
 !!"" !
!!!
!
!
!
! !!!!!
. [65] 
Thus, for CW light incident on brain tissue (here I am assuming typical brain optical 
properties of !! ! !!!!"
!! and !!
!
! !"!"
!!) with an optode spacing of ! ! !!!!!", the 
effective optical pathlength is !!"!! cm. 
 When the incident light is modulated at frequency ! , the Green’s function 
solution for the semi-infinite geometry given the extrapolated boundary condition is: 
 ! !!! !
!
!!
!
!"!!
!!
!
!
!"!!
!!
, [66] 
In order to write this the magnitude of ! !!! , I break up ! !!!  into its real and 
imaginary components (using the definition of the complex wave vector: ! ! !! ! !!!, 
see Section 2.1.2), i.e., ! !!! ! ! ! !": 
 ! !!! !
!
!!
!"#!!!!!!!
!!
!
!!!!! !
!"#!!!!!!!
!!
!
!!!!! !
!
!!
!"#!!!!!!
!!
!
!!!!! !
!"#!!!!!!!
!!
!
!!!!! ,[67] 
The magnitude of ! !!! , i.e., ! !!! ! !! ! !! is written explicitly as: 
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! !!! !
!
!!
!"#!!!!!!!
!!
!!!!!! !
!"#!!!!!!!
!!
!!!!!!
!
!
!"#!!!!!!
!!
!!!!!! !
!"#!!!!!!!
!!
!!!!!!
!
,
  
 !
!
!!
!
!!!!!!
!!
!
!
!
!!!!!!
!!
!
! !
!
!!! !!!!!
!!!!
!"#!!!! !! ! !! !, [68] 
Thus the expression for !!"" in the frequency domain becomes:  
 !!"" !
!
!!
!"
!!!
,  [69] 
where ! is the term under the square root in ! !!! , i.e., 
  ! !
!
!!!!!!
!!
!
!
!
!!!!!!
!!
!
! !
!
!!! !!!!!
!!!!
!"#!!!! !! ! !! !.  [70] 
Although the expression for !!"" in the frequency domain is quite messy, nonetheless it 
is still solvable.  
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3 Diffuse Correlation Spectroscopy  
While the previous chapter focused on the use of diffusing photons to extract the 
absorption and scattering properties of biological tissue, this chapter discusses how to 
use diffusing photons to probe the dynamical properties of deep (> 1 cm below the 
tissue surface) tissue.  To study tissue dynamics, we employ a technique dubbed in the 
biomedical optics community as diffuse correlation spectroscopy (DCS) [68, 102, 103]; 
the method has its origin in soft condensed matter research wherein it is known as 
diffusing wave spectroscopy (DWS) [104, 105].   
In DCS, coherent near-infrared light is injected into a highly scattering medium, 
such as tissue, wherein it travels deeply and scatters multiple times before detection at 
some distance from the light source. The electric field at a single point on the tissue 
surface is built from a superposition of multiply-scattered light fields that have traveled 
along different paths from the light source.  These fields will constructively or 
destructively interfere to form bright or dark (i.e., high or low intensity) spots, or speckles, 
on the tissue surface.  If the tissue scatterers are motionless and the light source is 
perfectly coherent, then the intensity of light at the spot will not change over time.  
However, in in-vivo tissue experiments, although the light source is well-approximated as 
being perfectly coherent, some of the scattering particles (e.g., red blood cells) are 
moving.  This motion changes the phases of the multiply-scattered light fields traveling 
from source to detector, which, in turn, causes the intensity of the speckle to change 
over time.  
Thus, intensity fluctuations of the speckles at the tissue surface contain 
information about the motion of the scatterers within tissue [69].  Faster fluctuations (i.e., 
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more rapid decay of the intensity temporal autocorrelation function) are indicative of 
faster motion of the scatterers.  In the case of tissue, although many kinds of scatterers 
move, it is the motion of the red blood cells that contributes dominantly to the 
fluctuations in observed speckle intensity [68, 102, 103, 106].  Therefore, by 
characterizing the fluctuations of speckle intensity over time, we can gather information 
about blood flow in tissue.  
In order to monitor speckle fluctuations in time, we measure the normalized 
intensity autocorrelation function of the multiply-scattered light, !! !! ! ! !!!! !!!!!! ! !
!! ! !!!! !! !.  Here ! !! ! ! !!!! !! ! is the intensity at time ! and detector position !, 
and !" denotes the ensemble average (approximated by a time average for the data 
presented herein).  The more rapidly the intensity fluctuates in time, the faster the 
intensity will become uncorrelated, which is analogous to a faster decay in the temporal 
intensity autocorrelation function.  The details of the DCS experimental setup and 
instrumentation are found in Chapter 4.  
Figure 8 demonstrates experimental DCS data obtained from the head of a 
neonate with a congenital heart defect during a simple hypercapnia intervention.  Source 
and detector fibers were positioned 2.5 cm apart on the patient’s forehead.  A 
normalized intensity autocorrelation curve, !!!!!, obtained during a baseline period of 
room air inhalation is plotted versus lag time, !, in black.  CO2 is known to be a potent 
cerebrovascular vasodilator causing significant increases in cerebral blood flow (see 
Sections 5.1 and 6.4.2).  Notice, when the patient inhaled the CO2 gas mixture, the 
decay time of !!!!! decreased substantially, indicating an increase in cerebral blood flow.  
Figure 8 clearly demonstrates that blood flow has an effect on the decay rate of the 
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intensity autocorrelation function.  However, to quantitatively model the effect of blood 
flow, we need to employ correlation transport theory for the temporal electric field 
autocorrelation function.   
3.1 Correlation Diffusion Equation 
Ackerson et al [107] first suggested that the un-normalized electric field temporal 
autocorrelation function, !! !! ! ! !!!! !!!
!!!! ! ! !! , should obey a correlation 
transfer equation based on modifications of the radiation transport equation (RTE).  
Recall that the RTE describes the conservation of light radiance.  Here !!!! !! is the light 
electric field at time !  and position ! , and !" denotes the ensemble average 
(approximated by a time average for the data presented herein).  As was the case for 
the RTE, the correlation transfer equation can be further reduced to a correlation 
diffusion equation after several assumptions are made [68, 69, 102, 103].   
For an optically homogeneous, dynamic, turbid medium, the correlation diffusion 
equation that governs the behavior of the un-normalized electric field autocorrelation 
 
Figure 8, Sample intensity autocorrelation curves measured with DCS on a neonate with 
hypoplastic left heart syndrome. The black “Room Air” curve, taken on the patient’s forehead 
during room air inhalation, decays slower than the grey “Hypercapnia” curve obtained while the 
patient inhaled a CO2 gas mixture. The increased decay rate of the correlation curve during 
hypercapnia indicates an increase in cerebral blood flow. 
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function is [102, 103]: 
 !!! ! !!! !
!
!
!!!
!
!!
!
!!
!
! !! !! ! ! !!" ! !  [71] 
Here !! [cm
-1] and !!
!  [cm-1] are the tissue absorption and reduced scattering coefficients, 
respectively; ! ! ! !!!!
!
! !!!; ! is the speed of light in the tissue equal to the speed of 
light divided by the tissue index of refraction, !; !! [cm
-1] is the magnitude of the optical 
wave vector, !!"!! , and !  is the wavelength of incident light; !  represents the 
probability that a scattering event in the sample is off a moving scatterer; !!!!!!  [cm2] 
is the mean-squared displacement of the moving scatterers in time !.  The main moving 
scatterers in tissue detected by DCS are red blood cells.  Note that there is no explicit 
time-dependence (!) in Equation 71, which results from the assumptions that the light 
sources are CW and that the tissue dynamics are in a quasi-steady state, i.e., the 
scatterer dynamics are not changing over the time scale of the measurement.  Also, note 
that in the limit that ! approaches zero, we obtain the photon diffusion equation for a 
continuous wave light source.   
The derivation of Equation 71 and its corresponding assumptions have been 
described in depth elsewhere by [68, 69, 103].  Briefly, for Equation 71 to be accurate, 
photon propagation must be well-described as a diffusive process (i.e., the photon 
diffusion equation for the fluence rate should be valid), the correlation time ! must be 
much less than the time it takes for the scatterers to move the wavelength of light 
(!!
!
!!!"! ! ! ! ! ), and, importantly, the scatterer dynamics (i.e., !!"! ! ! ) must be 
isotropic.  In tissue, we assume that because the capillary network is so complex and 
convoluted, the distribution of directions for red blood cell propagation is approximately 
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uniform. Thus, the motion of blood cells in tissue can be approximated as being 
isotropic.  In larger arteries and veins, the isotropic dynamics assumption is likely 
violated, but because the high concentration of blood in these vessels strongly absorbs 
the light, most of the DCS signal will come from the capillaries, arterioles, and venules. 
Notice that the correlation diffusion equation has the same form as the 
frequency-domain photon diffusion equation.  Thus, the form of the solutions we found 
for the photon diffusion equation will be the same as for the correlation diffusion equation.  
In all studies presented in this dissertation, we assume a semi-infinite homogeneous 
medium with a tissue-air planar interface geometry in the plane ! ! !.  Additionally, we 
employ a CW point source of the form ! ! ! !!!!!! !! ! ! !!! and use the extrapolated-
zero boundary condition wherein !! ! ! !!! ! ! ! ! (see Chapter 2, Section 2.1.3).  The 
semi-infinite solution of !!!!! !! to the correlation diffusion equation given this boundary 
condition is obtained using the method of images [108]: 
 !! !! ! !
!!!
!
!!
!!
!
!! ! !!
!!
!
!
!! ! !!
!!
! [72] 
Here !! ! ! !!!
! !!! !
!
!
!!!
!
!!
!
!!
!!!! !; !! and !! [109] are the distances between the 
detector and the real-source/image-source, respectively, i.e., !! ! !!
!
! !
!
!  and 
!! ! !!
!
! !!! ! !!!!
!; !! ! !!!!
!  [109] is the depth at which a collimated source on the 
tissue surface can be approximated as a point source;!!! ! !!!"!!!
!   [109] in the case of 
refraction indices of tissue and air (equal to 1.4 and 1.0, respectively).  The parameters 
!!
!!!!  and ! are related to the dynamics of the tissue.  Thus, by fitting the measured 
!! !! !  for these parameters, we determine information about blood flow in tissue. 
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Before going further, we stress that our instrumentation measures the intensity 
temporal autocorrelation function, while the correlation diffusion equation applies to the 
electric field temporal autocorrelation function.  To compare theory with experiment, the 
intensity autocorrelation function must related to the normalized electric field temporal 
autocorrelation function, !! !! ! ! ! !! ! !
!!!! ! ! !! ! !!!! !! ! .  This connection is 
derived via the Siegert relation [110], !! !! ! ! ! ! ! !!!!! !!
!. Here ! is a constant that 
depends on the source coherence, detection optics, ambient light and other external 
factors.  ! is usually approximately !!!, where ! is the number of detected speckles (or 
modes) [69, 111].  Experimentally, we can determine !  from the intercept of the 
measured !!!!! !! as the delay time, !, approaches zero
4.   
The Siegert relation is valid if the electric field, !!!! !!, is a Gaussian distributed 
variable with zero mean [110, 112].  However, in tissue, some light arriving at the 
detector has only undergone static scattering.  Thus, strictly speaking, the Siegert 
relation cannot be perfectly valid [69, 103].  Some techniques are available for 
addressing this problem, but, practically speaking, the contribution of statically-scattered 
light is a small enough fraction of the detected light in our experiments so that the 
Siegert relation is approximately accurate.      
From many experimental observations of the intensity autocorrelation function on 
human subjects, we have found the mean squared displacement, !!!!!! , to be linearly 
proportional to the lag time, !, i.e., !!!!!!  behaves in a manner formally similar to the 
mean-squared displacement of a particle exhibiting Brownian motion [61, 62, 69, 102, 
                                                
4 In a typical experimental setup discussed within this dissertation, single mode detection fibers are used.  Single mode 
fibers allow transmission of two orthogonal polarization modes, thus ! !
!
!
! !!!. 
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103]. Thus, we define !!!!!!  to take the form of !!!! , where !!  is an effective 
Brownian diffusion coefficient.  Note that, in a typical experiment with a DCS probe on a 
human forehead, this effective diffusion coefficient is approximately two orders of 
magnitude greater than the traditional definition of the Brownian diffusion coefficient of a 
particle the size of a red blood cell in blood5 [68, 113].   
 In order to get a sense of how the absorption and scattering coefficients, source-
detector separation, and tissue dynamics (here we group ! and !! together to describe 
the tissue dynamics) affect the decay rate of the electric field autocorrelation function, I 
have varied each parameter independently and plotted the resultant !!!!! (see Figure 
9).  When varying one parameter, the other parameters were fixed to typical values for 
an adult human head, i.e., !!! ! !!!"
!! cm2/s, !! !"#!" ! !!! cm
-1, !!
!
!"#!" ! !" 
cm-1, ! ! !!! cm.   It is evident from this figure that the absorption coefficient, varied 
within a reasonable range, has little affect on the decay of !!!!!.  On the other hand, the 
reduced scattering coefficient, the source-detector separation, and the tissue dynamics 
have a profound affect on !! !  decay.  Higher values of the absorption coefficient 
cause !!!!! to decay a little slower, while higher values of !!!, !!
! , and ! cause the 
curve to decay faster.  Of course, the source-detector separation, !, is known to the 
experimenter and so causes minimal error.  Sometimes, !!
!  is also known to the 
experimenter from independent DOS measurements. 
3.2 Previous validation studies  
                                                
5
 To get an idea of the magnitude of the !! for a red blood cell, I consider a red blood cell in water at room temperature 
and employ the Einstein-Stokes equation, !! ! !!! !!"#.  For simplicity, I assume the red blood cell is a perfect sphere 
of radius 5 µm and that the viscosity of water at 293 K (20°C) is !!!"!! kg/m/s, thus !! ! !!!!!"
!!" cm
2
/s.  
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For a given source detector separation and fixed absorption and scattering coefficient, 
the decay rate of the autocorrelation function is dictated by the tissue dynamics, i.e., 
blood flow in tissue.  Thus, we define a blood flow index, !"# ! !!!, with units of cm
2/s, 
to quantify this decay rate. BFI reflects CBF, and changes in BFI relative to baseline 
measurements (i.e., rBFI) reflect analogous changes in CBF (i.e., rCBF) [114]. Although 
this data analysis approach is empirical, numerous studies have validated it as a 
measure of relative blood flow.  These studies and their findings are summarized in 
Table 2.  This dissertation highlights two validation studies conducted  on pediatric 
populations in Sections 5.1 and 5.2.   
3.3  Summary 
A B  
C D  
Figure 9, Dependence of the normalized electric field autocorrelation function, !!!!! on (A) 
!!!, (B) !!, (C) !!
! , and (D) source-detector separation, !.  When varying one parameter, the 
other parameters were fixed to typical values for an adult human head, i.e. !!! ! !!!"
!! 
cm
2
/s, !!!!"#!"! ! !!! cm
-1
, !!
! !!"#!"! ! !" cm
-1
, ! ! !!! cm.    
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DCS detects changes in blood flow directly by monitoring temporal fluctuations of 
scattered light. It does not rely on tracers to indirectly infer information about CBF, and it 
can be employed continuously to provide information about microvascular 
hemodynamics. DCS continuously monitors relative changes in microvascular CBF as 
opposed to DOS that monitors cerebral blood oxygen saturation and volume.  
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4 Hybrid DOS/DCS Instrumentation 
A hybrid DOS/DCS instrument has been designed in our laboratory for translation to the 
clinic [61, 111, 115].  I have worked on its construction and maintenance: I have also 
worked in a similar fashion on two other hybrid DOS/DCS instruments developed in our 
laboratory.  This chapter describes these instruments.  I will refer to these instruments, 
respectively, as the homodyne, heterodyne, and ISS devices.  A subsection of detailed 
description is devoted to each instrument.   
4.1 Homodyne Hybrid Device 
The homodyne instrument consists of a homodyne detection DOS device 
combined with a DCS module.  In the DOS homodyne detection scheme, as seen in 
Figure 10, phase-shifted light is detected and the resulting electronic signal is amplified 
and sent to the RF input of an in-phase/in-quadrature (IQ) demodulator.  The IQ 
demodulator is the heart of a homodyne instrument.  The outputs of the IQ demodulator, 
 
Figure 10, Illustration of a typical homodyne detection scheme used to extract ! and !, the 
amplitude attenuation and phase shift of light obtained after passing through a highly scattering 
medium. Abbreviations: NIR = Near-Infrared, LPF = low pass filter, RF = radio frequency, IQ = 
In-Phase/In-Quadrature, A/D = Analog-to-Digital. 
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after passing through a low pass filter (LPF), are the sine and cosine components of the 
signal amplitude, which can be used to derived the amplitude attenuation (!) and phase 
shift (! ) of the detected signal, i.e., ! ! !! ! !!  and ! ! !"#!!!! !!  (see Section 
2.1.3).  The ! and ! signals are sent to an analog-to-digital converter for transmission to 
a computer.   
A schematic of the front panel of the home-made instrument is shown in Figure 
11.  The components are mounted within a 19” rack-mount cart (Hammond 
Manufacturing, Ltd).  Each individual DOS component, except for the Analog-to-Digital 
converter, is stored in a Nuclear Instrumentation (NIM) bin (Mech-tronics), shown by 
white rectangles in the figure.  These bins provide a means for easily supplying power to 
each box (module), and they provide excellent shielding from electromagnetic noise.  
      
Figure 11, (Left) Front panel of the homodyne instrument consisting of both DOS and DCS 
modules. (Right) Wiring schematic of the DOS module of the homodyne instrument.  
Abbreviations: DCS = diffuse correlation spectroscopy, ADC = Analog-to-Digital converter, Atten 
= Electronic Attenuators, APD = Avalanche photodiode, PMT = Photomultiplier tube, Amp = 
Amplifier, LPF = low pass filter, RF = radio frequency, IQ = In-Phase/In-Quadrature. 
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The instrument is bulky, but it is, nevertheless, portable and robust for patient 
measurements in the clinic.   
 A schematic of the DOS module is shown on the right of Figure 11.  The DOS 
module consists of three diode lasers, two optical switches, and 4 optical detectors with 
corresponding detection electronics.  The 1x4 switch (FSM-14, Piezosystem Jena Inc) is 
used to alternate between light source wavelengths sent to the tissue (3 switch inputs for 
the 3 DOS diode lasers, plus an additional input for the DCS laser), while the 1x9 switch 
(FSM-19, Piezosystem Jena, Inc.) is used to send light to up to 9 different spatial 
positions on the optical probe(s).  On the detection side are two large diameter 
avalanche photodiodes (APDs) and two photomultiplier tubes (PMTs).  The electronic 
output of these detectors is amplified and then sent to an I/Q demodulator.  Detailed 
specifications of major instrument components are described below.  
Laser Diode Sources 
 The homodyne DOS module consists of three pigtail coupled diode lasers from OZ 
Optics that operate at 685 nm (ML1413R, Mitsubishi Electric), 785 nm (DL-4140-001S, 
Sanyo Electric Co., Ltd.), and 830 nm (DL-8032-001, Sanyo Electric Co., Ltd.), 
respectively.  These diodes are driven using either homemade [116] or commercial 
drivers (LD-1100, Thorlabs), depending on their type.   
A high-power (17dBm) sinusoidal radio-frequency (RF) oscillator (VSA-70009, 
Wilmanco) amplitude modulates the lasers at 70.009 MHz.  This oscillator is stable 
within !0.003% over a very wide temperature range.  The RF oscillator signal voltage is 
combined with the DC driving component that drives the laser in continuous wave (CW) 
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mode; combination is accomplished using a bias-tee from Minicircuits (ZFBT-4R2G+).   
For optimal detection of this modulated laser light, long-term stability and high 
modulation-depth is required.  To test modulation depth, a PIN diode enables easy 
conversion of an optical signal to an electronic one that is viewable on an oscilloscope. 
The modulation-depth, !!"# , is defined as !!"# !
!!!!!
!!"#
!!""#  where !!!  is the 
peak-to-peak voltage, and !!"# is the DC mean of the modulated laser light signal.  By 
manipulation of the DC operating current of the driver and manipulation of the strength of 
the RF modulation, one may obtain a desired !!"#  of close to 100% while still 
optimizing output CW power.  Typically, these lasers operate at an average power that is 
approximately one-half to one-quarter of the company specified CW power.  Power 
output ranges from 10 to 40 mW.     
Optical Switch 
The 1x4 and 1x9 multimode optical switches from Piezosystems Jena Inc have a fast 
switching time (!! ms) and low insertion loss (!!!! dB).  These switches are coupled to 
optical fibers with core diameter of 200/220 !m.  The switches can be controlled 
electronically with four 5 V TTL signals.   
Detectors 
The homodyne DOS module consists of four detectors, 2 APDs and 2 PMTs.  The APDs 
(C5331, Hamamatsu Photonics) have a 1.5 mm active area and come packaged with a 
high-speed/high-sensitivity current-to-voltage amplifier circuit.  They were chosen for 
their high photo-sensitivity in the NIR (i.e., greater than 0.5 A/W in the wavelengths we 
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are interested in) and for their ability to operate with high efficiency at 70 MHz. 
In the low photon count detection limit (in the NIR), two R928 photomultiplier 
tubes with extended red sensitivity from Hamamatsu Corporation were chosen.  This 
detector features a quantum efficiency (i.e., the number of electrons produced per 
photon detected) of 1 to 7% in the wavelength range of interest (680-830nm) and a 
photosensitivity of ~0.02 A/W.  Additionally, it features a very low noise equivalent power 
of 1.3!!"!!" W (i.e., the amount of light required to produce a signal-to-noise ratio of 
unity).  For these reasons, as well as cost, this PMT appears to be the detector of choice 
in NIR DOS systems [77, 117]. 
Detection Electronics 
The PMT and APD output is an electronic signal proportional to the incoming optical 
signal.  This electronic signal is bandpass filtered at 70 MHz with a pass band of plus or 
minus 7 MHz (Minicircuits SBP-70), amplified 24 dB (ZFL-500LN, MiniCircuits), and then 
amplified 19 dB (ZFL-500HLN, Minicircuits) again (amplification in series reduces noise), 
before passing to the I/Q demodulator.  As mentioned previously, the I/Q demodulator is 
the heart of the homodyne device.  It extracts the variations in amplitude and phase of 
the detected signal using a local oscillator reference.  The model we used in our 
instruments (ZFMIQ-70D, Mini-Circuits) consists of a 90! splitter, two double balanced 
mixers, and a 0! splitter/combiner as seen in Figure 12 designed to work optimally at 70 
MHz.  With local oscillator (LO) and detected signal (RF) as inputs (both driven at carrier 
frequency !) the outputs !  and !  contain (among other things) the sine and cosine 
components of the complex RF signal.   To extract amplitude and phase of this RF 
signal, ! and ! are both fed to a low-pass filter (SLP-30, MiniCircuits) in order to remove 
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the !!  frequency component.  After filtering the !  and !  signals, the amplitude 
attenuation and phase shift of the detected light are obtained using ! ! !! ! !! and 
! ! !"#
!!!! !!.   
Analog-to-Digital Converter 
After low-pass filtering, the ! and ! signals from each detector are sent to an analog-to-
digital converter (ADC) for read-in by a computer.  A 16-bit ADC from National 
Instruments, model NI-USB-6251, was chosen for this purpose due to its fast sampling 
rate, large number (8) of analog inputs, and USB communication with the computer.  At 
the ADC input, additional 100 Hz low-pass filters were inserted for further noise rejection 
(Figure 13).   
 
Figure 12, Schematic diagram of an I/Q demodulator for use in homodyne detection.  Inputs, 
LO and RF, come from the oscillator and detected signal, respectively.  The outputs, ! and 
!, can be combined to extract the amplitude attenuation, A, and phase shift,!!, of the 
detected signal.  
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DCS Module 
The DCS module (seen in Figure 14 and detailed in Figure 15) consists of two long-
coherence-length lasers with optical isolators (CrystaLaser, RCL785S-100-SO) 
operating at 785 nm to deliver light to the tissue.  The coherence length of the lasers (> 
50 m) is chosen to be much greater than the mean pathlength a photon travels before 
detection (on the order of 10 centimeters for neonates) [75, 118].  Additionally, the 
wavelength of 785 nm was chosen for its availability, as well as its proximity to the 
isosbestic point around 800 nm, i.e., where the absorption spectra of oxy- and deoxy-
hemoglobin intersect (see Figure 1).  This light can either be switched on/off with a TTL 
 
Figure 13, ~100 Hz low pass filter designed for the ADC board input. 
 
 
Figure 14, Photograph of the DCS module containing an eight-channel detector array.   
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signal directly coupled to the laser, or it can remain on and be turned on/off by the 1x4 
color optical switch in the DOS module.    
DCS light is detected using up to eight single mode fibers sent to two 4-channel 
arrays of fast photon counting silicon avalanche photodiodes (SPCM-AQ4C, Perkin-
Elmer, Canada).  These detectors were chosen for their ability to detect single photons 
with approximately 50% photon detection efficiency within the NIR wavelength we 
employ (785 nm).   They have a low dark count rate of 500 counts/sec (i.e., low for 
APDs), as well as the capability of detecting up to 2 Megacounts/sec per channel; they 
are powered by three DC power supplies (operating at +2V, +5V and +30V, (Part 
numbers: LPT81 Astec, DMS-PS1-CM Murata/Datel, HSB28-1.0 Lambda, respectively). 
The detectors output a 25 ns TTL pulse for each detected photon via an SPCM-AQ4C-
IO module with convenient BNC connector outputs.  The TTL pulses are transmitted to 
two custom-built 4-channel multi-tau correlator boards (FLEX03OEM-8CH, 
correlator.com, Bridgewater, NJ) that derive the intensity autocorrelation function based 
 
Figure 15, Interior of DCS flow box. 
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on the photon arrival times [111, 115, 119].  The intensity autocorrelation function is then 
transmitted to a computer via a USB 2.0 port.  Updated data from the correlator is 
transmitted every 47 ms.   
4.2 Heterodyne Hybrid Device 
The heterodyne hybrid instrument consists of a heterodyne detection DOS device 
combined with a DCS module.  A schematic of the front panel of the instrument is shown 
in Figure 16 (left).  This instrument is much smaller than the homodyne instrument and 
has been mounted on a more portable cart (Convoi, Anthro Corporation).   As was the 
case with the homodyne instrument, the DOS components of the heterodyne system are 
mounted within a 19” rack-mount cart and stored in NIM-bins for RF isolation. The DCS 
module in the heterodyne instrument is identical to the DCS module in the homodyne 
instrument (see Section 4.1).  The remainder of this section will discuss the intricacies of 
 
Figure 16, (Left) Front panel of the heterodyne instrument consisting of both DOS and DCS 
modules. (Right) Wiring schematic of the DOS module of the heterodyne instrument.  
Abbreviations: DCS = diffuse correlation spectroscopy, PMT = photomultiplier tube, ADC = 
Analog-to-Digital Converter, RF = radio frequency, Amp = amplifier. 
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the heterodyne DOS module.       
For heterodyne detection, an RF and an audio frequency are employed as seen 
in Figure 17.  Heterodyne systems have the advantage of phase shift determination at a 
lower frequency thus improving accuracy.  The RF oscillator drives the laser diode at a 
carrier frequency !!.  Light from the laser diode is delivered to the tissue/sample and 
collected via optical fibers some distance away.  The detected signal has some 
amplitude attenuation (!) and phase shift (!) as compared to the input signal, although it 
still oscillates at frequency !! . This phase-shifted/ amplitude-attenuated signal is 
detected by a photomultiplier tube (PMT), amplified and then sent to a frequency mixer 
that acts as a downconverter.  At the mixer, the detected !! signal is combined with a 
signal of frequency !! ! !! created by a single sideband system (highlighted in grey in 
Figure 17 (top) and detailed in Figure 17 (bottom)).   Here !!  is an audio carrier 
frequency, provided by a second sinusoidal oscillator.  The output from the mixer is 
filtered such that only the low frequency component !! remains.  Thus, the resultant 
signal still contains amplitude attenuation and phase shift information at the audio 
frequency !!.  This signal is then sent to a phase sensitive detector (PSD), or lock-in 
amplifier, to extract amplitude attenuation (!) and phase shift (!) by comparing with the 
carrier reference frequency.  The outputs of the PSD are the same as the homodyne 
detection, namely ! ! ! !"# !  and ! ! ! !"# ! .  These outputs get sent to an A/D 
converter and to a computer to extract the values of ! and !.   
Figure 16 (right) shows a schematic of the DOS module for the heterodyne 
instrument.  The source side consists of the same three diode lasers as the homodyne 
instrument (see Section 4.1), operating at 685 nm, 785 nm, and 830 nm, respectively, 
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and amplitude modulated by a high-power 70.055 MHz RF oscillator (VSA-70055, 
Wilmanco).  These lasers are all confined within a single NIM-Bin to save space, as 
opposed to the homodyne instrument in which each laser has its own NIM-Bin. 
 
 
 
Figure 17, (TOP) Illustration of a typical heterodyne detection scheme used to extract ! and !, 
the amplitude attenuation and phase shift of light obtained after passing through a highly 
scattering medium. Abbreviations: NIR = Near-Infrared, RF = radio frequency, IQ = In-
Phase/In-Quadrature, A/D = Analog-to-Digital. (BOTTOM) A single sideband system used to 
down convert the RF carrier frequency !! to the difference between !! ! !!.  
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The DOS laser outputs are sent to a 1x4 optical switch used to switch through 
each DOS wavelength (with an extra location for the DCS laser).  The output of this color 
switch is sent to two 1x4 optical switches connected in series.  These two switches are 
used to send light to up to 7 different source locations.    
Detection Electronics 
On the detection side, the heterodyne instrument employs two photomultiplier tubes 
(R928, Hamamatsu Photonics, discussed in Section 4.1).  The detection electronics are 
designed to access one detector at a time. Thus the electronic output of each detector is 
first amplified (36 dB, part number C-5594, Hamamatsu Photonics) and then sent to a 
digitally controlled electronic switch (ZASW-2-50-DR, Mini-Circuits).  
The 70.055 MHz output from the electronic switch is sent to a frequency mixer 
(ZFM-2, Mini-Circuits) where it is combined with a 70.047 MHz reference signal created 
by a single sideband system (discussed in Section 2.2).  After passing through the low 
 
Figure 18, Detailed schematic of detection electronics NIM-Bin in heterodyne DOS module. 
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pass filter, the output of the mixer, as seen in Figure 18, oscillates at the 8 kHz audio 
frequency, and it contains the amplitude attenuation and phase-shift information needed 
from the detected signal.   This signal is then transmitted to the lock-in amplifier for 
extraction of amplitude and phase.   
Lock-in Amplifier 
We chose a dual phase lock-in amplifier from Femto (LIA-BVD-150-L) for its small size 
and onboard reference oscillator (see Figure 19).   Additionally, not only does it accept a 
wide range of voltage inputs (3µV to 1V), it allows for manual and digital setting of the 
sensitivity range based on the intensity of this input signal.   
4.3 ISS Hybrid Device 
With the help of a generous donation from the Steve and June Wolfson Family Trust, we 
purchased a commercial frequency domain DOS device from ISS, Inc. (Imagent!, ISS, 
Inc.). The device was modified slightly for integration with our DCS modules.  This 
resultant composite instrument has been dubbed in our lab as the “ISS Instrument” (see 
Figure 20), and the remainder of this section will discuss its specifications. The DCS 
 
Figure 19, Photograph of the front and side view of the lock-in amplifier from Femto. 
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module in the ISS instrument is identical to the DCS module in the homodyne instrument 
(see Section 4.1), thus the majority of this section will focus on the DOS module.   
4.3.1 ISS Imagent!  
The Imagent! system is a frequency domain instrument, operating at a modulation 
frequency of 110 MHz, with heterodyne detection at a cross-correlation frequency of 5 
kHz [120, 121].  It contains of 16 diode lasers sources (6 x 826 nm, 5 x 688 nm, 5 x 787 
nm, respectively) all operating with output power of approximately 5 mW, and it contains 
two photomultiplier tube detectors, as seen in Figure 20 (right), and a 16-bit analog to 
digital converter.  The 16 sources are rapidly multiplexed in sequence electronically, 
eliminating the need for optical switches like those used in the homodyne and 
heterodyne instruments.    Approximately 0.32 seconds is required to switch through all 
16 sources.   This particular instrument can also be expanded to house up to 4 PMTs 
and 32 diode lasers if desired.  Presently, 2 PMTs and 16 diode lasers accommodate 
our clinical experiments needs.  
 
Figure 20, (Left) Photograph of the ISS Instrument.  (Right) Schematic of the front panel of the 
Imagent!, containing16 laser diode sources and 2 PMT detectors. 
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4.3.2 Standard Operation of ISS Hybrid Instrument  
For integration with the DCS module, the ISS diode lasers and PMTs are programmed to 
turn-off when the DCS module is acquiring data.  In this way, the ISS lasers do not 
interfere with the DCS detectors, and the DCS laser does not saturate the ISS detector.  
To avoid instabilities caused by the warm up time of the PMT, two frames of data are 
ignored just after the ISS lasers/PMTs are turned on (here I define a frame as one 
sweep through all 16 lasers, ~ 320 ms).  Typical operation of the hybrid ISS instrument is 
summarized by a flow chart in Figure 21.   
4.4 Instrument Performance 
To characterize the stability, dynamic range, and accuracy of each of these instruments 
for determining optical properties, we have quantified performance in phantom and 
physiological tests on human subjects.  The following section describes in detail the 
tests performed to assess the capabilities of each instrument. 
Stability:  The amplitude/phase data should be stable within 1%/1 !  for the 
duration of a typical clinical experiment (approximately 2 to 3 hours).  Several factors 
contribute to signal stability, including but not limited to, the repeatability of the optical 
 
Figure 21, Flow chart describing standard operation of the ISS Imagent DOS module and DCS 
module in the ISS instrument. 
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switches and the RF and CW stability of the diode lasers.  To test stability, the amplitude 
and phase of a signal obtained from a solid phantom with static optical properties was 
observed over a significant time period.  Additionally, we measured the long-term 
stability of the CW power output of the lasers using a power meter.  
 Figure 22 shows sample signal stability of amplitude and phase obtained on a 
phantom.  Data was acquired at intensities akin to those seen in patient experiments.  
The data was taken for more than 10 hours and a mean and standard deviation of each 
parameter were computed during each hour.  The amplitude stays stable to within < 1 % 
within an hour and the phase is constant to within a degree over the entire ten-hour 
period.  
Table 3 summarizes the stability data of both the offsets and signal.  Amplitude 
stability is reported as the average percent variation from the mean; phase stability is 
reported as standard deviation (in degrees).  Stability data was taken at all wavelengths, 
and the greatest instability is listed in the table.  The heterodyne and ISS instruments 
 
Figure 22, Stability of the AC amplitude and phase on a solid phantom measured with the ISS 
DOS module.  Signal magnitude is typical of that seen in a clinical experiment. 
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clearly have superior signal stability for all laser wavelengths.      
Dynamic Range:  Attenuation of light falls off exponentially with source-detector 
separation. Thus a large instrumentation linear range is advantageous for the detection 
of light in a wide-range of separations.  To characterize the dynamic range, the power 
from the laser is attenuated in 1 dB steps (monitored with an optical power meter), and 
the intensity and phase detected from the phantom is recorded at each step.  Raw ! and 
! data are adjusted for offset to extend the linear range by subtracting !!"" and !!"", the 
values of ! and ! found when the light source is removed from the setup.  New offset 
subtracted amplitude and phase data are computed via the new values of ! and !, 
namely ! ! !!""  and ! ! !!""  Plotting the input power [dBmW] versus output voltage 
[dBmV] reveals a range in which the power and voltage are linearly related with a slope 
of 2 (! ! !!!!, thus the !"# !  is proportional to ! !"# ! ).  Within this range, the phase 
should also remain constant.  To quantify the dynamic range, we impose a restriction 
Instrument Parameter PMT 1 PMT 2 APD 1 APD 2 
Homodyne 
Offset Stability- Amplitude (%) 1.0 2.4 1.8 2.3 
Offset Stability- Phase!!!) 0.5 1.5 0.7 1.3 
Signal Stability- Amplitude (%) 9.0 9.2 9.6 12.6 
Signal Stability- Phase!!!) 0.8 1.2 1.1 2.75 
Heterodyne 
Offset Stability- Amplitude (%) 5 5   
Offset Stability- Phase!!!) 3.0 4.2   
Signal Stability- Amplitude (%) 1 1.5   
Signal Stability- Phase!!!) 0.4 0.7   
ISS 
Offset Stability- Amplitude (%) -- --   
Offset Stability- Phase!!!) -- --   
Signal Stability- Amplitude (%) 1.0 1.0   
Signal Stability- Phase!!!) 0.8 1.5   
Table 3, Offset and signal stability of each detector in all DOS instruments discussed.  All 
stability data was acquired over a period of at least 10 hours.   
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that, within this range, the phase must be stable to within 1! and the amplitude must not 
deviate more than 1% from the best linear fit.  A setup to test linearity is shown in the left 
of Figure 23.  Sample linearity data obtained from a homodyne detection device is 
shown in the right of Figure 23. For this particular instrument, the dynamic range of both 
amplitude and phase extend over approximately 52 dBmV, or about 2.5 orders of 
magnitude. The effect of offset subtraction on the dynamic range is most notable from 
data in this figure.  Thus, when obtaining experimental data, offset measurements are 
required.  If the offset stability of the instrument is sufficiently low (<1% variation over the 
duration of the experiment), then a single offset measurement will suffice.  If the offset is 
not stable, it is wise to take offset data intermittently for more accurate assessment of 
signal changes.   
 Table 4 summarizes the dynamic range of each instrument discussed in this 
dissertation.  The data was taken with a PMT voltage gain of 800 V for all instruments.  
For the ISS instrument, the upper limit of the dynamic range could not be reached 
because of the source fibers that were used.  Thus the dynamic range is most likely 
underestimated.  This table shows that all three instruments demonstrate approximately 
the same linear range, although there is some variation amongst detectors.  
Phantom Experiments:  Once satisfied with stability and the dynamic range of an 
Instrument Dynamic Range (dB) PMT 1 PMT 2 APD 1 APD 2 
Homodyne Instrument 51.3 31.6 53.3 41.7 
Heterodyne Instrument 55.3 48.1   
ISS Instrument 45.1 46.0   
Table 4, Dynamic range of all detectors in each instrument.  
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instrument, phantom experiments must be performed to test the accuracy of the 
instrument in extracting accurate optical properties.  Typically, a titration of both 
absorption and scattering of a liquid phantom are performed using ink and Intralipid, 
respectively.  We titrate !! in steps of approximately 0.03 cm
-1 by adding India ink to a 
liquid phantom of water and intralipid while keeping !!
!  constant.  To titrate !!
! , we add 
additional intralipid to a phantom of intralipid, water, and ink to step !!
!  in increments of 
1-2 cm-1.  A detailed description of how to make liquid phantoms can be found in [116].  
These measurements are unfortunately only approximate, since each batch of intralipid 
has slightly different optical properties.      
 Figure 24 demonstrates ink titration data taken with the ISS instrument.  
Expected values of !! are plotted on the x-axis (the absorbance of ink is measured 
using a spectrophotometer prior to titration, thus if we know the amount of ink we are 
adding, we can predict how much !! should change), and measured values are shown 
on the y-axis.  ISS measurements are shown in red (data only obtained at 685 and 830 
nm).  Presumably, since only the ink concentration was changed, the reduced scattering 
  
Figure 23, (LEFT) Setup for testing the dynamic range of an optical spectrometer.  (RIGHT) 
Linearity of a homodyne instrument at 830nm.  The raw data is shown in blue, while the red 
data has been adjusted by the offset signal.   
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coefficient should remain constant throughout titrations.  The ISS instrument is thus able 
to resolve the optical properties of the liquid phantom to within 10% of the expected 
values.  
Physiologic Experiments:  A blood phantom can be used to test the accuracy of 
the instrument in addition to Intralipid/ink phantoms.  The blood is diluted with water, and 
then oxygen is bubbled into the blood/water solution.  Yeast can be added for blood 
deoxygenation.  A detailed description on the making and the measuring of blood 
phantoms can be found in the Appendix of Chapter 3 in Regine Choe’s PhD Thesis 
[116].   
 
Figure 24, Ink titration results using the ISS instrument (red).  Ink was added to titrate !! in three 
known steps.  Expected values of !!are plotted on the x-axis, and measured values are shown 
on the y-axis.  The solid black line indicates perfect agreement between our predicted !! and 
the measured !! or !!!. 
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Ultimately the goal of these tests is to confirm the validity of the DOS instrument 
in human and animal experiments.  Typically, the optical probe is placed on the forearm 
and a cuff occlusion experiment is performed similar to that published by Yu et al [122, 
123].  After a period of baseline monitoring for approximately 5 minutes, a blood 
pressure cuff is inflated on the upper arm to a pressure of above 180 mmHg to occlude 
arterial flow for 3 minutes. Following occlusion, one expects to see a stabile baseline, 
followed by a dramatic drop in tissue oxygen saturation (StO2) of around 20% and a drop 
in blood flow (BF) of approximately 90%.  Total hemoglobin concentration should remain 
approximately constant.  After 3 minutes the cuff is released and recovery is measured 
for at least 3 minutes.  Cuff release causes BF and StO2 overshoot to significantly 
greater than baseline values.  After a few minutes, the signal should return to baseline 
 
Figure 25, Cuff occlusion test using the ISS instrument.  Time series of the changes in tissue 
oxygen saturation (StO2) and relative changes in arm muscle blood flow (rBF) are shown on 
left and right, respectively.   
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values.  To test a new optical probe and/or a new DOS instrument, forearm cuff 
occlusion should be performed to ensure accuracy and reliability.   Obviously, results will 
vary due to physiological differences between subjects.  However, the overall trend 
consisting of a sharp drop in flow and saturation, followed by an overshoot and return to 
baseline, should be observed in all healthy subjects.  
  Figure 25 shows sample arm cuff data taken with the ISS instrument.  The 
experiment employed two source detector pairs, both separated 2.5 cm, one for DCS 
and one for DOS.  The modified Beer-Lambert law was used for DOS analysis.  Baseline 
values of tissue oxygen saturation and absorption and scattering coefficients were 
obtained from literature values.  The figure on the left shows StO2 versus time, while the 
right shows relative change in blood flow versus time.  Both time series demonstrate the 
expected behavior during cuff occlusion.  Similar results are found with both the 
homodyne and heterodyne devices (data not shown).   
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5 Validation of DCS in Critically Ill Neonates 
5.1 rCBF correlations with Velocity Mapping MRI 
Assuring adequate tissue perfusion is central to support of patients in the critical care 
arena. In particular, information about cerebral blood flow is valuable for assessment of 
brain perfusion and prevention of secondary injury.  As discussed in Section 1.2, very 
few existing methods, however, provide clinicians bedside access to this information. 
Currently available perfusion diagnostics are either low-throughput, indirect, expensive, 
invasive and/or require patient transport [11, 124].  Diffuse correlation spectroscopy 
(DCS) is a new optical technique (discussed in depth in Chapter 3) that appears to be an 
excellent tool for assessing cerebral blood flow in a continuous and non-invasive manner 
at the bedside.  The technique, however, must be validated in a variety of clinical 
settings and against myriad well-established (but still non-ideal) blood flow modalities in 
order for this new optical tool to gain wide acceptance.   
Patients with congenital heart defects represent one population that could benefit 
greatly from a non-invasive bedside monitor of cerebral blood flow.  Recent work, for 
example, has shown that when compared to healthy full-term children, patients with 
complex congenital heart defects have a high incidence of peri-operative brain injury and 
a significantly higher incidence of neurocognitive impairments as compared with healthy 
full-term children [125-127].  During periods of hemodynamic instability, such as in peri-
operative care, a monitor of cerebral blood flow could provide insight into the timing, 
development, and evolution of these brain injuries  
The remainder of this section validates DCS measurement of relative changes in 
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cerebral blood flow (CBF) against a well-established magnetic resonance technique, 
phase encoded velocity mapping (VENC MRI) in a population of pediatric patients with 
congenital heart defects.  VENC MRI does not measure cerebral blood flow in the brain; 
rather, it measures blood flow in the main vessel supplying blood to the brain, i.e., the 
aortic arch, and in the main vessels draining blood from the brain, i.e., the jugular veins 
and the superior vena cava.  These measures of flow in the jugular veins have been 
shown to agree strongly with other measures of cerebral blood flow [128, 129].  While 
VENC MRI provides high-quality, reliable blood flow data, these measurements must be 
carried out in the MRI scanner making them unsuitable for continuous monitoring.   We 
find that relative changes of blood flow in the jugular veins and superior vena cava 
correlate strongly with relative changes in cerebral blood flow measured with DCS.  
These results indicate DCS may be employed as a continuous bedside monitor of CBF 
in patients with congenital heart defects, as well as in a wide variety of other patients.   
5.1.1 Materials and Methods 
Patients with single ventricle complex congenital heart defects at The Children’s Hospital 
of Philadelphia were recruited for this study (approved by the Institutional Review 
Board).  All measurements were performed on the morning of the patient’s staged 
cardiac surgery.  Immediately prior to surgery, general anesthesia was induced via mask 
induction with Sevoflurane.  After intravenous access was obtained, 0.2 mg/kg 
pancuronium was administered for neuromuscular blockade.  After intubation, a nasal 
endotracheal tube was placed. The patient was subsequently mechanically ventilated 
and sedation was maintained with 1-2% Sevoflurane while an arterial catheter was 
placed in an upper extremity.  Patients were brought to the MRI scanner and a non-
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invasive optical probe was placed on the forehead for continuous optical monitoring.  
Figure 26 shows the experimental timeline.  Briefly, after a 30-minute baseline period of 
ventilation with FiO2 (fraction inspired oxygen) of 0.21, inspired CO2 was added to the 
room air mixture to achieve a FiCO2 of approximately 30 mmHg.  The CO2 mixture 
remained on for a 30-minute hypercapnic period to allow for gas equilibration and 
stabilization of the higher hypercapnic blood flow.  During this period of equilibration, 
anatomical brain MRI was obtained.  Non-invasive cuff blood pressures, 
electrocardiogram, peripheral oxygen saturation, and FiCO2 were monitored and 
recorded throughout the duration of the study.  Arterial blood gases were obtained at the 
start of the baseline period and at the end of the hypercapnia period to assess changes 
in the partial pressure of carbon dioxide (pCO2) in the blood.  
!"#"#"# $%&'()*+,-.(.)/(0-,123)4&551+6)478)
To measure blood flow in the main vessels supplying and draining from the brain during 
both room air inhalation and hypercapnia, a magnetic resonance technique known as 
phase-encoded velocity mapping (VENC MRI) was employed [130-132].  In brief, the 
technique relies on the fact that magnetic spins of intravascular protons flowing along a 
 
Figure 26, Timeline of hypercapnia protocol.  The patient inhaled room air for 30 minutes at 
which point CO2 was added to the gas mixture for a fraction of inspired CO2 of 30 mmHg. 
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magnetic field acquire a phase-shift that is linearly proportional to their velocity: 
 !" ! !"#!!. [73] 
Here !" is the phase-shift, ! is the gyromagnetic ratio, v is the velocity, " is the time 
between the centers of two magnetic pulses and !! is the area of one of the gradient 
pulses. A magnetic field gradient is aligned along the axis of the vessel(s) of interest, 
namely the aorta, jugular veins, and superior vena cava in our experiments, thereby 
inducing a phase shift in spins that move or flow along this gradient. The phase shift 
accumulated by the MRI signal obtained from a specific voxel is proportional to the 
velocity within that voxel. The direction of flow is aligned with the use of oblique 
magnetic field gradients. Combined with phase error correction techniques, velocity is 
accurately measured. 
Our investigation used a Siemens 1.5-Tesla Avanto MRI system (Siemens 
Medical Systems, Malvern, NJ).  After localizers in multiple planes, a stack of static, 
steady-state free precession axial images were acquired spanning the entire thorax and 
neck. These images evaluated cardiovascular anatomy and were used for localized 
through-plane velocity mapping. The effective repetition time was the R-R interval 
(range, 450 to 650 ms).  The echo time was 1.5-3 ms; the number of segments per 
heartbeat was 29; the number of excitations was 3; and the image matrix size was 128 x 
128 pixels, interpolated to 256 x 256, with a field of view ranging from 180 to 200 mm 
and slice thickness of 3 mm.  “Multiplanar reconstruction,” a software package resident 
on the Siemens MRI system, used the transverse images to calculate the exact slice 
position and double-oblique angles to obtain a ventricular outflow tract view and long-
axis images of the jugular veins and superior vena cava. If two ventricular outflow tracts 
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were present, each one was obtained separately. An imaging plane perpendicular to 
flow was then determined for: (1) the ventricular outflow tract at the sinotubular junction 
(if two were present, they were each calculated separately); (2) jugular vein above the 
superior vena cava; and (3) the superior vena cava proximal to the pulmonary artery 
anastomosis and distal to the innominate and subclavian veins.  The retrospective phase 
encoded velocity mapping sequence was then performed with a repetition time of 35 ms, 
echo time of 3 ms, number of segments per heartbeat of 3, field of view of 180 mm, a 
slice thickness of 5 mm, obtaining 20-23 phases depending upon the heart rate utilizing 
parallel imaging and 5 averages. VENC MRI encoding was 60-90 cm/s.   
Quantitative velocities were obtained in a region of interest (ROI) that was semi-
automatically traced along the margins of the blood vessel of interest.  Blood flow was 
computed by the sum of the product of the velocities measured in each pixel and the 
area of each pixel in the ROI. By integrating this flow over the cardiac cycle and 
multiplying by the heart rate, we obtained an average blood flow in units of liters per 
minute. The protocol not only included VENC MRI but also a contiguous stack of static, 
steady state free precession images in the axial plane; this stack was used to locate the 
exact slice positions for VENC MRI so that this plane was perpendicular to flow. 
For each patient, velocity maps were obtained at the sinotubular junction in the 
aortic root, in the left and right jugular veins, and in the superior vena cava during room 
air inhalation and during hypercapnia (see). From these maps, we calculated a net flow 
(as described above) per cardiac cycle.  The signal was averaged over multiple cardiac 
cycles to minimize effects of respiratory motion, but, in the process, averaging also had 
the advantage of improving the signal-to-noise ratio, yielding an average blood flow 
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value for each vessel acquired over approximately 1 minute.  Thus, we obtained a mean 
blood flow with units of Liters/minute in the aorta (BFAorta), superior vena cava (BFSVC), 
and by summing the blood flow in the right and left jugulars, the jugular veins (BFJug).  
Relative changes in blood flow (rBF) through these vessels due to hypercapnia were 
computed using the following formula, !"# ! !"!"! !"!""#!!"# !!""! .  
Cerebrovascular reactivity (CVR), defined as the change in blood flow divided by the 
change in partial pressure of CO2 ( !"#!! ), was computed as 
!"# ! !!"# ! !""#! !"#!!. 
!"#"#"$ %&''()*+,-.&/01+023+4566*10.&52+7-*/.65)/5-&*)+
Optical measurements of both changes in oxy- and deoxy-hemoglobin concentrations 
and changes in cerebral blood flow were obtained continuously with a custom-made 
optical probe (Fiberoptic Systems, Inc., Simi Valley, CA).  The probe contained two 
separate source-detector pairs, one for DOS and one for DCS, both separated by 2.5 
cm; thus the mean penetration depth of diffusing photons reached cortical tissue.  The 
DCS detector was a bundle of 8 single mode fibers used to improve the signal-to-noise 
ratio.  The probe was molded to conform to the patient’s head, and it was secured gently 
to the forehead with a soft head wrap.  Additionally, a fiducial marker was placed over 
the probe to locate fiber positions on anatomical MRI images. 
Optical data were acquired using a hybrid diffuse optical spectrometer, consisting 
of a commercially available diffuse optical spectroscopy (DOS) system (Imagent, ISS, 
Champaign, IL) and a diffuse correlation spectrometer (DCS) custom-made in our 
laboratory.  The DOS instrument operates in the frequency domain at 110 MHz with 
three wavelengths, 686, 786, and 826 nm.  It uses a heterodyne detection at 5 kHz to 
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quantify diffusive wave AC amplitude attenuation, phase shift, and average DC value of 
the detected light.  For DOS data analysis, the modified Beer-Lambert law [91, 133], 
  !"#!!!!! !!!!!! ! !! ! "# ! ! !!!!!!!, [74] 
was employed to compute changes in the absorption coefficient, !!!!!!.  Here !!!! is 
the DC light intensity measured at wavelength ! and time !, !!!!!!is the mean DC light 
intensity measured at wavelength ! during the five minutes of room air inhalation when 
VENC MRI scans were obtained; !"#!!!  is the wavelength dependent diffuse 
pathlength factor accounting for the increase in photon pathlength due to multiple 
scattering, equal to 5.4, 5.0, and 4.7 for 686, 786, and 826nm, respectively [92], and!! is 
the DOS source detector separation distance (2.5 cm for this experiment).  Note that the 
measured AC amplitude attenuation and phase-shift were not employed in this analysis.  
DOS data were excluded for analysis if the intensity of light detected was outside the 
dynamic range of the instrument.    
The DCS instrument is described in depth in Section 4.1.  In brief, the device 
uses a long-coherence-length laser (> 5 meters, CrystaLaser, RCL-080-785S) operating 
at 785 nm to deliver coherent light to the tissue. Light is detected at the tissue surface 
with a bundle of 8 single mode detection fibers and is transmitted to a fast photon 
counting avalanche photodiode (APD).  A custom built 8-channel correlator board 
(FLEX03OEM-8CH, correlator.com, Bridgewater, NJ) derives the intensity 
autocorrelation function based on the photon arrival times from the APDs.  
For DCS analysis, we used the semi-infinite homogeneous medium solution to 
the correlation diffusion equation to fit our intensity autocorrelation curves, !!!!! for a 
 84
blood flow index (BFI), where BFI is related to the motion of the moving scatterers, 
namely red blood cells, and their concentration [61]. The fitting procedure assumes an 
initial value of !! and !!
!
!(0.1 cm-1 and 9 cm-1, respectively, at 785 nm) for all patients 
[134].  Additionally, we fit the data assuming the mean squared displacement of the 
moving scatterers obeys a Brownian motion model, and thus the leading exponential 
decay rate of !!!!! should be proportional to the square root of the correlation time, 
!![61, 68, 135].  The reduced scattering coefficient, !!
! , was assumed to remain constant, 
and the measured changes in !!  at 786 nm computed with the DOS setup were 
incorporated into each fit of !!!!!.  DCS data were discarded if the intensity (i.e., photon 
count rate) of all detectors was less than 10 kHz (i.e., if the intensity signal-to-noise ratio 
was less than 10) or if !!!!! did not decay in a manner consistent with the Brownian 
motion model (note, this could be due to dynamics or breakdown of the semi-infinite 
homogeneous medium approximation, etc.), i.e., !! ! !!!!", where   
  !! !
!!!!!!!!!!!!!!"#
!
!!!!!!!!!!!!"#
!
!!! . [75] 
Here !!!!!! and !!!!!!!"# are the measured and fit values of the intensity autocorrelation 
 
Figure 27, (Left) Sample intensity autocorrelation function, !!!!!, that fits well to the Brownian 
motion model; (Right) Sample poor !!!!! fit to the Brownian motion model. 
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function at lag time !! , respectively; !!!!!  is the noise of the measured correlation 
function at lag time !!, computed using the formulation given in [111, 136]; and the sum 
is over the first N bins for which !! !! ! !!!".  Examples of included and excluded!!!!!! 
data along with their corresponding !! values are shown in Figure 27.  A flow chart of 
DCS data inclusion/exclusion is seen in Figure 28. 
For comparison with velocity mapping MRI data, a mean relative change in CBF 
obtained by DCS was calculated for each patient.  A mean and standard deviation of the 
blood flow index, !"# !and !BFI respectively, were computed during the approximately 5 
minute long room air and hypercapnia velocity mapping scans. We defined the change 
in CBF due to hypercapnia as !"#$!"# ! !"# !"! !"# !""#!!"# !!""#, where the 
subscript indicates data acquired during the hypercapnic or room air velocity mapping 
MRI scan.  Additionally, cerebrovascular reactivity (CVR) was defined as !"# !
!!"#$!"# ! !""#! !"#!!.  
!"#"#"$ %&'&()&(*'+,-.'+/)(),
To test the hypothesis that each of the relative variables differed from room air during 
 
Figure 28, Flow Chart of decision criteria for including DCS data in analysis. 
 
 86
hypercapnia, we carried out a Wilcoxon signed rank test [137].  Analyses used R 2.11 
[138]; hypotheses tests and associated p-values (p) were two-sided.  Statistical 
significance was declared for p-values! !!!!". 
  To quantify the relationship between relative changes in blood flow in the jugular 
veins, superior vena cava, and aorta measured by velocity mapping MRI and relative 
changes in cerebral blood flow measured by DCS, we fit to a simple linear regression 
model and using this model estimated Pearson’s correlation.  Pearson’s correlation, R, 
measures the extent to which a linear model explains variations in the data.  Note that R 
could be very high, even for a case where the slope of the line between the two 
measures varied substantially from unity.  We used Lin’s concordance correlation 
coefficient (CCC) to measure agreement between the two measures.  The CCC is, in 
fact, the product of Pearson’s R, a measure of precision, and a bias correction factor 
which reflects the degree that the linear association between two variables differs from 
45° through the origin, i.e., R = CCC/Bias Correction. Bland-Altman plots of the 
difference versus the mean of the two measures of relative flow changes were 
constructed as a graphical approach to assessing agreement [139].  
5.1.2 Results 
Sixty-two children with single ventricle congenital heart defects were recruited for the 
study.  All patients were scheduled for staged surgical cardiac repair on the day of the 
study.  Sixty-one patients completed the entire study; one was eliminated due to time 
constraints.  Forty-five patients were also eliminated from analysis due to either low DCS 
light intensity or because the DCS optical data poorly fit the Brownian motion model and 
(see DCS methods).  Sixteen of these 61 patients satisfied the inclusion criteria of 
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having high-quality DOS, DCS, and VENC MRI data (see Figure 28).  Table 5 lists the 
median and interquartile range values of patient age, weight, height, head 
circumference, sex, and surgical procedure for the 16 patients included in this analysis 
as well as the 45 patients who were discarded from this analysis.  The patients included 
for analysis had a median age of 0.5 years and were largely male (77 %).  A Wilcoxon 
signed rank test revealed that patients included for this analysis were younger (p = 
0.004), shorter (p = 0.007), and weighed significantly less (p < 0.001) than those who 
were discarded.  
 Figure 29 shows velocity mapping MRI and DOS/DCS data from a typical subject 
included in this analysis.  The top images show the phase maps of the region in and 
around the right and left jugular veins during the room air (left) and hypercapnia (right).  
The veins are circled in white for ease of viewing.  It is evident that during hypercapnia, 
the phase contrast in both vessels increases, indicating an increase in velocity in these 
vessels.  The middle and bottom portions of Figure 29 show the continuous time trace of 
DOS measures of !!" and !!"#!!(middle) and DCS measures of rCBF (bottom).  The 
shaded grey regions indicate the time periods in which velocity mapping MRI scans were 
 
Included Subjects: 
Median (IQR) 
Discarded Subjects: 
Median (IQR) 
p-value 
Age (yrs) 0.5 (0.4, 2.8) 3.0 (2.3, 3.5) 0.004 
Weight (kg) 6.8 (5.6, 12.2) 13.4 (11.6, 15.1) < 0.001 
Height (cm) 66.0 (63.1, 91.4) 88.9 (83.8, 93.4) 0.007 
Sex (Male:Female) 13:3 26:19 -- 
Skull/Scalp/CSF Thickness (cm) 0.79 (0.6, 0.9) 0.79 (0.68, 0.96) 0.44 
CSF Thickness (cm) 0.26 (0.19, 0.5) 0.23 (0.15, 0.3) 0.18 
Table 5, Patient demographics for the included (N = 16) and discarded (N = 43) subjects.  
Average skull, scalp and CSF thickness were computed underneath the optical probe using 
anatomical MRI images.  
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made.  For comparison between DCS and velocity mapping MRI, the DCS data were 
averaged over the grey shaded regions to extract an average rCBF due to hypercapnia 
for each patient. 
Table 6 summarizes the median and interquartile range of both the baseline 
(room air) and changes in all physiological parameters of interest. Since the DOS and 
DCS measures were all relative to the room air baseline, we just report changes.  An 
asterisk (*) indicates a Wilcoxon signed rank test p-value of less than 0.05.  Hypercapnia 
induced significant (!! ! !!!!") increases in CBF as measured by DCS and by phase-
encoded velocity mapping MRI.  Additionally, hypercapnia led to significant increases in 
 
Figure 29, (Top) Phase encoded velocity mapping magnitude (A, B) and phase (C, D) images of 
the jugular veins taken during baseline (left) and hypercapnia (right).  (Bottom) Sample time 
series of optical data.  DOS measures of !Hb and !HbO2 are shown on the top by dotted line 
and open circle, respectively, while DCS measures of rCBF are shown on the bottom.  The grey 
shading indicates the time of the velocity mapping scans.  Mean DCS data were acquired in 
these regions for comparison to VENC MRI results. 
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heart rate, oxy- and total hemoglobin concentrations, and of course, pCO2.  Arterial pH 
decreased significantly with CO2 administration, and no population-averaged changes 
were observed in deoxyhemoglobin concentration changes.  
As seen in Figure 30 and summarized in Table 7, a comparison of phase 
encoded velocity mapping MRI measures of relative changes in cardiac output in the 
superior vena cava to DCS measures of changes in cerebral blood flow were linearly 
related with high Pearson and concordance correlation coefficients (R = 0.89, CCC = 
0.89) and a slope (95% CI) of 0.92 (0.65, 1.19).  A similar correlation to DCS flow 
changes was observed with MRI measures of relative changes in cardiac output in the 
jugular vein, R = 0.92, CCC = 0.91, slope (95% CI) = 0.83 (0.63, 1.03).  Weaker 
Source Variable Baseline Change due to CO2 p-value 
Arterial Blood 
Gas 
pH 7.39 (0.02) -0.18 (0.04) < 0.001 
pCO2 38 (5) mmHg 30 (13) mmHg < 0.001 
EKG Heart Rate 103 (29) bpm 8 (24) bpm 0.021 
Cuff 
Mean Arterial 
Pressure 
59 (16) mmHg 2.5 (27) mmHg 
0.57 
Transcutaneous SpO2 78 (10) % 1 (7) % 0.68 
Velocity Mapping 
MRI 
BFAorta 2.99 (1.21) L/min 126.4 (23.1) % < 0.001 
BFJugular 0.59 (0.22) L/min 151.5 (47.3) % < 0.001 
BFSVC 0.84 (0.27) L/min 146.0 (42.2) % < 0.001 
CVR-Aorta -- 0.8 (0.8) %/mmHg < 0.001 
CVR-Jug. -- 1.6 (2.9) %/mmHg < 0.001 
CVR-SVC -- 1.6 (2.5) %/mmHg < 0.001 
DCS 
CBF -- 141.0 (49.8) % < 0.001 
CVR -- 1.8 (2.7) %/mmHg 0.001 
DOS 
Hb -- 0.4 (4.8) µM 0.85 
HbO2 -- 9.8 (5.4) µM < 0.001 
THC -- 10.2 (8.0) µM < 0.001 
Table 6, Median (interquartile range) baseline values followed by median (interquartile range) 
changes due to hypercapnia, and p-values obtained by Wilcoxon signed rank test. 
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correlations were also observed between rBF in the aorta and rCBF from DCS with a 
slope (95% CI) of 1.26 (0.03, 2.50) (p = 0.045).     
5.1.3 Discussion 
We observed significant agreement between changes in CBF measured with 
diffuse correlation spectroscopy and changes in blood flow in the jugular veins and 
superior vena cava measured with VENC MRI.  Although the two techniques measure 
entirely different vascular structures related to cerebral hemodynamics, this strong 
agreement is encouraging. DCS measures cerebral blood flow in the microvasculature.  
The optical probe was secured to the forehead; thus, in this study we were monitoring 
changes in CBF at the surface of the frontal cortex.  VENC MRI measures blood flow in 
the jugular veins and superior vena cava, both of which are capacitance vessels that 
accommodate the large volume of blood flowing through them.  Hypercapnia induces 
significant global changes in cerebral blood flow in the grey and white matter [140, 141].  
Therefore, in normal function, the microvascular CBF changes in the frontal cortex 
measured by DCS should represent similar changes throughout the brain, and these 
microvascular changes should also be reflected in the macrovascular changes in blood 
Site CCC 
Bias 
Correction 
Slope Estimate 
(95% CI) 
Intercept Estimate 
(95% CI) [%] 
R
2
, 
p-value 
Jugular 
Veins 
0.91 0.99 0.83 (0.63, 1.03) 21.1 (-10.0, 52.2) 
0.84, 
p < 0.001 
Superior 
Vena Cava 
0.89 0.99 0.92 (0.65, 1.19) 14.2 (-27.7, 55.1) 
0.79, 
p < 0.001 
Aorta 0.25 0.50 1.26 (0.03, 2.50) -9.2 (-163.0, 144.6) 
0.20, 
p = 0.045 
Table 7, Summary of concordance correlation coefficients (!!) and bias correction factor, along 
with the estimated slope and intercept for a linear regression between DCS measures of rCBF and 
Phase Encoded Velocity Mapping rBF and the adjusted R
2
 and p-values. 
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flow drainage in the jugular veins [128, 129].  Naturally, this micro/macro agreement 
presumes the patient has a healthy brain with no regions of watershed or hypoxia that 
 
 
 
Figure 30, (TOP) Changes in blood flow measured with velocity mapping MRI in the Jugular 
Veins (left), Superior Vena Cava (middle), and Aorta (right) compared to rCBFDCS. The solid line 
represents the best-fit line to the data, while the dotted line indicates the line of perfect 
concordance.  The grey ribbon denotes the 95% confidence interval for the mean rCBFDCS. 
(BOTTOM) Bland-Altman plots of the difference in rBF, measured with VENC-MRI, and rCBF, 
measured with DCS, versus the mean of these parameters.  Solid horizontal lines indicate the 
mean difference between each VENC parameter and rCBF measured with DCS, while the 
dotted lines indicate the 95% limits of agreement. 
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may cause the frontal cortex to be a poor representation of the whole brain.  Further, all 
patients were studied under conditions of general anesthesia with mechanical ventilation 
and neuromuscular blockade, conditions which are similar to the conditions present in 
the immediate post-operative recovery period. These conditions preclude regional 
activation of cerebral cortex due to cognitive processes or movement. 
This agreement between VENC MRI and DCS is encouraging, as one of the 
major advantages of DCS is its portability.  Thus, as opposed to the sporadic CBF 
measures that phase encoded velocity mapping MRI provides, these results suggest 
DCS may be employed to accurately assess relative changes in CBF in a continuous 
fashion at the patient’s bedside.  DCS may be a particularly attractive option for critically 
ill patients who are difficult to transport safely to an MRI, who are unable to have an MRI 
due to metallic implants, or who would benefit from continuous CBF monitoring. 
 As per the poor correlation between DCS and aortic flow, a priori we would not 
expect changes in aortic flow due to hypercapnia to accurately represent microvascular 
CBF changes seen with DCS.  Aortic blood flow represents systemic blood flow, i.e., 
flow to both the brain and the body.  Since CBF represents only one portion of the total 
cardiac output, we should expect the fractional change in CBF from the aorta during 
hypercapnia to be dependent on cerebrovascular reactivity, as well as the geometry of 
the aortic arch and its branches.  Total flow changes to both body and brain should 
match total aortic flow changes; however, the individual components (brain and body 
flows) alone will not necessarily tract aortic flow changes as not all tissues respond to 
CO2 in a uniform way.  
A handful of publications have studied the cerebral hemodynamic effects of 
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hypercapnia on patients with congenital heart defects [59, 142-145].  Durduran et al [59] 
measured a mean (standard deviation) cerebrovascular reactivity to increased CO2 of 
3.1 (1.9) %/mmHg in neonates with congenital heart defects using DCS.   The 
population studied in this work was considerably older than the neonates previously 
studied, ranging in age from 3 months to 5 years old.  In this population we found a 
slightly lower mean (standard deviation) CO2 reactivity of 1.8 (2.7) %/mmHg.  Fogel et al 
[145] studied older CHD patients with VENC-MRI during hypercapnia, mean (standard 
deviation) age of 2.2(0.5) years.  They found a mean increase in jugular flows of 230 % 
with a mean change in pCO2 of 23 mmHg, indicating a cerebrovascular reactivity of 
approximately 5%/mmHg.  Our results thus fall within the published values for this 
patient population of infants with congenital heart defects.  
Optical Data Quality 
While 61 patients who underwent optical monitoring during hypercapnia, only 16 
had data that stood up to the stringent requirements we placed on data quality.  The 
main reasons for exclusion from the study were either low intensities of detected light by 
DOS/DCS (N = 22) and/or poor fits of the DCS data to the semi-infinite homogeneous 
medium correlation diffusion equation solution (N = 23).  The problem with low intensities 
was typically due to limited time for probe placement.  The problem with poor quality fits 
is currently not as well understood.  For example, we have used this particular DCS 
instrumentation and optical probe on numerous other studies [65, 146], and these data 
have yielded intensity correlations that fit nicely to the effective Brownian diffusion 
model.  Therefore, we believe the unusual correlation curves in these patients are 
caused by the anatomy and/or optical properties of the brain in this unique population.  
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One possible structural source of error along these lines would arise from patients with 
excessive amounts of cerebrospinal fluid and/or thicker skulls; our population falls into 
this group, having a median (IQR) skull thickness of 0.79 (0.30) and csf thickness of 0.26 
(0.31) cm. We are currently working on Monte Carlo modeling of light propagation using 
anatomical images segmented by brain, cerebrospinal fluid, and skull/scalp as the input 
geometry.  Additionally, we are performing bench-top experiments with phantoms to 
attempt to replicate these slow decaying correlation curves and to understand their 
origin. However, because this paper aims to further validate DCS against VENC MRI, we 
only included the data that fit well to the theory of effective Brownian motion and that are 
representative of the experimental DCS correlation curves we observe in most of the 
other populations we have studied [59-61, 63, 65].   
Correlations between rCBF measured with DCS and rBF measured with VENC 
MRI for all patients, regardless of the quality of the DCS data fits (N = 39) were 
computed and the results can be found in Appendix 5.1.5.  Including data from patients 
with poor intensity autocorrelation function fits significantly reduces (although does not 
negate) the agreement and correlation between DCS and VENC MRI.   
Optical Approximations 
Due to limitations in probe size, we were restricted to a single source-detector 
separation for DOS measurements.  Thus, the modified Beer-Lambert law was used to 
quantify changes in the absorption coefficient and thus changes in oxy- and deoxy-
hemoglobin.  However, many assumptions are required to employ the modified Beer-
Lambert Law.  In particular, it is assumed that !!! is small relative to its baseline value, 
and we assume that !!
!  remains constant.  These assumptions appear to be valid in the 
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present experiment.  On average, !!!  at 786 nm was 0.015 cm
-1, a change of 
approximately 15% of the presumed baseline value of !!!  = 0.1 cm
-1 at 786 nm.  Similar 
results were found for 688 and 826 nm.  Additionally, although !!
!  was not explicitly 
measured in this experiment, we feel justified in assuming !!
!  does not change due to 
hypercapnia [147].  Red blood cells contribute very little to the total cell volume of brain 
tissue, thus the majority of light scattering events are most likely due to mitochondria and 
other organelles as well as cell nuclei [96, 97].  Even if the blood volume increases 
substantially due to hypercapnia, this increase would have a small effect on the net 
scattering coefficient.   
To fit the DCS data for a blood flow index, we assumed initial values for the 
absorption and reduced scattering coefficients (!!  and !!
! ).  Because we are only 
interested in relative changes in the BFI, our choice of initial !! and !!
!  has little to no 
effect on the resulting value of rCBF.  However, changes from these initial values of !! 
and !!
!  that occur during the duration of the study may influence the magnitude of rCBF.  
Thus, we incorporated changes in !! obtained with DOS into our fitting procedure for 
BFI.  However, as mentioned previously, our DOS analysis assumed that the scattering 
coefficient remained constant during the duration of the study. This assumption is most 
likely valid for hypercapnia.  However, if false, a 10% increase in the scattering 
coefficient could alter the magnitude of rCBF by approximately 20%.  Thus, future work 
would benefit greatly from the use of multiple source detector DOS amplitude and phase 
measurements used to continuously quantify !! and !!
! .   
We have anatomical brain images of each patient, and we computed the mean 
(standard deviation) skull/scalp/CSF thickness underneath our optical probe to be 0.81 
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(0.31) cm.  Because of the 2.5 cm source-detector separations used for both DOS and 
DCS, photons travel on average a depth of 1 to 1.25 cm into the tissue.  Thus, we are 
confident the optical measurements are probing the surface of the cortex.  However, in 
the future, DCS quantification of rCBF can be further improved.  A semi-infinite model 
was used to fit DCS data. As known from the anatomical scans, this model greatly 
simplifies the head geometry of these patients. In reality, the scalp, skull, cerebral spinal 
fluid, grey matter, and white matter possess different optical properties that can be 
accounted for, at least partially, in Monte Carlo simulations of light propagation [148-
150]. Although the semi-infinite model can be improved upon, it provides a sufficient 
approximation for this pilot study.  
MRI Assumptions 
VENC MRI is a very accurate technique that does not depend on assumptions of 
flow profiles. Nevertheless, eddy currents and higher order Maxwell terms can introduce 
errors into the measurements. In addition, if a blood vessel is tortuous, flow may not be 
perpendicular to the imaging plane and this may introduce errors as well. Finally, partial 
volume effects will “average out” velocities in a given voxel, decreasing the accuracy of 
the measurement. In our study, eddy currents and Maxwell terms were minimized and 
the authors took great pains to ensure the imaging plane was perpendicular to flow. The 
dimensions of our VENC MRI images were 1 x 1 x 5 mm, well within accepted norms. 
Prior to each MRI scan, phantoms were used to calibrate the system. 
5.1.4 Conclusions 
We have demonstrated a highly significant correlation between measures of relative 
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changes in cerebral blood flow measured with diffuse correlation spectroscopy and 
relative changes in blood flow in the jugular veins and superior vena cava in pediatric 
patients with congenital heart defects.  This agreement further strengthens the promise 
of DCS as an accurate and non-invasive modality for continuous CBF monitoring at the 
bedside.   
5.1.5 APPENDIX:  Results with All Patients Included 
For comparison to the results presented herein, I have also computed the correlations 
between rCBF measured with DCS and rBF measured with VENC MRI for all patients, 
regardless of the !!-value of the fit to the DCS intensity autocorrelation function.  Thirty-
nine patients had DCS intensities greater than 10 kHz and were thus included in this 
analysis.    
Site CCC 
Bias 
Correction 
Slope Estimate 
(95% CI) 
Intercept Estimate 
(95% CI) [%] 
R
2
, 
p-value 
Jugular 
Veins 
0.68 0.94 0.52 (0.33, 0.72) 78.3 (47.6, 109.1) 
0.29, 
p < 0.001 
Superior 
Vena Cava 
0.56 0.91 0.59 (0.30, 0.87) 75.3 (32.9, 117.8) 
0.36, 
p < 0.001 
Aorta 0.22 0.41 1.26 (0.51, 2.01) -0.2 (-95.1, 94.7) 
0.26, 
p = 0.002 
Table 8, Summary of concordance correlation coefficients (!!) and bias correction factor, along 
with the estimated slope and intercept for a linear regression between DCS measures of rCBF and 
Phase Encoded Velocity Mapping rBF and the adjusted R
2
 and p-values for the N = 39 patients 
with intensity of DCS data > 10 kHz (regardless of the quality of the DCS data fit). 
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Figure 31 and Table 8 summarize the comparison of phase encoded velocity 
 
 
Figure 31, (TOP) Changes in blood flow measured with velocity mapping MRI in the Jugular 
Veins (left), Superior Vena Cava (middle), and Aorta (right) compared to rCBFDCS for the N = 39 
patients with intensity of DCS data > 10 kHz (regardless of the quality of the DCS data fit). The 
solid line represents the best-fit line to the data, while the dotted line indicates the line of perfect 
concordance.  The grey ribbon denotes the 95% confidence interval for the mean rCBFDCS. 
(BOTTOM) Bland-Altman plots of the difference in rBF, measured with VENC-MRI, and rCBF, 
measured with DCS, versus the mean of these parameters.  Solid horizontal lines indicate the 
mean difference between each VENC parameter and rCBF measured with DCS, while the 
dotted lines indicate the 95% limits of agreement. 
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mapping MRI measures of relative changes in cardiac output in the superior vena cava, 
jugular veins, and aorta to DCS measures of changes in cerebral blood flow. As evident 
from these plots, including data from patients with poor intensity autocorrelation function 
fits significantly reduces (although does not negate) the agreement and correlation 
between DCS and VENC MRI.   
5.2 BFI correlations with Doppler ultrasound velocities 
Between 1990 and 2005 the percentage of preterm births in the United States rose by 
20% [1].  Preterm births now account for almost half of children with cerebral palsy, as 
well as a significant portion of children with cognitive, visual, and hearing impairments 
[151]. Three forms of acquired brain injury affect the likelihood of mortality and 
neurodevelopmental deficits in very low birth weight (< 1500 g), very preterm (< 32 
weeks gestation age) neonates: hypoxic ischemic insult, periventricular leukomalacia 
(PVL) and intraventricular hemorrhage (IVH) [2, 3]. PVL is a specific form of necrosis of 
the cerebral white matter adjacent to the lateral ventricles that is often associated with 
impaired motor development and is a major cause of cerebral palsy. During the early 
stages of brain development, this region of white matter is highly susceptible to injury 
from lack of blood flow and oxygen delivery due to the maturation stage of the 
supporting cells (oligodendrocytes) [4]. IVH refers to hemorrhaging from the germinal 
matrix, an immature bed of vascular tissue along the ventricular wall that is typically 
present only in preterm infants less than 32 weeks gestation age. Such hemorrhages are 
caused by fluctuations in cerebral blood flow (CBF) and may induce profound cognitive 
and physical handicaps. A continuous monitor of CBF at the bedside could therefore be 
a valuable supplement for gathering information about a patient’s condition [5] and for 
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guiding treatment. Microvascular information about cerebral perfusion, in particular, is 
attractive because the microvasculature controls oxygen and nutrient delivery to relevant 
tissues.  
Currently, transcranial Doppler ultrasound (TCD) and near-infrared spectroscopy 
(NIRS) are the only techniques deemed feasible for the estimation of CBF in this clinical 
population. TCD measures cerebral blood flow velocity (CBFV) in the cerebral arteries 
by monitoring the frequency shift of acoustic waves that scatter from moving red blood 
cells [31, 152]. With additional information about the cross-sectional area of the 
insonated vessel, CBFV permits calculations of arterial CBF. However, cerebral vessels 
are small in size, making their diameter difficult to measure [36]. To avoid this source of 
error, one could focus on relative changes in flow. However, these blood vessels can 
change caliber over time, leading to large errors in calculations of relative change, which 
in turn cause errors in estimates or  
Near-infrared spectroscopy measures tissue oxy- and deoxy-hemoglobin 
concentrations, taking advantage of the tissue absorption “window” in the near-infrared 
[153]. A comprehensive review of near-infrared spectroscopy in the neonate was 
recently published by Wolfberg and du Plessis [154]. Although NIRS measurements of 
tissue oxygenation and total hemoglobin concentration are increasingly more common in 
the clinic, the calculation of CBF from NIRS data is indirect and relies on the Fick 
principle, which states that the total uptake of a tracer by tissue is proportional to the 
difference between the rates of inflow and outflow of the tracer to and from the tissue 
[155]. This calculation requires the use of a tracer, typically oxygen or indocyanine green, 
and requires certain assumptions to be valid, namely that cerebral blood volume, CBF, 
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and cerebral oxygen extraction must remain constant. 
In this chapter we employ another recently developed optical technique to 
measure CBF: diffuse correlation spectroscopy (DCS). DCS [102, 104, 105, 115, 135] 
has shown promise as a monitor of relative changes in blood flow (see Table 2). Like 
NIRS, DCS also employs near-infrared light to probe the dynamics of deep tissues. 
However, DCS detects changes in CBF directly by monitoring temporal fluctuations of 
scattered light. It does not rely on tracers to indirectly infer information about CBF, and it 
can be employed continuously. Finally, in contrast to TCD, DCS provides information 
about microvascular hemodynamics.  
In the present investigation, diffuse correlation spectroscopy and transcranial 
Doppler ultrasound monitor the hemodynamics of four very low birth weight, very 
preterm neonates during a 0º to 12º postural change. Because this study is a feasibility 
test, we limited head of bed elevation to values within the range of the clinical isolette 
beds. Many studies have been conducted to determine the physiological response of 
preterm infants to postural manipulations [37, 156-164]. Most of this work has focused 
on changes in vitals signs, such as heart rate, blood pressure, and/or arterial oxygen 
saturation, although some groups have also used near-infrared spectroscopy to probe 
cerebrovascular oxygenation during postural change [161-163].  To this author’s 
knowledge, only one study by Anthony et al. has been done with Doppler ultrasound to 
monitor the effects of HOB elevation to cerebral blood flow velocity in the main arteries 
[37], and no experiment has examined the resulting changes in microvascular cerebral 
blood flow. Anthony et al. defined four classifications of peak systolic velocity response 
within 30 seconds of a 20º HOB elevation: (1) a sudden change within 5 seconds, (2) a 
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sudden change within 5 seconds, followed by a corrective change, (3) no change, (4) 
cycling or no discernible trace. Responses 2 and 3 were the most common. Two major 
questions raised by this finding are: what relationships exist between these large-vessel 
changes and the microvascular cerebral blood flow, and what impact, if any, does 
postural manipulation have on this microvascular flow. Our present study aims to 
address both of these questions by examining the use of diffuse correlation 
spectroscopy on preterm neonates. 
Our results indicate that on a measurement by measurement basis, significant 
correlations were found between absolute values of the blood flow index (BFI) measured 
by DCS and peak systolic velocity (PSV) and mean velocity (MV) measured by TCD; a 
weaker, but still significant, correlation was found between BFI and end diastolic velocity 
(EDV) measured by TCD. As per the entire patient population, both modalities found no 
significant relative changes in hemodynamics during this relatively small (12!) postural 
intervention. Thus we demonstrate the use of DCS on this population of preterm infants, 
we show agreement between DCS and TCD for the first time, and we suggest that such 
small postural changes do not significantly affect cerebral blood flow in this population. 
5.2.1 Methods and materials 
The DCS instrument uses a long-coherence-length laser (CrystaLaser, RCL-080-785S) 
operating at 785 nm to deliver light to the tissue. A single mode fiber secured by a black 
foam pad detects light 1.5 cm from the source. The fiber is custom designed with a 90! 
bend on the patient end, permitting the probe to rest adjacent to the forehead. Light is 
detected by a fast photon counting avalanche photodiode that outputs a TTL signal for 
every photon received. This TTL signal is transmitted to a custom built 2-channel 
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correlator board (FLEX03OEM-2CH, correlator.com, Bridgewater, NJ) which derives the 
intensity autocorrelation function based on the photon arrival times [165]. Figure 32 
shows a sketch of the probe on the infant’s head.  
Protocols for both DCS and TCD measurements are shown in Figure 33.  Head-
of-bed (HOB) angle manipulations were limited by the range of the isolette beds (Ohio 
Care, Ohmeda Isolette).  These beds easily adjust from an angle of 0º to approximately 
12º in seconds.   
For DCS, data were acquired for 30 minutes: three 5 minute HOB = 0º sessions, 
alternating with three 5 minute HOB = 12º sessions. Intensity autocorrelation curves 
were averaged over a period of 3 seconds and were acquired every 7 seconds, resulting 
in around 300 BFI data points per study. These curves were then converted to electric 
field autocorrelation functions using the Siegert relation with a fitted value for !  of 
approximately 0.5. Theoretically, we expect ! to be approximately equal to the inverse of 
the number of modes allowed to pass through the detection optics. In our case of single 
mode detection fibers, the number of modes is two. For analysis, we solved the 
 
Figure 32, The fibers used to deliver and detect light are secured to the infant’s forehead using 
a soft black pad. The pad is held in place with a mask that wraps around the head. 
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correlation diffusion equation analytically, assuming the sample geometry was a 
homogeneous, semi-infinite medium.  We used the semi-infinite solution (Equation 1) to 
fit our data for BFI. This fit is made possible by assuming constant values for µa and µs’ 
(0.1 cm-1 and 10 cm-1, respectively, at 785 nm) for the whole population and throughout 
the study. These values were chosen from literature references [166, 167].  
A mean relative change in CBF was calculated after each HOB = 12º event using 
the preceding HOB = 0º event for a baseline, i.e., for the ith repetition, 
!"#$! ! !"#!!!"#! !"#!!!"!!!""#, where !"#!!!! indicates the mean BFI over all data 
points taken at the ith HOB = ! event.  After !"#$! was calculated for each HOB change 
(3 total per day of study), a mean relative change in cerebral blood flow, !"#$ , was 
determined for each day. Here !! denotes the mean value over all !"#$! measured on 
a given day. Additionally, to compare absolute measurements of BFI to the velocities 
found from TCD, a mean blood flow index, !"#, was calculated for each day of study. 
For the purposes of this analysis, we used the initial HOB=0º data to calculate BFI, i.e., 
!"# ! !"#!!!!!"!, since the baby was most peaceful during this time period.  
 
Figure 33, Diagram of the protocol used for DCS (top) and TCD (bottom) measurements.  DCS 
and TCD measurements were NOT taken at the same time. For DCS, data was taken 
continuously (8 data points per minute) for 5 minutes at each head of bed angle adjustment.  
The head of bed 0! to 12! elevation was repeated 3 times, making the total study time 35 
minutes. By comparison, for TCD only 3 data points were taken at each HOB angle before the 
bed was repositioned, and the HOB angle was only elevated twice. 
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The protocol for TCD measurements differed slightly from the DCS protocol. Only 
two or three measurements of peak systolic velocity (PSV), end diastolic velocity (EDV), 
and mean velocity (MV = (PSV !EDV)/PI, where PI is the pulsatility index measured by 
the ultrasound scanner), were obtained at each head of bed angle. A Philips ATL HDI 
5000 ultrasound scanner (Philips Medical Systems, Bothell, WA) with a C8-5 MHz 
broadband curved array transducer was used for data acquisition. Typically this process 
was repeated twice. As in the case of the mean rCBF calculation, mean relative changes 
of each parameter for the ith repetition (!"#$!, !"#$!, !"#!) comparing the responses at 
elevated HOB to lying flat were computed after each HOB change, i.e., !!"#$! !
!"#!!!"#! !"#!!!"!!!""#. Daily mean changes in velocities, !"#$ , !"#$ , !"# , 
were calculated in the same manner as !"#$ . For comparison to DCS, mean velocities 
at the initial HOB = 0º event ( !"# ! !"#!!!!!"! , !"# ! !"#!!!!!"! , and !" !
!"!!!!!"!) were calculated for each day of study. Unfortunately TCD and DCS data 
could not be collected at the same time due to the size of the infant’s head. However, 
the data were acquired on the same day by both modalities. 
For the purpose of this analysis, we considered each of the nine days of data 
acquisition to be independent observations. To test for an association between !"# and 
each of !"#, !"#, and !", as well as between !"#$  and each of !"#$ , !"#$ , and 
!"# , we used Spearman’s rank-based non-parametric approach [168]. Rejection of 
the null hypothesis in this case implies a positive or negative, and possibly non-linear, 
association between the variables. Pearson’s correlation coefficient was used to 
estimate a linear association between !"#, and each of !"#, !"#, and !". To test the 
hypothesis that each of the four relative variables differed from baseline during HOB 
elevation, we conducted a Wilcoxon signed rank test [137]. Analyses were carried out 
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using R 2.8 [138]; hypotheses tests and associated p-values (p) were two-sided. A 
family-wise error rate of 0.05 was maintained using Hochberg’s method [169] to adjust 
for multiple comparisons within each of the three sets of analyses (associations with !"#, 
associations with !"#$ , and comparison with baseline); adjusted p-values, pA, are also 
reported. 
5.2.2 Results 
In total, we acquired nine days of data sets on four preterm infants with both DCS and 
TCD. The mean gestation age of our population was 26.3 weeks (range = 25-27 weeks) 
and the mean birth weight was 896 g (range = 640-1150 g). At the time of the study, the 
mean weight was 1185 g (range = 650-1900 g), and the mean corrected gestational age, 
defined as gestational age plus the time since birth, was 29.2 weeks (range = 26-34 
weeks).  
!"#"#"$ %&'()*'+,-./
Diffuse light signals (~100,000-500,000 photons/sec) were sufficient for all patients. 
Autocorrelation curves were averaged over a period of 3 s, leading to fairly smooth data 
and good signal-to-noise ratio. Sample autocorrelation curves are shown in Figure 34. 
The solid black line is the raw data. The dotted black line shows the fit to the data. The 
median (range) !"# for all nine days of measurement at the initial HOB = 0º position was 
1.62!10-8 (0.98!3.31!10-8) cm2/s. Median !"#$ !over the nine days of measurements 
was 93.4 (87.3 to 112.8) % (see Table 9).  
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5.2.2.2 Results-TCD 
The TCD data at the initial HOB=0! event revealed a median (range) !"# of 44.1 (20.9 
to 70.3) cm/s; median !"# was 8.3 (5.1 to 12.8) cm/s; median !" was 21.3 (11.4 to 
30.6) cm/s. Median relative changes in these parameters ( !"#$ ! !"#$ , and !"# ) 
after the postural intervention are shown in Table 9. A Wilcoxon signed rank test on 
these relative parameters revealed no significant changes from baseline values during 
HOB elevation.  
5.2.2.3 Comparison of DCS and TCD 
Figure 35 (left) shows the relationship between baseline PSV and BFI for TCD and DCS. 
The error bars in the horizontal and vertical directions represent the standard deviation 
in the mean value of the given parameter over all data points recorded at the first 
HOB=0º event. The estimated Spearman rank correlation coefficient, rs, was 0.76, 
indicating a significant positive correlation (p = 0.018, pA = .036) between !"# and !"#. 
Baseline !" and!!"# (Figure 35, center) revealed a significant correlation as well with rs 
 
Figure 34, (Left) Typical normalized intensity autocorrelation curve derived directly from the 
correlator board as a function of time, ! (data measured on the forehead of a preterm infant). 
(Right) The corresponding normalized electric field autocorrelation curve, g1(r,!), calculated 
using the Siegert relation with a fitted value for ". The solid line shows the raw data. The dotted 
line is the best-fit curve to a Brownian motion model, which we use to derive the blood flow 
index (BFI). 
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= 0.78 (p = 0.013, pA = .036). As seen in Figure 35 (right), the relationship between !"# 
and !"# also achieved significance (rs = 0.67, p = 0.047, pA = .047). The solid grey lines 
in Figure 35 depict the best linear fit to the data. Pearson’s correlation coefficient, R2, 
was calculated, and modest positive linear correlations between !"# and !"#, !" and 
!"#, and !"# and !"# were detected (R2 =0.58, 0.44, 0.13). 
Both techniques showed no significant hemodynamic population-averaged 
changes during HOB elevation as compared to HOB flat (Table 9). In addition, 
correlations between !"#$  and relative ultrasound parameters did not reach statistical 
 Median (%) Range (%) p-value 
!!"#$! 93.4 87.3 to 112.8 0.12* 
!!"#$! 103.0 91.1 to 128 0.34** 
!!"#$! 104.0 61 to 138 0.91** 
!!"#! 100.1 80 to 125 0.53** 
Table 9, Median and range of average daily hemodynamic response to postural 
elevation 
 
Figure 35, (Left) Correlation between population averaged mean TCD PSV taken at the initial 
HOB=0º (PSV) and population averaged mean DCS BFI also taken at the initial HOB=0º (BFI). 
(Center) Correlation between population averaged mean TCD MV taken at the initial HOB=0º 
(MV) and DCS BFI. (Right) Correlation between population averaged mean TCD EDV taken at 
first HOB=0º event (EDV) and DCS BFI. The solid line in each plot shows the best linear fit 
between the two variables. Both Pearson’s and Spearman’s correlation coefficients (R
2
 and rs, 
respectively) were calculated. The R
2
 Pearson values are displayed for each plot. 
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significance for the HOB perturbation (i.e.,! !"#$  and !"#$ , rs = 0.52, p = 0.15, pA = 
0.19; !"#$  and !"#$ , rs = 0.55, p = 0.12, pA = 0.19; !"#$  and !"# , rs = 0.49, p = 
0.19, pA = 0.19).  
5.2.3 Discussion 
The study was conducted to demonstrate the feasibility of diffuse correlation 
spectroscopy (DCS) for continuous monitoring of cerebral blood flow (CBF) in preterm 
infants and to compare measurements of DCS with transcranial Doppler ultrasound 
(TCD); the latter technique is used routinely for this population. A priori, the two 
modalities need not be strongly correlated since they measure different quantities: TCD 
measures flow in primary arteries, and DCS measures flow in tissue microvasculature. 
Our results show that a correlation exists between TCD measurements of peak systolic 
and mean velocities in the middle cerebral artery and DCS measurements of blood flow 
index, and that this correlation is statistically significant in this population. Furthermore, a 
weak but significant correlation exists between BFI and end diastolic velocity. The 
relative weakness of this correlation is due primarily to the low signal-to-noise ratio 
(SNR) of the EDV measurements for this population. Intuitively, one might expect BFI to 
correlate most strongly with MV, given that BFI is extracted from an autocorrelation 
curve which is averaged over three seconds (approximately 7 cardiac cycles). However, 
since MV is derived from EDV, it is strongly influenced by the low SNR of the EDV data.  
While absolute values of BFI from DCS and velocities from TCD correlate 
significantly, correlations between relative changes in these parameters did not achieve 
significance. It is not entirely clear why the absolute velocity measurements correlate 
well with BFI, while relative changes do not correlate with rCBF. We hypothesize that 
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there may have been insufficient statistical power given the limited sample size and 
relatively large physiological and measurement noise as well as inter- and intra-subject 
variability. Future experiments would benefit from concurrent TCD and DCS data 
acquisition.  Our TCD results of relative velocity changes concur with Anthony et al. [37], 
who showed that most infants showed little or no middle cerebral artery velocity 
response to postural changes. However, a direct comparison between the studies is 
difficult because Anthony et al. used a larger bed elevation (20°) and monitored 
continuously before and after the bed tilt for only 30 seconds. For the future, DCS 
quantification can be improved. For example, a semi-infinite model was used to fit DCS 
data. This model simplifies the head geometry of the infants. In reality, the scalp, skull, 
cerebral spinal fluid, grey matter, and white matter possess different optical properties 
that can be accounted for, at least partially, in calculations [115, 149, 170]. Although the 
semi-infinite model can be improved upon, it provides a sufficient approximation for this 
pilot study.  Finally, throughout our measurements we have assumed a constant 
absorption and reduced scattering coefficient (!! and !!
! ) for all patients and for the 
duration of the study [166, 167]. The exact values used, however, had little affect on our 
results. For example, a tenfold change in !! and tripling !!
!  (0.01-0.15 cm-1 and 5-15 cm-1 
respectively) did not significantly affect !"#$  or the correlations between !"#!and !"#, 
!", and !"#. Of course, individual deviations of !! and !!
!  from the population average 
could affect the strength of these correlations. Because our population of preterm infants 
was fairly homogeneous, i.e., clinically stable with no life threatening conditions and of 
approximately the same gestational age, we felt some justification in assuming !! and !!
!  
to have little variation (i.e., less than 15%) across subjects, as is the case for full term 
neonates [100, 171]. Future work would, however, benefit from the use of a hybrid 
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DCS/DOS instrument [63, 64, 115, 172] to gather absolute optical properties from DOS 
for each patient individually and then employ them when fitting for BFI. 
5.2.4 Conclusion 
We have demonstrated the feasibility of diffuse correlation spectroscopy to continuously 
monitor changes in cerebral blood flow in very low birth weight preterm infants. The skull 
anatomy of preterm infants enables us to probe a significant amount of the cortex, 
making them an attractive patient population for bedside DCS measurements. 
Physiologically, we also showed that when posed with a small head of bed angle 
challenge of 12º, the infants maintained a constant blood flow on the microvascular 
scale. This result was corroborated in the macrovasculature by findings from transcranial 
Doppler ultrasound measurements. Measurements of blood flow index as measured by 
DCS were found to correlate significantly with measurements of peak systolic, end 
diastolic, and mean velocities of the middle cerebral artery calculated with TCD. These 
results further validate diffuse correlation spectroscopy as an accurate monitor of 
cerebral blood flow. 
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6 Applications of DOS/DCS in Patients with Heart Defects 
6.1 Introduction 
Approximately 35,000 infants are diagnosed yearly with congenital heart defects (CHD) 
[6].  A third of these infants will have severe, complex cardiac lesions that will require 
surgical repair in the first few months of life. Importantly, cardiac surgery for serious 
forms of CHD in the neonatal period has progressed to the point wherein mortality is 
minimal.  Thus, clinicians are now focusing on the prevention of neurologic injury and the 
improvement of neurocognitive outcome in these high-risk infants.  This chapter is 
structured as follows:  Section 6.1 briefly motivates the need for cerebral monitoring of 
patients with congenital heart defects; Section 6.2 describes the study protocol used to 
monitor these patients before and after cardiac surgery; Section 6.3 describes the 
patient population recruited for our studies; and Section 6.4 summarizes four preliminary 
results obtained from these measurements, namely the effects of hypercapnia, blood 
transfusion, and sodium bicarbonate bolus, as well as the progression of tissue oxygen 
saturation and cerebral blood volume following cardiac surgery. 
6.1.1 Neurological Injury Accompanying CHD: Periventricular Leukomalacia & 
Structural Brain Immaturity 
Patients with severe forms of CHDs encounter both short-term and/or longer-term 
neurological consequences related to their heart defect.  Recent literature has shown 
that patients with complex CHDs have immature brain development for their gestational 
age [126, 173].  Additionally, seizures, stroke, hemorrhages, and periventricular 
leukomalacia are observed post-operatively in a fraction of these patients [125, 174-
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176].   
Periventricular leukomalacia (PVL) is a specific form of necrosis of the cerebral 
white matter adjacent to the lateral ventricles.  During the early stages of brain 
development, immature cells within this region of white matter are highly susceptible to 
injury from lack of blood flow and oxygen delivery [4, 177].  PVL is most often considered 
to be a neurological consequence of preterm birth because it occurs with high frequency 
in preterm infants [178].  The neurodevelopmental consequences of PVL in preterm 
infants include impaired motor function, developmental delay, microcephaly (a condition 
characterized by a significantly smaller brain than normal), cerebral palsy, and attention 
deficit/hyperactivity disorder (ADHD). 
Patients with complex CHD requiring surgical repair in infancy have 
neurodevelopmental outcomes that are remarkably similar to those of preterm infants.  
At school age, these patients are at higher risk for impaired cognitive and fine motor 
skills, learning and speech problems, attention deficit/hyperactivity disorder (ADHD), and 
potentially lower IQ than the general population [7-10].  Since CHD patients share a 
common brain injury with preterm infants, i.e., PVL, it is thought that the presence of 
PVL leads to the neurodevelopmental deficits found in CHD patients.   
Furthermore, recent work on CHD neonates has revealed structural brain 
immaturity.  Examples of structural brain immaturity include delays in myelination (the 
insulation surrounding neurons), delays in cortical development, and delays in 
maturation of the germinal matrix and glial cell migration [126, 173].  These effects are 
similar to the immature brain development observed in preterm infants, and they have 
been linked with the development of post-operative PVL [127].  Thus, by further 
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understanding the risk factors and the causes of development of new or worsened PVL 
in CHD patients, we may also gain new understanding of PVL in premature infants. 
The incidence of preoperative PVL in CHD patients is thought to be about 25% 
[26, 179].  Risk factors for this injury have been discovered. McQuillen et al have 
reported that the use of balloon atrial septostomy, a procedure performed to further open 
the atrial septal defect (see Section 6.1.3), was highly correlated with pre-operative 
injury in patients with transposition of the great arteries, a specific form of CHD (see 
Section 6.1.4) [180, 181].  Furthermore, recent evidence points to longer time-to-surgery 
and low oxygen content in the arterial blood as predictors of preoperative PVL [182]. 
Data from post-operative MRI scans reveal a substantially higher incidence (i.e., 
greater than 50 %) of new or worsened post-operative injury, mainly in the form of PVL 
[26, 125, 179].  Perioperative risk factors for this post-operative injury include high base 
deficit (indicating excessive acid in the body) during cardiopulmonary bypass (CPB), low 
cerebral tissue oxygen saturations [180], and prolonged exposure to CPB [180].  Risk 
factors in the early (i.e., less than 48 hours) post-operative period include diastolic 
hypotension, hypoxemia, and tissue oxygen saturations that remained low, i.e., < 45 % 
for longer than 180 minutes [125, 174, 180].   
This chapter highlights the use of both pre- and post-operative DOS/DCS 
monitoring in an effort to further elucidate the effects of CHD physiology on cerebral 
hemodynamics and to potentially predict and/or avoid adverse outcome in the form of 
PVL.  Our clinical studies focus on two main congenital heart defects: Transposition of 
the Great Arteries (TGA) and Hypoplastic Left Heart Syndrome (HLHS).  Both diagnoses 
are forms of ductal dependent heart lesions, i.e., legions dependent on the ductus 
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arteriosus for systemic or pulmonary blood flow.  As of 2000, these ductal dependent 
heart legions occur in approximately 7 out of 10,000 live births [6, 183]. These defects 
are dependent on an open ductus arteriosus (a shunt connecting the pulmonary artery to 
the aorta) and an open atrial septal defect (a shunt connecting the right and left atria) for 
mixing of systemic and pulmonary blood to provide oxygenated blood flow to the brain 
and body.  Additionally, for survival, both of these defects require surgical repair (TGA) 
or palliation (HLHS) within the first week of life.  The remainder of Section 6.1 will 
provide a brief review of normal circulation and will discuss these two defects and their 
surgical repair in more depth.  
6.1.2 Physiology of a Healthy Heart  
Figure 36 shows a schematic of healthy circulation in a healthy heart.  In a healthy heart, 
the right side of the heart pumps deoxygenated blood to the lungs, while the left side of 
the heart pumps oxygenated blood to the brain and body. Deoxygenated (venous) blood 
returns from the brain and body to the right atrium and is pumped to the lungs via the 
right ventricle and the pulmonary arteries.  Oxygenated blood then returns from the 
lungs to the heart via the pulmonary veins into the left atrium, passes to the left ventricle, 
and is then pumped through the aorta to the brain and body [184].  
6.1.3 Hypoplastic Left Heart Syndrome (HLHS) 
HLHS is a particularly severe form of CHD characterized by an underdeveloped, or 
hypoplastic, left ventricle, and stenosed or atretic (closed) mitral and aortic valves [185]. 
Due to the lack of blood flow out of the left side of the heart, the aortic valve (the valve 
separating the aorta and left ventricle) and the ascending aorta (the portion of the aorta 
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immediately coming off of the left ventricle) becomes hypoplastic or atretic.  These 
malformations are fatal if not corrected and require surgery within the first week of life.  
Palliative cardiac surgery for HLHS is performed in a series of three staged 
reconstructions.  All patients included in our studies undergo the first stage of surgery, 
known as the Stage I/Norwood procedure.  The goal of the Norwood procedure is to 
build a new aorta (dubbed a “neoaorta”) to carry blood to the body, brain, and lungs. 
Since the aorta is severely hypoplastic, the pulmonary artery is connected to the aorta to 
permit adequate systemic outflow. An artificial shunt is then connected to the first vessel 
that arises from the aorta with the other end connected to the pulmonary artery to 
provide blood flow to the lungs. Since the left ventricle is inadequate in size (or there is 
no left ventricle at all), the right ventricle serves as the systemic ventricle to pump blood 
through the new outflow tract. In addition, with only one ventricle, there must be 
adequate mixing of both deoxygenated and oxygenated blood.  An atrial septectomy is 
 
Figure 36, Schematic of healthy circulation in a normal heart.  The aorta carries oxygen rich 
blood from the left ventricle to the systemic circulation.  Venous blood returns from the 
systemic circulation into the right atrium and is pumped to the lungs via the pulmonary 
arteries.  Oxygenated blood from the lungs returns to the heart via the pulmonary veins. 
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performed to permanently open the connection between the atria and to create an 
unobstructed source of systemic (oxygenated) blood flow and a stable source of blood 
flow to the lungs.  In practice, patients are first anesthetized (isoflurane, fentanyl, 
pancuronium) and orally intubated.  Then they are cooled to approximately 25 to 28°C 
and placed on cardiopulmonary bypass, whereby a cannula is placed in the aorta and in 
the right atria to bypass the heart.  Because of the intricacies of the surgical technique, 
the heart must be stopped.  Thus, the patient is cooled further to 18 to 20°C, and the 
heart is isolated from the rest of the body by clamping the pulmonary artery.  Deep 
hypothermic circulatory arrest is maintained for approximately 45 to 60 minutes to 
complete the surgical procedure, at which time the patient is re-warmed to 34°C and is 
separated from cardiopulmonary bypass.   
6.1.4 Transposition of the Great Arteries (TGA) 
As the name suggests, TGA involves the transposition of the aorta and the pulmonary 
artery [185].  The aorta stems from the right ventricle and the pulmonary artery comes 
off the left ventricle.  These malformations are typically repaired during the first few days 
of the first week of life in order to preserve the left ventricle’s ability to support systemic 
circulation. 
 Surgical repair to correct for TGA is called the arterial switch procedure.  This 
procedure effectively moves the aorta and pulmonary artery so that deoxygenated blood 
is pumped to the lungs and oxygenated blood is pumped to the brain and body.  Patients 
are first anesthetized (isoflurane, fentanyl, pancuronium) and orally intubated.  Then they 
are cooled to approximately 25 to 28°C and placed on cardiopulmonary bypass, whence 
a cannula is placed in the aorta and in the right atria to bypass the heart.  The aorta and 
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pulmonary arteries are clamped off and then detached from their defective anatomy and 
finally reattached in the correct manner.  The coronary arteries are excised from the 
aorta above the right ventricle and mobilized to the left ventricle outflow track. The 
patient is then re-warmed to 34°C and separated from cardiopulmonary bypass.  
6.2 Study Protocol 
With institutional review board (IRB) approval, all full-term newborn infants with complex 
CHD admitted to the cardiac intensive care unit at The Children’s Hospital of 
Philadelphia were screened for participation in this study.  Inclusion criteria included full 
term age (gestational age 40 ! 4 weeks), an intention to undergo surgery with 
cardiopulmonary bypass (CPB) with or without deep hypothermic circulatory arrest 
(DHCA), medical stability for 24 hours prior to surgery, and admission CHD diagnosis of 
hypoplastic left heart syndrome (HLHS) or transposition of the great arteries (TGA).  
Exclusion criteria included: small for gestational age (< 2 kg), a history of neonatal 
depression (5 minute APGAR score < 5 or umbilical cord pH < 7.0), or evidence of other 
end-organ dysfunction.  In addition, subjects should not have experienced pre-operative 
cardiac arrest requiring chest compressions, and subjects with HLHS must not have 
been clinically treated with hypercarbia (increased inhalation of CO2) for over-circulation 
to the lungs. 
 An overview of the clinical study timeline is shown in Figure 37.  In brief, once 
parental consent was obtained, the patient underwent a pre-operative MRI on the 
morning of surgery to assess the extent, if any, of pre-operative brain injury, as well as to 
measure cerebrovascular reactivity during a hypercapnia intervention.  Then, the patient 
was taken for cardiac surgery.   
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Following surgery, the patient was returned to the cardiac intensive care unit 
(CICU).  Once stabilized, continuous monitoring of optical parameters, namely relative 
changes in cerebral blood flow (rCBF), changes in oxy-hemoglobin concentration 
(!"!"!! ), changes in deoxy-hemoglobin concentration (!!!" ), and changes in total 
hemoglobin concentration (!"#$), as well as continuous monitoring of vital signs (heart 
rate, arterial blood pressure, right atrial pressure, transcutaneous arterial oxygen 
saturations, temperature, and respiration rate) commenced for the next 10 to 12 hours 
while the patients underwent standard CICU post-operative management.  Finally, a 
second MRI was performed 3 to 7 days after surgery to assess post-operative brain 
injury.    
6.2.1 DOS/DCS Instrumentation 
A hybrid DOS/DCS instrument (described in Section 2.2) was used for all optical 
measurements.  Two separate optical probes are employed in this study (Figure 38).  
The first probe is intended solely for DOS measurement of absolute tissue absorption 
and reduced scattering coefficients.  Herein we will refer to this DOS probe as the ISS 
infant probe, as it was purchased from ISS, Inc.  The second probe is intended to 
quantify relative changes of both DOS and DCS parameters (i.e., not absolute 
 
Figure 37, Time line of study participation. Patients are monitored both pre- and post-
operatively on the day of cardiac surgery, and are then imaged once more 3-7 days post-
surgery.  Blue arrows indicate acquisition of anatomical MRI images, green indicates surgery, 
and orange indicates continuous optical and vital sign monitoring (note the orange arrow prior 
to surgery indicates the monitoring performed during a hypercapnia intervention) 
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measures).  Herein we will refer to this probe as the “flat probe” due to its slim geometry. 
 As shown in Figure 38A, the ISS infant probe (Infant Flexible Sensor, ISS, Inc.) 
consists of 8 source fibers and 1 detector fiber, and a total of 4 source-detector 
separations (1.5, 2.0, 2.5, and 3.0 cm).  Two-wavelength (688 and 826 nm) DOS 
measurements are made at each separation.  To quantify absolute optical properties 
using this probe, calibration measurements are made on a solid phantom prior to patient 
measurements.  Specifically, the probe is placed on two separate solid (“semi-infinite”) 
phantoms for calibration, and the semi-infinite geometry diffusion model is used to 
extract phantom optical properties and thus compute calibration corrections (see Section 
2.1.3).  The calibration coefficients computed with the solid phantoms are used to correct 
AC amplitude and phase-shift data obtained on the patient’s forehead.  Equations 41 
and 42 are used to fit the slopes of AC amplitude (!) and phase shift (!) versus 
 
 
Figure 38, (TOP) A. Schematic of source/detector configuration for the ISS infant probe 
(separations 1.5, 2.0, 2.5, 3.0 cm) used for intermittent DOS measurements, B. Schematic of 
the flat probe used for DOS/DCS long term monitoring.  (BOTTOM) Photos of the ISS neonate 
probe (left) and the flat probe on a baby doll (right). 
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separation for !! and !!
!  at 688 and 826 nm.  Data is discarded if the Pearson’s R2 
correlation coefficient for the relationship between !"!!!!!! vs. ! or ! vs. ! is less than 
0.975.  Poor fit to the model may arise from poor probe contact, or possibly from laser 
light reaching the detectors without traversing through the tissue [99]. 
The flat probe was custom-made by Fiberoptic Systems (Simi Valley, CA).  A 
schematic of the flat probe is given in Figure 38B.  It consists of side-firing fibers cut at 
45! angles to reduce the probe thickness to approximately 3 mm.  Two source detector 
pairs, both separated by 2.5 cm, are imbedded in the probe for DOS and DCS 
measurements, respectively.  The DOS source fiber is 200 µm in diameter, while the 
detector fiber diameter is 600µm.  The DCS source fiber diameter is also 200 µm, but on 
the detector side we employ a bundle of 8 single mode detectors (these single mode 
fibers are used increase the signal-to-noise ratio by averaging over all 8 detectors).  The 
optical probe was secured to the patient’s forehead using a soft foam mask. 
6.2.2 MRI Measurements 
MRI images were acquired on a Siemens Avanto 1.5-Tesla MRI.  Anatomical MRI 
sequences included multiplanar reconstructed (MPR) volumetric T1 and T2 SPACE 
(Sampling Perfection with Application optimized Contrasts using different flip-angle 
Evolutions) sequences acquired in the axial plane and later reconstructed in the sagittal 
and coronal planes.  Susceptibility (both standard echo gradient and susceptibility 
weighted imaging), and diffusion weighted imaging (DWI) sequences were also acquired.  
A clinical neurologist (DJL) reviewed all images for presence/absence of new and/or 
worsened periventricular leukomalacia (PVL), stroke, and/or hemorrhages.  
Abnormalities were identified and localized using their signal intensity, appearance, 
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anatomic location, and presence or absence of diffusion positivity on diffusion weight 
images (indicating acute injury and low water motion).   
6.2.3 Pre-Operative Measurements 
On the morning of surgery, anesthesia induction and endotracheal intubation were 
performed in either the cardiac operating room or the cardiac intensive care unit.  
Sedation and neuromuscular blockage were maintained with 5-10 µg/kg fentanyl and 0.2 
mg/kg pancuronium, respectively.  If not already placed, arterial and venous lines for 
blood gases were also obtained.   
For a subset of patients, baseline absolute optical property measurements were 
made while obtaining vascular access once the patient was sedated.  For the 
measurements, the probe was manually held in place over the right and then left frontal 
cortices for 20 seconds.  A black cloth was held over the probe to reduce the effects of 
stray room light.  Measurements were repeated 4 times on each side for a total of 8 data 
points per patient.  Data was discarded if the patient was moving, crying, or irritable 
during data collection. For the jth measurement (where j = 1 to 8) on the patient, the 
following system of equations was solved for concentrations of tissue oxy- and deoxy-
hemoglobin, !!"!!!
 and !!"!, respectively: 
 !!! !! ! !!" !! !!"! ! !!"!! !! !!"!!!
! !!!"!!!!!
!!!!. [76]  
Here !!"!! !!  and !!" !!  are the extinction coefficients of oxy- and deoxy-hemoglobin 
at the wavelengths, !!, employed (688 and 826 nm).  The absorption effects of water 
(!!!!!
!!!!) were accounted for by assuming a tissue water content of approximately 
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75% [99, 186].  Total hemoglobin concentration of the jth measurement, !"#! , was 
defined as !"#! ! !!"! ! !!"!!!
, and cerebral oxygen saturation, !"#!!, was defined as 
!"!!!
! !!"!!!
!"#! !!""#.  Finally, for each patient, a simple mean and standard 
deviation were computed over all 8 measurements (assuming that no data was thrown 
out because of poor data quality or patient motion).  Sample pre-operative THC and 
ScO2 data is seen in Figure 39.  Note that although data is collected on both right and 
left head, for the purposes of this analysis, we are averaging over all data to obtain a 
global mean.  
The subject was then transported to the MRI suite.  On arrival at the MRI suite an 
arterial blood sample was drawn to assess baseline arterial partial pressure of carbon 
dioxide (pCO2) and arterial oxygen saturations using co-oximetry (AVOX 1000, Opti 
Medical Systems).  A venous blood sample is also drawn to assess venous oxygen 
saturations using co-oximetry. 
 
Figure 39, Pre-operative measurements of baseline ScO2, !!"!!, !!", and THC using the ISS 
infant probe.  
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Figure 40 shows the hypercapnia study protocol that commenced once the patient 
arrived at the MRI scanner (also described by Durduran et al [59]).  The flat optical probe 
was placed on the patient’s forehead off-of-midline and secured gently with a foam mask 
for continuous DOS/DCS monitoring of relative changes in cerebral blood flow, oxy- and 
deoxy-hemoglobin concentrations.  Optical data was acquired every 3.5 seconds.  After 
a 30-minute baseline period of room air inhalation, supplemental CO2 was added to the 
inspired gas mixture until an inspired CO2 of 2.7% was achieved (measured by a 
capnometer, a device that measures partial pressure of CO2 in the inspired gas mixture).  
CO2 remained on for approximately 30 minutes.  Vital signs were continuously captured 
during the procedure, i.e., electrocardiogram, cuff blood pressure, transcutaneous 
oxygen saturations, and fractional inspired CO2.  Anatomical MRI scans were obtained 
throughout the experiment too (see Section 6.2.2).  Arterial blood samples are drawn 
during the baseline period and again at the end of hypercarbia in order to assess 
changes in pCO2.  Venous and arterial blood gas co-oximetry was obtained for accurate 
blood oxygen saturations. 
6.2.4 Post-operative Continuous Monitoring 
The patient returned to the cardiac intensive care unit following surgery and was 
 
Figure 40, Timeline of the preoperative hypercapnia experiment.  Optical (DOS/DCS) 
measurements, along with vital signs were captured continuously for the duration of the 60-minute 
study.  CO2 was added to the inspired gas mixture at 30 minutes to produce hypercapnia. 
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stabilized before the start of any post-operative measurements.  Following stabilization, 
the flat optical probe was secured to the patient’s forehead with a foam mask for 
continuous monitoring of relative changes in cerebral blood flow, and oxy- and deoxy-
hemoglobin concentrations.  Complete sets of optical data were acquired every 7.5 
seconds.  The flat probe was repositioned every 2 hours to the contralateral side of the 
forehead to minimize risk of burns or pressure sores.  A researcher was at the bedside 
for the duration of the post-operative monitoring.  Marks were made in the optical data 
files to denote any interventions or manipulations that might occur, i.e., drug delivery, 
movement, examinations, etc.   
 Vital signs were also captured continuously using a Component Neuromonitoring 
System from Moberg Research, Inc.  Heart rate, arterial blood pressure, transcutaneous 
oxygen saturations, respiration rate, temperature, and right atrial pressures were all 
recorded at a rate of 0.5 Hz.  Vital sign data was manually time-locked with optical data 
at the start of recording.  
 For a subset of patients recruited most recently (N=10), absolute measurements 
of absorption and reduced scattering coefficients were made intermittently using the ISS 
infant probe (note that for the other patients, absolute measurements were not acquired, 
only relative changes from a presumed baseline absorption coefficient value were 
obtained).  When the patient returned from surgery, absolute measurements were made 
to assess baseline values; then the flat probe was placed on the patient to measure 
relative changes in the absorption coefficient.  Subsequently, every 2 hours when the flat 
probe is repositioned, we made an absolute DOS measurement with the ISS probe 
using the procedures listed in Section 6.2.1. Note, the ISS probe and the flat probe were 
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never used at the same time on the infant’s head due to size constraints.  
6.3 Patient Population 
To date, we have recruited twenty-nine full term infants with complex congenital 
heart disease.  Fourteen were diagnosed with HLHS, and fifteen were diagnosed with 
TGA.  One patient was not measured because his condition worsened before the day of 
surgery.  Median and interquartile range (IQR) of all patient demographics are 
summarized for the 28 patients studied in Table 10.  
Table 11 lists the portion(s) of the study in which each patient participated.  As 
seen from this table, twenty-eight patients completed the pre-operative MRI to assess 
pre-operative brain injury.  All twenty-eight patients also completed the pre-operative 
hypercapnia portion (listed as “Pre-Op CO2 Study” in Table 11) of the study as well, 
although the data from one patient (Patient ID = 3) was discarded due to poor optical 
data quality (low intensities of both DCS and DCS detected light).  Twenty-seven 
patients completed the post-operative optical/vital-sign monitoring portion of the study, 
although only 25 were included for analysis due to poor optical data (low intensity of 
either DOS and/or DCS data).  Additionally, absolute optical properties were obtained 
prior to the pre-MRI hypercapnia experiment as well as intermittently throughout the 
 Median (IQR) 
Cardiac Diagnosis (HLHS/TGA) N = 14/15 
Sex (Male/Female) N = 16/13 
Gestation Age (weeks) 39 (1.6) 
Day of Life 3 (2) 
Birth weight (kg) 3.26 (0.55) 
Head Circumference (cm) 34 (1.1) 
Table 10, Patient characteristics summarizing all 28 patients studied.  Data is reported as 
median (interquartile range). 
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post-operative MRI for the last ten patients.  Finally, 25 patients completed the post-
operative MRI assessment of brain injury.      
6.4 Initial Results 
6.4.1 Pre/Post-operative Cerebral Oxygenation & Cerebral Blood Flow 
!"#"$"$ %&'()*'(&+,-,./0/10*2,3456/+*'(&+,,7,./0/10*2,82&&9,:2&;,
For patients with congenital heart defects, several publications have implicated low 
tissue, venous, and/or arterial oxygen saturations in the pre- and post-operative periods 
as contributors to adverse outcome (e.g., longer hospital stay, extracorporeal membrane 
oxygenation support, organ failure, death) or brain injury [174, 182, 187-192].  However, 
several difficulties arise when relying on arterial and/or venous oxygen saturations to 
predict adverse outcome.  Arterial oxygen saturations are poor indicators of actual 
oxygen delivery at the brain tissue level in patients with cyanotic congenital heart defects 
[188, 192, 193].  Thus if one is monitoring only arterial oxygen saturations, then one may 
overlook poor oxygen extraction at the tissue level as a predictor of adverse outcome.  
Alternatively, while cerebral venous saturations are a valuable measure indicative of 
cerebral oxygen extraction, [189, 190, 192, 193] monitoring cerebral venous saturations 
requires invasive and potentially dangerous catheterization of the superior vena cava.   
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Non-invasive cerebral tissue saturations (ScO2) measured by NIRS offer a 
natural compromise to monitoring arterial or venous saturations.  However, to my 
knowledge, all ScO2 data reported to date were obtained with commercially available 
NIRS devices, which are fairly reliable as trend monitors, but are not reliable for absolute 
quantification as they operate in the CW domain (see Section 2.1.1).   
ID 
Cardiac 
Dx 
Pre-Op 
MRI 
Pre-Op 
CO2 
Study 
Post-Op Vital-
Sign & Optical 
Monitoring 
Absolute 
Optical 
Properties 
Post-Op 
MRI 
Study 
Portion 
1 HLHS X X X  X b 
2 TGA       
3 HLHS X X X  X  
4 HLHS X X X  X b,d 
5 HLHS X X X  X b,c 
6 HLHS X X X  X b,c 
7 TGA X X X  X b 
8 TGA X X   X b 
9 TGA X X X  X b 
10 TGA X X X  X b 
11 TGA X X X   b 
12 HLHS X X X  X b,c,d 
13 TGA X X X  X b 
14 TGA X X X  X b,c,d 
15 HLHS X X X   B,c 
16 TGA X X X  X b 
17 HLHS X X X  X b,c 
18 TGA X X X  X b 
19 TGA X X X  X b,d 
20 TGA X X X X X a,b 
21 HLHS X X X X X a,b,c,d 
22 HLHS X X X X X a,b,c 
23 HLHS X X X X X a,b,d 
24 TGA X X X X X a,b 
25 TGA X X X X X a,b,c 
26 HLHS X X X X X a,b,c 
27 TGA X X X X X a,b 
28 HLHS X X X X X a,b,c,d 
29 HLHS X X X X  a,b,c 
 14/15 28 28 27 10 25  
Table 11, Summary of the patients recruited and measured for each portion of the study.  An 
X indicates that optical and/or MRI data was obtained.  A red X indicates that optical data 
quality was too poor for patient inclusion in our final analysis.  The far right column indicates 
the portion(s) of the study in which each patient participated: a = absolute optical properties 
(Section 6.4.1), b = hypercapnia (Section 6.4.2), c = sodium bicarbonate (Section 6.4.3), d = 
blood transfusion (Section 6.4.4). 
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 Thus, in the present investigation we aim to monitor pre- and post-operative 
cerebral oxygen saturations, ScO2, in patients with CHD using a frequency domain, 
multi-separation DOS instrument that is much more sophisticated and provides 
substantially more comprehensive information than the commercially available NIRS 
products used in previous work [174, 191].  In particular, our DOS instrumentation 
permits quantification of not only ScO2, but also of total hemoglobin concentration, THC, 
a parameter related to cerebral blood volume, and of the reduced scattering coefficient 
of the tissue, a parameter related to the cellular structure and density. We hypothesize 
that patients with sustained low tissue oxygen saturations (ScO2), low cerebral blood 
volume (THC), and/or low tissue scattering will be more susceptible to developing new 
or worsened PVL as seen by MRI 3-7 days post-surgery (see Section 6.2.2).     
!"#"$"% &'()*+,-./+012/3/4(05-6/2/72+,-&89:/4+();4-<-6/2/72+,-=,;;>-?,;@-
The protocol for making absolute measurements of pre- and post-operative ScO2, THC, 
and !!
!!!! using the ISS neonate probe is described in detail in Section 6.2.  Each patient 
had a pre-operative measurement of THC and ScO2 taken approximately 3 hours before 
surgery, followed by multiple post-operative measurements obtained when time and 
personnel permitted.   
To quantify the blood flow index (BFI), the flat probe was secured to the forehead 
 Median (IQR) 
Sex (M/F) N = 6/4 
Gestation Age (weeks) 39.1 (1.4) 
Day of Life (days) 3 (1.5) 
Birth Weight (kg) 3.24 (0.32) 
Head Circumference (cm) 33.8 (1.0) 
Table 12, Patient characteristics. 
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following each session of absolute measurements.  DCS intensity autocorrelation curves 
were acquired for approximately 2 minutes.  This data was fit for the BFI by using the 
semi-infinite solution to the correlation diffusion equation with the optical properties, i.e., 
!! and !!
! , measured with the ISS neonate probe.  A mean and standard deviation BFI 
was computed over the 2 minutes of monitoring 
To standardize time lines for each patient, we define ! ! ! as the time in which 
the patient was disconnected from the cardiopulmonary bypass (CPB) machine. For 
statistical analysis, post-operative measurements were binned into one of 3 categories:  
measurements made 0-4 hours post CPB, measurements made 4-8 hours post CPB, 
and measurements made 8-12 hours post CPB.  If a patient had multiple measurements 
taken within one of these time periods, the measurements were averaged together.   
A two-sided Wilcoxon rank sum test was used to test for differences between the 
distributions of pre-operative ScO2, THC, !!
!!!!, and BFI values and binned post-operative 
values.  To test for differences in THC, !!
!!!!, BFI and ScO2 in patients with and without 
brain injury, data was binned according to presence or absence of injury and a two-sided 
Wilcoxon rank sum test was employed.  A p-value of less than !!!"  was deemed 
statistically significant. 
!"#"$"% &'()*+(,-,.'/'0/1*,2345'61+786,9,.'/'0/1*,:*88;,<*8=,
Ten patients were recruited for this study at the Children’s Hospital of Philadelphia, N = 6 
with hypoplastic left heart syndrome and N = 4 with transposition of the great arteries.  
Patient characteristics are summarized in Table 12.  All ten patients underwent pre-
operative MRI scans for neurological assessment.  Periventricular leukomalacia (PVL) 
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was diagnosed in 1 out of the 10 pre-operative images.  One patient opted out of the 
post-operative MRI.  New or worsened PVL was revealed in 3/9 post-operative scans, 
microhemorrhages were seen in 7/9 post-operative scans, and stroke was observed in 
0/9 post-operative scans, as seen in Table 13.     
  Median (range) of the pre-operative absorption and reduced scattering 
coefficients are summarized in Table 14. Note here that both absorption and scattering 
values are considerably lower than those of healthy neonates [100]. 
Figure 41 shows the progressions of ScO2, THC, !!
! !!""!!"!, and BFI over time.  
Data is broken up into segments of time, i.e., pre-surgery (N = 10), 0-4 hours (N = 9), 4-8 
hours (N = 9), and 8-12 hours (N = 9), and a boxplot of mean values of ScO2, THC, 
!!
! !!""!!"! , and BFI is shown.  It is evident from these figures that ScO2 drops 
significantly in almost all patients 0-4 hours post-CPB as compared to pre-operative 
values (p = 0.038).  Likewise, THC increases substantially 0-4 hours post-CPB as 
Brain Injury Pre-Surgery 1 Week Post-Surgery 
Periventricular Leukomalacia (Yes/No) N = 1/9 N = 3/6 
Stroke (Yes/No) N = 0/10 N = 0/9 
Hemorrhage (Yes/No) N = 0/10 N = 7/2 
Table 13, Summary of brain injury in our cohort pre- and post-operatively.   
 
 Pre-Operative Median (Range) 
!!!!""!!"! (cm
-1) 0.078 (0.060 to 0.114) 
!!!!"!!!"! (cm
-1) 0.075 (0.043 to 0.1103) 
!!
!!!""!!"! (cm-1) 4.5 (3.2 to 7.5) 
!!
!!!"!!!"! (cm-1) 3.8 (1.3 to 6.1) 
Table 14, Median (range) values of the mean absorption and reduced scattering 
coefficients for N=10 pre-operative measurements. 
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compared to pre-operative values (p = 0.007).  Both ScO2 and THC appear to return 
back to pre-operative levels over the course of 8-12 hours post-CPB (p = 0.241 and p = 
0.121, respectively).  No significant differences were observed between pre- and post-
operative values of the blood flow index or reduced scattering coefficient.  However, 
!!
! !!""!!"! does increase slightly in the first 0 to 4 hours after surgery as compared to 
pre-operative values (p = 0.074), after which time !!
! !!""!!"! returns to pre-operative 
levels.     
 Dichotomizing patients by the presence of absence of PVL revealed differences 
 
Figure 41, From top left to bottom right, boxplots of progressions of ScO2, THC, !!
! !!""!!"!, 
and BFI changes over time after cardiac surgery. For each box, the red line marks the median 
of the distribution, the blue box contains the 25th to 75th percentile of the data, and the 
whiskers extend to the most extreme data points not considered outliers.  p-values less than 
0.05 indicate a significant difference between the post-operative data in a given time bin and 
the pre-operative data. 
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between populations by 8-12 hours post-CPB (see Figure 42).  While the results do not 
quite reach statistical significance, the trend in ScO2 looks promising.  These preliminary 
results, although they are only from a small number of patients, suggest that patients 
who develop new or worsened post-operative PVL have lower oxygen saturations 8-12 
hours after surgery when compared to those without PVL.  No differences were 
observed in THC,!!!
! !!!, or BFI between patients with and without PVL (data not shown).  
!"#"$"# %&'()''&*+,-,./0/1023,4567/+28&*+,9,./0/1023,:3**;,<3*=,
This study has examined the progression of pre- and post-operative measures of 
cerebral tissue oxygen saturation (ScO2) and total hemoglobin concentration (THC).  
ScO2 decreases significantly between 0 to 4 hours after surgery in all patients and then 
returns to pre-operative values in most patients.  Cerebral blood volume, represented by 
THC, increases substantially in the 0 to 8 hour period after cardiac surgery and does not 
 
Figure 42, Comparison of ScO2 values of patients with and without white matter brain injury 
(PVL).  Titles of each subplot reflect the time period being plotted and the number of patients in 
the No PVL/PVL groups.  By 8-12 hours post-surgery, patients with PVL may have lower ScO2 
values than those without injury.  
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return to pre-operative levels until 8 to 12 hours post-surgery.  A decrease in ScO2, 
despite the increase in cerebral blood volume, may suggest a problem with gas 
exchange in the lungs in the early post-operative period (~0 to 8 hours). Swelling in the 
lungs, which is often observed in the post-operative period in these patients, may 
potentially cause insufficient oxygen exchange in the lungs.  Alternatively, increased 
cerebral oxygen consumption due to increased neuronal metabolic rate during recovery 
from cardiopulmonary bypass may explain the fall in ScO2 and rise in THC.  Further 
investigations into pulmonary gas exchange and post-operative cerebral metabolism will 
clarify the mechanisms for the behavior of ScO2 and THC after surgery.  
Additionally, we observed that patients who develop post-operative 
periventricular leukomalacia (PVL) have the lowest tissue oxygen saturations 8 to 12 
hours after surgery.  While these results do not quite reach statistical significance, they 
are promising and consistent with the idea that PVL is a form of brain injury caused by 
lack of oxygen.  Patient recruitment is ongoing in order to improve our statistics and to 
investigate the relationship between post-operative ScO2 values and the extent of the 
PVL legion.   
Arterial oxygen saturations are poor indicators of actual oxygen delivery at the 
brain tissue level [188, 192, 193].  The results of our study strengthen the argument for 
monitoring ScO2 continuously in the post-operative period, rather than just monitoring 
transcutaneous SaO2.  After surgery, all TGA patients had SaO2 of ~100%.  Therefore, 
low cerebral saturations would be undetectable by pure pulse-oximetry or arterial blood 
gas readings.  Furthermore, if while monitoring ScO2, it is determined that cerebral 
saturations are lower than desired, then there are clinical methods to improve ScO2, e.g. 
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by increasing oxygen delivery or by decreasing oxygen metabolism.  Transfusion of 
blood products may increase oxygen delivery.  Neuromuscular blockades, sedation, 
mechanical ventilation to reduce the burden of respiration, afterload reducers to improve 
diastolic function, and/or controlled cooling may be suitable options to decrease oxygen 
metabolism.  
One other striking finding from this work is the very low reduced scattering 
coefficient measured at both wavelengths employed. Zhao et al has published 
absorption and reduced scattering coefficients for healthy term infants using a 
homodyne frequency domain instrument at 3 wavelengths, 788, 814, and 832 nm [100].  
While the absorption coefficients measured by Zhao were comparable to our pre-
operative values, they observed a mean reduced scattering coefficient (N = 23) of 
almost twice our measured pre-operative median value (3.8 cm-1 versus 8.4 cm-1 at 830 
nm).  The scattering coefficient we observed in this population is actually much more 
similar to that of preterm infants (5 cm-1 [194]).  This low scattering value may therefore 
be due to the relative immaturity of these patient’s brains and the lesser degree of 
myelination [93, 126, 195, 196]. 
Finally, we note that several assumptions went in to the optical measurements of 
ScO2, THC, and !!
! .  The region under the optical probe was assumed to be a semi-
infinite medium with homogenous optical properties.  This assumption appears to be 
valid, as the mean distance to the cortex measured via anatomical MRI scans of 0.57 
(0.13) cm, approximately 1/3 the distance of our smallest source-detector separation 
(1.5 cm).  Thus, photons launched and received by all source-detector pairs spend the 
majority of their time in the cortex [197].  Additionally, we also assumed the coupling 
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coefficient between the phantom and the probe was roughly equivalent to the coupling 
between the optode and the skin; this assumption enabled us to calibrate the probe and 
to extract absolute optical properties.  Despite these assumptions, our measurements of 
ScO2 and THC fall well within the ranges measured in other neonatal populations [99, 
100, 174, 191, 198].   
!"#"$"% &'()*+,-'(,./.&010213*.45670(38-'(.9.&010213*.:*'';.<*'=.
Cerebral oxygen saturation, total hemoglobin concentration, reduced scattering 
coefficient, and blood flow index were measured in ten neonates with congenital heart 
defects before and intermittently for 12 hours following cardiopulmonary bypass surgery.  
Pre-operative reduced scattering coefficients in this population were considerably lower 
than literature values for healthy term infants, perhaps reflecting the relative brain 
immaturity in these infants as compared to healthy controls.  Post-operatively, ScO2 
decreased significantly 0 to 4 hours after CPB compared with pre-operative values, and 
then ScO2 slowly returned to pre-operative values.  Post-operatively THC increased 
significantly and remained elevated compared to pre-operative values for up to 8 hours 
after CPB.   Additionally, patients with periventricular leukomalacia, a specific form of 
hypoxic ischemic white matter injury, were distinguishable by a failure to recover to pre-
operative ScO2 levels by 8 to 12 hours.   
By monitoring ScO2 in CHD patients post-operatively, we can potentially predict 
PVL in future patients and develop treatment algorithms to prevent the injury. However, 
in order for these results to be clinically significant, we must increase the number of 
patients included in this analysis to account for factors that may confound our results, 
e.g. the influence of cardiac diagnosis.  Thus, recruitment for this study is ongoing.  We 
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hope to recruit at least twenty patients with both TGA and HLHS in order to dichotomize 
the population by both cardiac diagnosis and presence/absence of brain injury and to 
increase the statistical power of our results. 
6.4.2 Hypercapnia 
!"#"$"% &'()*+()',-.-/01234+1,)+--
CO2 is the most potent regulator of cerebral circulation [199, 200].  The presence of 
elevated levels of CO2 causes cerebral vasodilation, while low CO2 levels causes 
cerebral vasoconstriction.  CO2 reactivity, defined as the change in cerebral blood flow 
(CBF) per change in arterial pCO2, is a property of the physiologic reserve of cerebral 
blood flow in the cerebrovascular bed.  Impaired CO2 reactivity has been associated with 
poor neurodevelopmental outcome and a higher risk of death in all age groups [201-
203].   
CHD patients have a significant incidence of stroke and periventricular 
leukomalacia [125, 174-176, 179].  However, routine MRI scans of these patients to 
assess the presence of brain injury is not performed due to prohibitive cost.  The onsets 
of both stroke and periventricular leukomalacia may be highly dependent on cerebral 
circulation, which, in turn, is highly dependent on changes in arterial pCO2.  In the 
following investigation of hypercapnia in our CHD population, we hypothesize that 
patients with lower than average CO2 reactivity (i.e., those patients who have difficulty 
responding to fluctuations in CO2) will be more likely to have some form of brain injury, 
e.g., stroke or PVL.  If correct, impaired CO2 reactivity could used as a clinical indicator 
of be measured as part of standard clinical practice to indicate the presence or absence 
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of brain injury, with impaired reactivity requiring further imaging tests to identify the 
specific form and extent of injury.  
DOS and DCS are ideal modalities to non-invasively assess CO2 reactivity at the 
bedside.  Thus, in this investigation we employ concurrent DOS and DCS monitoring in 
neonates with congenital heart defects before cardiac surgery and during a hypercapnic 
intervention.  Herein we describe the cerebral hemodynamic response to hypercapnia in 
these neonates, we obtain empirical data about cerebrovascular reactivity to 
hypercapnia, and we explore the relation of measured reactivity to brain injury in patients 
with ductal dependent CHD.  
!"#"$"$ %&'&()*&+,-.-(/(0,1234&1*.&((
For the DOS data analysis, we assume the scattering coefficient does not change during 
hypercapnia, and that the changes in the absorption coefficient are small compared to 
the baseline absorption coefficient values.  Thus, we are effectively assuming that the 
modified Beer-Lambert (MBL) law can be employed for our patient population under the 
hypercapnia perturbation (see Sections 2.1.5 and 5.1), i.e. 
 !"#
! !!!
!! !
! !!!!!!! !!!!""!!!. 
Here ! !! !  is the DC intensity of the detected diffuse light at wavelength ! and time !, 
!! !  is the mean DC intensity at wavelength ! during the baseline room air inhalation 
period, and !!!!!! !! is the change in absorption coefficient at wavelength ! and time ! 
compared to at ! ! !.  To determine !!""!!!, baseline optical properties, i.e., tissue 
absorption and reduced scattering coefficients, were quantified approximately 30 
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minutes prior to the hypercapnia experiment in a subset of N=10 patients (see Sections 
6.2.1 and 6.2.3).  For these patients, !!""!!! in the MBL law were computed exactly.  
Alternatively, if absolute optical properties were not measured, a mean !!""!!! 
(calculated from the subset of the 10 CHD patients with absolute measures) was used.  
 For DCS data analysis, we solved the correlation diffusion equation analytically, 
assuming the sample geometry was a homogeneous, semi-infinite turbid medium.  We 
then used the semi-infinite solution (see Section 3.1) to fit our data for a blood flow index 
(BFI).  In the subset of patients for whom baseline µa and µs’ were measured (see 
Section 6.2), evolving optical properties were introduced as inputs into the DCS fits.  In 
those patients for whom baseline µa and µs’ were not measured, a mean value from the 
measured subset of patients was employed along with the changes in µa computed with 
the MBL law, were input into the DCS fits (see Table 14).  !"#$ was quantified using the 
following formula, !"#$!!! ! !"#!!! !"#!" !!""# , where !"#!"  is the mean blood 
flow index during the baseline room air inhalation period.  Therefore, !"#$!!! of 100% 
would indicate no change from baseline values.   
A sample time series of DOS and DCS data from a single patient is seen in 
Figure 43 top and bottom, respectively.  Changes in oxy-hemoglobin concentrations are 
in red, deoxy-hemoglobin concentrations is in blue, and cerebral blood flow is in green.  
CO2 was added to the gas mixture at the ventilator inlet at approximately 40 minutes into 
the study.  Data is missing around 25 minutes into the measurement due to an MRI 
sequence that caused a substantial motion artifact in the optical data.  
To quantify the cerebral response to CO2, mean values of the various optical 
parameters were computed before the onset of CO2 and during a five-minute period after 
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stabilization of the response to CO2 (~20 minutes).  These five-minute periods for 
averaging are denoted with grey shaded rectangles in Figure 43.  Changes in mean 
DOS measures of oxy-hemoglobin (!!!"!! ), deoxy-hemoglobin (!!!" ), and total 
hemoglobin ( !"#$ ! !!!"!! ! !!!" ) were calculated as a difference between 
hypercapnia and baseline means. The mean relative change in CBF (!"#$) was found 
using a ratio of hypercapnic DCS blood flow index to baseline DCS blood flow index.  
CO2 reactivity was quantified as the ratio of !!"#$ per change in pCO2 as measured 
with arterial blood gas, where !!"#$ ! !"#$ ! !""#.  A Wilcoxon signed rank test was 
used to test if the median of each variable’s distribution was significantly different from 
zero (p < 0.05) [137].   
In the subset of 10 patients, from whom we obtained absolute baseline optical 
properties, relative changes in the cerebral metabolic rate of oxygen extraction 
(rCMRO2) was quantified.  rCMRO2 was calculated using the following formula 
(discussed and derived in depth in [62, 68]: 
 
Figure 43, Sample time series of hypercapnia data.  CO2 is turned on at approximately 39 
minutes.  Grey rectangles indicate the time period that is averaged for statistical analysis.   
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 !"#$!! !
!"!!!"
!!"!!!"
!"!!!"
!!"!!!"
!!"#$ ! !""#. [77] 
Here the subscript HC indicates a mean during hypercapnia and BL indicates a mean 
during the baseline period, SaO2 is the arterial oxygen saturation calculated using co-
oximetry on arterial blood samples, and ScO2 is the tissue oxygen saturation discussed 
in Section 6.2.  Again, an rCMRO2 value of 100% would indicate no change in 
metabolism due to hypercapnia.   
Additionally, Grubb’s non-linear relation [204], which describes the relationship 
between relative changes in total hemoglobin concentration (!"#$ ) and !"#$ , was 
tested in this population with a multivariate fit for ! in the following equation: 
 !"#$ ! !"#$!. [78] 
Here we define !"#$ ! !"#$ ! !"#!" !"#!", where !"#!" is the baseline THC.  For 
a subset of N=10 patients, !"#!" was measured using a multi-distance fitting algorithm 
based on analytic solutions in the frequency domain semi-infinite homogeneous medium 
diffusion approximation (see Sections 6.2.1 and 6.2.3).  For the other patients for whom 
we did not obtain baseline THC values, !"#!"  was estimated using hemoglobin 
concentrations measured from arterial blood gas samples6. 
Structural MRI scans (see Section 6.2.2) determined the presence and the extent 
of periventricular leukomalacia (PVL).   Patients were grouped according to the presence 
                                                
6
 For the subset of patients with measured !"#!" , we observed a significant linear relationship between !"#!"  and 
arterial hemoglobin concentration (Hb) obtained from arterial blood gas samples (R = 0.70, p < 0.05). Thus, for patients 
without measured !"#!" , the value of !"#!" !was extrapolated based on baseline hemoglobin levels gathered from 
arterial blood gas samples. 
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or absence of PVL, and Wilcoxon rank sum tests explored differences in CO2 reactivity 
between groups. Patients were also grouped according to cardiac diagnosis, and 
Wilcoxon rank sum tests explored differences between groups. 
!"#"$"% &'()*+(,-./0'1230453--
As seen in the histograms in Figure 44, hypercapnia induced significant increases in 
!!!"!!
, !"#$, and !"#$% in almost all subjects (p < 0.001).  Because each patient 
received slightly different amounts of CO2, data is reported as change in the parameter 
of interest per unit change in pCO2 in order to compare between subjects in a more 
objective manner.  For reference, vertical dotted lines are added to denote no change 
due to hypercapnia.  On average, !"#$!! and !"# showed no significant changes due 
to hypercapnia (p = 0.32 and 0.29, respectively), although some individual patients 
exhibited substantial responses of these parameters in both the positive and negative 
 
Figure 44, Histograms of mean changes in !!!"!!, !!!", !"#$!and !"#$% per change in arterial 
pCO2. For reference, vertical dotted lines are added to denote no change due to hypercapnia.  
The title of each subplot indicates median (range) CO2 reacitivities, along with p-values.  
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directions.  Median (interquartile range) changes and p-values obtained from Wilcoxon 
signed rank test are summarized in Table 15.   
 To explore the relation between changes in blood volume and changes in blood 
flow, Figure 45 is a scatterplot depicting the non-linear relationship between !"#$!and 
!"#$ along with error bars of each variable.  In order to estimate the Grubb’s exponent, 
a linear regression of !"#!!!"#$! versus !"#!!!"#$! was performed and revealed an 
estimate (95% confidence interval) of the Grubb exponent of 0.35 (0.11, 0.58).  This 
relationship is significant (! ! !!!!"), albeit with an !! of only !!!". Our value of the 
 
Figure 45, Relationship between !"#$ and!!"#$ during hypercapnia. 
 
Parameter Median (IQR) p-value 
!"#!! (mmHg) 26 (16) <0.001 
!rCBF (%) 79.5 (54.4) <0.001 
!"#!! (!M) 13.4 (9.0) <0.001 
!"# (!M) 0.8 (3.7) 0.29 
!"#$ (!M) 13.8 (9.6) <0.001 
CO2 Reactivity (%/mmHg) 3.3 (2.9) <0.001 
rCMRO2 (%)* 7.1 (53.8) 0.32 
Table 15, Median and interquartile range changes in the measured hemodynamic parameters.  p-
values were computed using a Wilcoxon signed rank test.  *Note that rCMRO2 was only measured 
in 10 out of 27 patients. 
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Grubb’s exponent agrees fairly well with previously published results, which range from 
0.28 to 0.38 [205].     
As shown in Figure 46, when grouped according to cardiac diagnosis, no 
significant differences in CO2 reactivity were observed, i.e., patients with TGA (N=14) or 
with HLHS (N=13) react in a similar fashion to hypercapnia (p=0.72).  When grouped 
according to presence (N=3) or absence (N = 24) of PVL, no significant difference in 
CO2 reactivity was identified (p=0.79); however, N = 3 is small and probably adversely 
affects the statistics.  Similarly, no differences in CO2 reactivity were observed between 
patients with pre-operative stroke (N=2) and those without stroke (N = 25, p = 0.25).  
Again the small number of patients with pre-operative stroke may adversely affect the 
statistics. 
A. B.  
C.  
Figure 46, Differences in CO2 reactivity between A. patients with HLHS versus TGA, B. patients 
without pre-operative PVL and with pre-operative PVL, C. patients without and with pre-
operative stroke. 
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This work has demonstrated the effects of hypercapnia on neonates born with two 
particular forms of cyanotic heart defects: hypoplastic left heart syndrome and 
transposition of the great arteries.  Significant increases in cerebral blood flow, 
concentration of oxy-hemoglobin, and total hemoglobin concentrations were observed 
during the hypercapnia perturbation.   Deoxy-hemoglobin concentrations and cerebral 
metabolic rate of oxygen extraction showed no population averaged changes due to 
hypercapnia, an observation which agrees quite well with the handful of publications that 
have studied cerebrovascular reactivity to hypercapnia in patients with congenital heart 
defects using a variety of different measurement techniques, including NIRS, velocity 
mapping MRI, ASL-MRI, DOS and DCS [59, 142-145].  Durduran et al also used DCS to 
measure a mean (standard deviation) cerebrovascular reactivity to increased CO2 of 3.1 
(1.9) %/mmHg in neonates with congenital heart defects [59].  Our population of 
neonates is similar to that published by Durduran, and we found a comparable median 
(IQR) CO2 reactivity of 3.3 (2.9) %/mmHg.  
While the median CO2 reactivity of these infants agrees well with other literature 
values, it should be noted that the values spanned a large range (0.15 to 7.6 %/mmHg).  
Thus, there exists a subset of the populations, with low CO2 reactivity, suggesting a 
small cerebrovascular reserve of cerebral blood flow.  We hypothesized that these 
patients would have the highest incidence of brain injury, an effect that has been seen 
[201-203].  Yet, as Figure 46 suggests, this hypothesis was not supported by the data in 
our study.  No significant differences in the distributions of CO2 reactivity were observed 
in patients with and without brain injury.  One caveat, of course, is that we have a rather 
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small sample size of the injured population (less than 10% of our patients had injury).  
Alternatively, the injury suffered by our patient population is much less severe than that 
reported in the previous works that cited a relation between impaired CO2 reactivity and 
adverse outcome.  Perhaps this population with more “minor” brain injury does not have 
impaired CO2 reactivity.  
The results presented herein also demonstrate a cross-validation between the 
parameters measured by the diffuse optical methods.  A significant correlation was 
observed between relative changes in CBF (rCBF) and relative changes in cerebral 
blood volume (rCBV).  The relationship between rCBF and rCBV is typically referred to 
as Grubb’s relation [204].  Grubb’s relation is frequently employed when a measure of 
only one of these two parameters is available.  Boas and Payne provide a nice summary 
of published values Grubb’s exponent in both humans and animals, ranging from 0.28 to 
0.38 [205].  Our value of the Grubb’s exponent agrees fairly well with previously 
published results.  However, the 95% confidence interval for our Grubb’s exponent is 
quite large (0.11 to 0.58).  Thus, this data makes the argument for employing both DOS 
and DCS monitoring in order to have access to both rCBV and rCBF data.  In the 
present population, Grubb’s relation has a substantial amount of variation.  Thus, if one 
employs only rCBF or rCBV alone in computations, the estimation of rCMRO2 could have 
substantial errors.     
Other Limitations of Optical Data 
Due to the head size of the neonates studied, plus the fact that all measurements 
were performed in an MRI scanner, we were restricted to a single source-detector 
separation for the DOS measurements.  Thus, the modified Beer-Lambert law was used 
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to quantify changes in the absorption coefficient and ergo changes in oxy- and deoxy-
hemoglobin.  However, many assumptions are required to employ the modified Beer-
Lambert Law.  In particular, it is assumed that !"! is small relative to its baseline value, 
and we assume that !!
!  remains constant.  These assumptions appear to be valid in the 
present experiment.  On average, !"!  at 786 nm was 0.015 cm
-1, a change of 
approximately 15% of the presumed baseline value of !!  = 0.1 cm
-1 at 786 nm.  Similar 
results were found for 688 and 826 nm.  Although we did not explicitly measure !"!
! , 
other researchers have observed little or no change in !!
!  during similar experimental 
conditions [147, 171].  Thus we feel our assumption of constant !!
!  is justified. 
To fit the DCS data for a blood flow index, we assumed initial values for the 
absorption and reduced scattering coefficients (!!  and !!!).  Because we are only 
interested in relative changes in the BFI, our choice of initial !! and !!! has little to no 
effect on the resulting value of rCBF.  However, changes of !! and !!! that occur during 
the duration of the study may influence the magnitude of rCBF.  For this reason, we 
incorporated changes in !!  obtained with DOS into our fitting procedure for BFI.  
However, as mentioned previously, our DOS analysis assumed that the scattering 
coefficient remained constant for the duration of the study. This assumption is most likely 
valid for hypercapnia (see Section 5.1).  However, if false, a 10% increase in the 
scattering coefficient could alter the magnitude of rCBF by as much as 20%.  Thus, 
future work would benefit greatly from the use of multiple source detector DOS 
amplitude and phase measurements used to continuously quantify !! and !!!.   
We also have anatomical brain MRI images of each patient, and we computed 
the mean (standard deviation) skull/scalp/CSF thickness underneath our optical probe to 
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be 0.57 (0.13) cm.  Because of the 2.5 cm source-detector separations used for both 
DOS and DCS, photons travel on average a depth of 1 to 1.25 cm into the tissue.  Thus, 
we are confident the optical measurements are probing the surface of the cortex.  
However, in the future, DCS quantification of rCBF can be further improved.  A semi-
infinite model was used to fit DCS data. As known from the anatomical scans, such a 
model greatly simplifies the head geometry of these patients. In reality, the scalp, skull, 
cerebral spinal fluid, grey matter, and white matter possess different optical properties 
that can be accounted for, at least partially, in Monte Carlo simulations of light 
propagation [148, 150]. Nevertheless, the semi-infinite model has been demonstrated to 
provide a sufficient approximation of relative changes in cerebral blood flow (see Section 
5.1).  
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We have quantified mean increases in cerebral blood flow and blood oxygenation during 
hypercapnia in infants with CHD, and we report significant correlations between 
measures of cerebral blood flow by DCS and cerebral oxygenation by DOS. Although 
CO2 reactivity has been shown to correlate with adverse outcomes, our results suggest 
that CO2 reactivity does not predict the presence of hypoxic-ischemic injury, albeit in a 
limited sample size.  Given the current distribution of our data, we require approximately 
17 additional patients with injury to determine a statistically significant difference 
between cerebrovascular reactivity in injured versus non-injured patients with 90% 
power.  Thus, patient recruitment is ongoing.  Nevertheless, these results do confirm that 
diffuse optical spectroscopy and diffuse correlation spectroscopy can provide valuable 
and individualized cerebral hemodynamic information in critically ill infants with CHD. 
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6.4.3 Sodium Bicarbonate  
!"#"$"% &'()*+()',-.-/'0)12-3)4+56',+(7-
Metabolic acidemia arises when the low systemic oxygen supply causes the brain to 
employ non-oxidative, anaerobic metabolic pathways, leading to the production of lactic 
acid.  Severe acidemia (called acidosis) can cause increased pulmonary vascular 
resistance, decreased contractility of the heart muscle, and is associated with increased 
mortality [206, 207]. Sodium bicarbonate (NaHCO3) is one of the most commonly used 
medications to treat metabolic acidemia in intensive care units that care for adults, 
children, and newborns alike.  It treats metabolic acidemia by neutralizing excess acid in 
the blood and restoring normal tissue pH.  Sodium bicarbonate reacts with the acid to 
yield water and carbon dioxide (CO2):   
 !! ! !"#!
!
! !!!!! ! !!! ! !!!. [79] 
Sodium bicarbonate has been reported to increase systemic blood pressures as 
well as the arterial partial pressure of CO2 (in ventilated infants) [208].  However, little is 
known about the effects of sodium bicarbonate on cerebral hemodynamics, and the 
efficacy of the treatment is widely debated [209, 210].   The few publications studying 
cerebral blood flow after administration of sodium bicarbonate report conflicting results 
[207, 208, 211-214]; Lou et al observed substantial decreases in cerebral blood flow 
measured by the 133Xe clearance technique five minutes after sodium bicarbonate 
administration in newborn infants with respiratory distress; Fanconi et al [208] observed 
significant increases in cerebral blood flow, inferred from increases in aortic flow velocity, 
due to sodium bicarbonate in newborn infants; and Young et al observed no change in 
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cerebral blood flow (measured with radioactive tracers) 30 minutes after drug 
administration in neonatal dogs.  These apparent disparities are potentially due to the 
wide variety of patients studied as well as the time frame after drug administration that 
the effects were assessed.  
Thus, the investigation described in this section aims to quantify the immediate 
cerebral hemodynamic effects due to rapid administration of sodium bicarbonate; the 
clinical study uses data collected on a subset of the pre-operative CHD patients 
discussed in Section 6.3.  We hypothesize that sodium bicarbonate bolus will result in a 
rapid increase in brain CO2, and thus it should have physiological effects that are similar 
to sudden hypercapnia, i.e., increasing cerebral blood flow and oxygenation.  
!"#"$"% &'(')*+',-./.)0)123/45)6/7'892+'(:)
All data included in this analysis was acquired in the pre-operative period either prior to 
or immediately after the hypercapnia intervention performed in the MRI scanner (see 
Section 6.2.3).  As seen in Figure 47, arterial blood gases taken prior to and immediately 
 
Figure 47, During the hypercapnia study protocol (see Section 6.2.3), arterial blood gases 
were drawn prior to and immediately after hypercapnia. A bolus of sodium bicarbonate was 
given to treat acidemia if indicated by the blood gas. 
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after the study revealed the need for sodium bicarbonate to treat acidemia.  To quantify 
effects of sodium bicarbonate on cerebral hemodynamics, patients were monitored with 
DOS and DCS continuously at a rate of 0.3 Hz (see Section 6.2.3).    
For DOS data analysis, we assumed the scattering coefficient does not change 
with the administration of sodium bicarbonate, and we further assumed that the changes 
in the absorption coefficient are small compared to the baseline absorption coefficient 
values.  Thus, assuming these assumptions are valid, the modified Beer-Lambert (MBL) 
law can be employed for our analysis (see Section 2.1.5), i.e. 
 !"#
! !!!
!! !
! !!!!!! !!!!""!!!. [80] 
Here ! !! !  is the DC intensity of light at wavelength ! and time !, !! !  is the mean DC 
intensity at wavelength ! during the 2 minutes prior to sodium bicarbonate, and !!!!!! !! 
is the change in absorption coefficient at wavelength !  and time ! .  To determine 
!!""!!!, baseline optical absorption and scattering properties were quantified in a subset 
of N=10 patients (see Sections 6.2.1 and 6.2.3).  If absolute optical properties were not 
measured, a then mean !!""!!!  (calculated from the subset of CHD patients with 
absolute measures) was employed in our analysis.  
For DCS data analysis, the correlation diffusion equation was solved analytically, 
for a sample geometry that was assumed homogeneous and semi-infinite.  We used the 
semi-infinite solution (see Section 3.1) to fit our data for the tissue blood flow index (BFI).  
In the subset of patients for whom baseline !! and !!! were measured (see Section 6.2), 
these optical parameters (including the changes in !! computed with the MBL law) were 
input into the DCS fits.  In those patients for whom baseline !!  and !!!were not 
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measured, a mean baseline value from the measured subset of patients was employed 
along with the changes in !! computed with the MBL law, were input into the DCS fits 
(see Table 14).   
Sample optical data is shown in Figure 48.   For analysis, each parameter was 
averaged during a two-minute window prior to and immediately following sodium 
bicarbonate administration.  A two-minute period was chosen because the effects of 
sodium bicarbonate are immediately evident, and because all patients had sufficient 
data within this window.  Changes in each parameter were quantified using the following 
formulas: 
!"# ! !!" !"#$ ! !!" !"#, 
!"#!! ! !!"!! !"#$
! !!!!! !"#
, 
!"#$ ! !"# !"#$ ! !"# !"#, 
 
Figure 48, For quantification of the effects of rapid administration of a bolus of sodium 
bicarbonate, each hemodynamic parameter was averaged for 2 minutes before and two minutes 
after administration.  Net changes were quantified either as a difference or ratio of pre- to post-
sodium bicarbonate values.  
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 !"#$% ! !"# !"#$ !"# !"# ! ! !!""#. [81] 
A Wilcoxon signed rank test was used to test if the median of each variable’s distribution 
was significantly different from zero (p<0.05) [137].   
!"#"$"$ %&'()*'+,-./0(1,203456.74*&,
As noted previously, 28 neonates were monitored pre-operatively during the 
hypercapnia intervention performed in the MRI scanner.  Of these 28 infants, 11 patients 
received sodium bicarbonate in the form of a rapid bolus administration followed by a 
flush of saline in an attempt to treat acidemia indicated by low arterial base excess 
Variable Median (IQR) 
Sex (M/F) 8/3 
Cardiac Diagnosis (TGA/HLHS) 2/9 
Gestation Age (weeks) 38.8 (1.3) 
Day of Life (days) 3 (2) 
Birth Weight (kg) 3.15 (0.69) 
Head Circumference (cm) 33.7 (1.2) 
Dosage NaHCO3 (mEq/mg) 1.12 (1.05) 
Table 16, Patient characteristics as well as dose of sodium bicarbonate (in 
milliequivalent per kilogram). 
Variable Median (IQR) 
pH 7.3 (0.15) 
pCO2 (mmHg) 43.5 (32.3) 
pO2 (mmHg) 61 (10.3) 
Bicarbonate (HCO3
-) 22 (4.5) 
Base Excess (BE) -4 (3.2) 
Table 17, Median (IQR) measures from arterial blood gas sample taken before 
administration of sodium bicarbonate (N=12 events). 
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(population median of -4, see Table 17).  Twelve sodium bicarbonate events were 
captured, as one patient received sodium bicarbonate before and after the hypercapnia 
intervention.  Demographics of the patients receiving sodium bicarbonate, along with 
median (IQR) dosage of sodium bicarbonate are summarized in Table 16.  The majority 
of the patients were males with hypoplastic left heart syndrome.  Patients received a 
median dose of sodium bicarbonate of 1.1 mEq/kg (ranging from 0.8 to 2.7 mEq/kg).  
Additionally, the results of arterial blood gases obtained prior to administration of sodium 
bicarbonate are summarized in Table 17.  
 As seen in Figure 49 and summarized in Table 18, sodium bicarbonate had little 
population-averaged effect on !!!"!!, !!!", or !"#$.  Changes in these parameters did 
not reach statistical significance.  On the other hand, !"#$% increased significantly with 
sodium bicarbonate and weak correlation (R = 0.54, p = 0.11) was observed between 
changes in cerebral blood flow and sodium bicarbonate administered dosage (Figure 
 
Figure 49, Boxplot summarizing the changes in deoxy-, oxy-, and total hemoglobin 
concentrations (left) and cerebral blood flow (right) due to sodium bicarbonate administration.  
Cerebral blood flow increased significantly.   
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50) 7 .  Additionally, the correlation observed between changes in oxy-hemoglobin 
concentration and the dose of sodium bicarbonate was also significant (R = 0.80, p = 
0.02).  Correlations between dosage and !!!"  and !"#$  did not attain statistical 
significance (p > 0.2).   
!"#"$"# %&'()''&*+,-.*/&)0-1&(234*+256--
In mechanically ventilated infants with congenital heart defects, sodium bicarbonate 
caused significant changes in cerebral blood flow immediately (within 2 minutes) 
following administration as measured by diffuse correlation spectroscopy. No significant 
changes in oxy- or deoxy-hemoglobin concentrations were observed in the patient 
population as a whole, although several individual patients did respond to sodium 
bicarbonate with either an increase or decrease in oxy-hemoglobin concentrations.  The 
observed increase in cerebral blood flow may be due to CO2, produced as a byproduct 
of sodium bicarbonate’s reaction with lactic acid.  As mentioned in Section 6.4.2, CO2 is 
a potent vasodilator whose presence leads to the increases in cerebral blood flow.  
Interestingly, we did not observe a significant increase in total hemoglobin concentration 
over the entire population, an expected response to cerebrovascular vasodilation.     
                                                
7
 The large error bars observed on some of the data points in this figure are due to the averaging window for analysis.  
When patients exhibit a substantial CBF response to sodium bicarbonate, the window encases the rise in CBF, thus 
leading to a large variation in the mean over the window. 
Variable Median (IQR) p-value 
!"#$% (%) 17.1 (24.6) 0.009 
!!!"(µM) -1.2 (3.2) 0.28 
!!!"!!
(µM) 0.5 (4.9) 0.63 
!"#$(µM) -0.1 (4.1) 0.70 
Table 18, Median and interquartile range changes in the measured hemodynamic 
parameters.  p-values were computed using a Wilcoxon signed rank test.   
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Potentially we did not monitor long enough to see these expected increases.   
Very little work has been published in human neonates on the effects of sodium 
bicarbonate to treat metabolic acidosis.  Our results agree fairly well with a few reports of 
the cerebral hemodynamic effects of sodium bicarbonate used to correct metabolic 
acidosis.  Van Alfen et al [207] employed NIRS and transcranial Doppler ultrasound 
(TCD) to study 15 preterm infants with metabolic acidosis treated with rapid 
administration of sodium bicarbonate.  As was the case with our results, at five minutes 
post-sodium bicarbonate they did not observe changes in total hemoglobin concentration 
(they report cerebral blood volume), and, in contrast to our finding of a significant change 
in cerebral blood flow, they did not observe a significant change in cerebral blood flow 
velocity in the internal carotid artery.  This discrepancy may be due to the fact that they 
were looking at macrovascular changes in flow velocity in a feeder artery, while DCS 
measures microvascular flow in cortical tissue.  Alternatively, the discrepancy may arise 
from the fact that 9/15 of their population were not mechanically ventilated, allowing for 
respiratory compensation to exhale the extra CO2 produced by sodium bicarbonate.    
 
Figure 50, Relationship between the change in (Left) cerebral blood flow and (Right) oxy-
hemoglobin concentration and the dose of sodium bicarbonate given.  
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Lou et al [213] used the 133Xe clearance technique to measure changes in 
cerebral blood flow five minutes after sodium bicarbonate injection in seven asphyxiated 
neonates with respiratory distress.  They found profound decreases in cerebral blood 
flow in these infants, contrary to our findings.  It is not clear why these results are 
contradictory; however, a possible explanation could be the difference in patient 
population.  The neonates in their cohort were asphyxiated, while the patients in our 
population were not.  Potentially, their brain injury was severe enough to deplete the 
cerebrovascular reserve, thus with the administration of sodium bicarbonate, vascular 
resistance is decreased in other tissues but constant in the brain, causing cerebral blood 
flow to decrease.   
Faconi et al [208] monitored cardiac output and aortic blood flow velocity 1 and 5 
minutes after a slow (~30 minutes) sodium bicarbonate infusion in 16 neonates who 
were paralyzed and mechanically ventilated.  Although they did not measure cerebral 
blood flow directly, they did observe significant increases in cardiac output and aortic 
velocities at both 1 and 5 minutes, suggesting increases in cerebral blood flow 
(consistent with our findings).  The researchers postulated that these aortic flow 
increases may be due to increases in the ability of the heart muscle to contract and 
decreases in the arterial tension against which the left ventricle must contract.   
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Sodium bicarbonate is one of the most commonly used medications in intensive care 
units that care for adults, children, and newborns alike. Infants with congenital heart 
defects often receive boluses of sodium bicarbonate in the pre-operative period to 
correct metabolic acidosis.  We monitored cerebral blood flow and oxygenation changes 
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immediately after sodium bicarbonate administration. Cerebral blood flow was observed 
to increase significantly with sodium bicarbonate.  These changes in cerebral blood flow 
were correlated (albeit somewhat weakly) with the given dose of sodium bicarbonate.  
On average oxy-hemoglobin concentration did not change with sodium bicarbonate 
administration, however changes in oxy-hemoglobin concentration were significantly 
correlated with dose.   
Future work will benefit from extended monitoring to determine the potential 
transience of the cerebral blood flow response.  We are in the process of recruiting more 
patients with the goal of increasing the statistical power of our analysis and extending 
monitoring time.  Understanding the changes in cerebral hemodynamics that occur as a 
consequence of rapid infusions of sodium bicarbonate may have a significant impact in 
the treatment of metabolic acidemia in patients with CHD, as well as potentially in 
premature infants whose cerebrovascular bed is immature and poorly tolerates rapid 
fluctuations in CBF.   
6.4.4 Blood transfusions 
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Critically-ill neonates often receive blood transfusions in order to maintain an 
adequate supply of oxygen to the tissue by increasing oxygen carrying capacity of the 
blood.  In particular, many of the post-operative CHD patients are anemic due to 
hemodilution from cardiopulmonary bypass and substantial blood loss post-surgery.  
These patients receive transfusions in order to maintain adequate tissue oxygen supply 
to the tissue.  Clinical indications for administering transfusion include hypotension, 
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tachycardia, and/or low hematocrit and hemoglobin values on arterial blood gases.  
Although post-operative CHD patients frequently receive transfusions, little 
quantitative information is available about the cerebral effects of these transfusions.  
Some work has been done to monitor cerebral oxygen saturations (ScO2), cerebral 
blood volume (CBV), and blood flow velocity in the large cerebral vessels during blood 
transfusions [215-222], but the majority of this work has been conducted on preterm 
infants, another critically ill neonatal population who frequently require transfusions.  
These investigations have found that tissue oxygen saturation increases due to 
increased oxygen carrying capacity of the blood.  Additionally, these investigations have 
seen small but significant decreases in cerebral blood flow with transfusion, presumably 
due to increased arterial oxygen content and blood viscosity. 
We have obtained pilot cerebral data due to transfusion using DOS/DCS in CHD 
patients with the ultimate goal of quantifying and better understanding the cerebral 
effects of blood transfusions in this particular population.  Post-operatively, CHD patients 
with transposition of the great arteries have “healthy” circulation, since their condition is 
repairable.  Thus, these patients are expected to respond in a similar manner to preterm 
infants to transfusion.  However, CHD patients with hypoplastic left heart syndrome 
(HLHS) do not have normal circulation following palliative heart surgery.  Despite this 
fact, we hypothesize that HLHS patients will still have a normal response to transfusion, 
i.e., an increase in cerebral oxygenation and decrease in cerebral blood flow will be 
observed in response to transfusion.  The following sub-sections characterize the 
responses to transfusion and compare the effects between cardiac diagnoses.  The 
reported results are the first observations about cerebral hemodynamic changes during 
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blood transfusions in CHD neonates. 
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All transfusion events included in this analysis were acquired in the post-operative period 
(see Section 6.2.4).  Patients were monitored with DOS and DCS continuously ever 7.5 
seconds, and vital signs were captured every 2 seconds.  A researcher was at the 
bedside to mark the start and end of transfusion.  Transfusions were excluded from 
analysis if the optical data was interrupted for probe repositioning, or if a significant 
physiological event (other than the transfusion itself) occurred during the transfusion, 
such as suctioning of the endotracheal tube, changes in ventilator settings, drug 
interventions causing changes in cerebral hemodynamics, etc.  
For DOS data analysis, we assumed the scattering coefficient does not change 
with transfusion, and that the changes in the absorption coefficient are small compared 
to the baseline absorption coefficient values.  Thus, the modified Beer-Lambert (MBL) 
law can be employed (see Section 2.1.5), i.e. 
 !"#
! !!!
!! !
! !!!!!! !!!!""!!!. [82] 
Here ! !! !  is the DC intensity of light at wavelength ! and time !, !! !  is the mean DC 
intensity at wavelength ! during the 2 minutes prior to transfusion, and !!!!!! !! is the 
change in absorption coefficient at wavelength ! and time ! compared to at ! ! !.  To 
determine !!""!!!, baseline optical properties, i.e., absorption and reduced scattering 
coefficients, were quantified in a subset of N=10 patients (see Sections 6.2.1 and 6.2.3).  
If absolute optical properties were not measured, a mean !!""!!! (calculated from the 
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subset of CHD patients with absolute measures) was employed.  
For DCS data analysis, the correlation diffusion equation was solved analytically, 
assuming the sample geometry was assumed homogeneous and semi-infinite.  We used 
the semi-infinite solution (see Section 3.1) to fit our data for a blood flow index (BFI).  In 
the subset of patients for whom baseline µa and µs’ were measured (see Section 6.2), 
these values, along with the changes in µa computed with the MBL law, were input into 
the DCS fits.  In those patients for whom baseline µa and µs’ were not measured, a mean 
value from the measured subset of patients was employed along with the changes in µa 
computed with the MBL law, were input into the DCS fits (see Table 14).   
Sample optical and vital sign data obtained during transfusion is shown in Figure 
51.   For analysis, each parameter was averaged for a two-minute window prior to and 
 
Figure 51, (Top Left) Arterial blood pressure, (Top Right) Heart rate, (Bottom Left) Changes in 
oxy-, deoxy-, and total hemoglobin concentrations (Bottom Right) changes in cerebral blood flow 
due to transfusion which is administered within the shaded region.  For quantification of the 
effects of transfusion, each parameter was averaged for two minutes before and two minutes 
after administration.  Net changes were quantified either as a difference or ratio of pre- to post-
transfusion values. 
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immediately following transfusion.  A two-minute period was chosen because all patients 
studied had sufficient data within this window.  Changes in each parameter were 
quantified using the following formulas: 
!"# ! !!" !"#$ ! !!" !"#, 
!"#!! ! !!"!! !"#$
! !!"!! !"#
, 
!"#$ ! !"# !"#$ ! !"# !"#, 
 !"#$% ! !"# !"#$ !"# !"# ! ! !!""#. [83] 
For the purpose of this analysis, we considered each transfusion event to be an 
independent observation.  A Wilcoxon signed rank test was used to test if the median of 
each variable’s distribution was significantly different from zero (p<0.05) [137].  To test 
for association between the volume of blood given and the response of hemodynamic 
variables, a simple linear regression model was employed.  
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We have captured a total of 16 post-operative blood transfusions of varying duration and 
amount from 7 out of the 28 CHD patients we measured.  Table 19 lists the patient 
characteristics of those who received transfusions.  The median (interquartile range) 
duration of transfusion was 24.1 (34.5) minutes and median amount of transfusion was 
25.3 (10.7) mL.  Median (IQR) baseline hematocrit was 36 (3) % and baseline 
hemoglobin was 12.5 (2.38) g/dL, as determined by pre-transfusion arterial blood gas 
samples.  
 163
 As summarized in Table 21, transfusions induced significant increases (p=0.007) 
in mean arterial pressure. Figure 52 depicts a histogram of cerebral hemodynamic 
responses to transfusion.  In this figure, a vertical dotted line indicates no change in the 
given parameter due to transfusion.  Total hemoglobin concentration increased 
significantly with a median (interquartile range) increase of 9.5 (10.9) ! M after 
transfusion (p=0.005).  Oxy-hemoglobin concentration also increased with transfusion by 
6.7 (9.9) !M (p=0.064).  Transfusions had mixed effects on !"#$, leading to a non-
significant (p = 0.21) population averaged change in CBF of 4.5 (24.5)%.  Deoxy-
hemoglobin concentration demonstrated a mild increase with transfusion that did not 
 Median (IQR) 
Diagnosis (HLHS/TGA) N = 5/2 
Sex (Male/Female) N = 4/3 
Gestation Age (weeks) 38.9 (1.0) 
Day of Life (days) 3 (1.5) 
Birth Weight (kg) 3.15 (0.52) 
Head Circumference (cm) 33.4 (1.2) 
Table 19, Patient characteristics, reported as median and interquartile range (IQR), of those who 
received blood transfusions post-operatively. 
 
 
Figure 52, Distribution of changes in hemodynamic parameters caused to transfusion.  Median 
(interquartile range) reported in the title of each subplot.  The dotted vertical line indicates no 
change due to transfusion.  
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reach statistical significance (p > 0.17).  Changes in all of these parameters did not 
significantly correlate (p > 0.1) with the amount of volume given (Table 20).    
The cerebral hemodynamic effects of blood transfusions were then grouped by 
the cardiac diagnosis of the patient.  As seen in Figure 53, Patients with TGA (N=5) 
showed a greater increase in !"#!! after transfusion compared to those with a palliative 
repair of their CHD (HLHS, N=10).  A similar trend was observed with changes in total 
hemoglobin concentration (p=0.075).   No differences between the two groups were 
seen with either deoxy-hemoglobin concentration changes or relative changes in 
cerebral blood flow.   
 
Figure 53, Differences between cardiac diagnosis in hemodynamic response to blood 
transfusion.  From top left to bottom right:  relative change in cerebral blood flow, change in 
deoxy-hemoglobin concentration, change in oxy-hemoglobin concentration, and change in total 
hemoglobin concentration.  The title of each subplot indicates the number of events in each 
group and the p-value indicating differences between the medians of each group. 
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These results demonstrate that blood transfusions in post-operative CHD patients aimed 
at improving the oxygen carrying capacity of the blood cause a wide-variety of 
hemodynamic responses.  We observed significant population averaged increases in 
mean arterial pressure and total hemoglobin concentration.  Oxy-hemoglobin 
concentrations also increased on average following transfusion, similar to observations 
by [215, 217, 218, 220] in preterm infants. Deoxy-hemoglobin concentration showed no 
significant population averaged changes.   
On average, no alterations in cerebral blood flow were observed, however it 
should be noted that cerebral blood flow for some individual patients changed quite 
Variable Median (IQR) p-value 
!"#$% (%) 5.2 (24.3) 0.21 
!!!"(µM) 0.8 (6.0) 0.17 
!!!"!!
(µM) 6.7 (9.9) 0.064 
!"#(bpm) 1.5 (10.3) 0.41 
!"#!!(%) -0.5 (2.8) 0.88 
!"#$(mmHg) 4.0 (5.4) 0.007 
Table 21, Median and interquartile range changes in the measured hemodynamic and vital sign 
parameters.  p-values were computed using a Wilcoxon signed rank test.   
 
R (p-value) 
!"#$% (%) -0.39 (0.14) 
!!!"(µM) 0.18 (0.52) 
!!!"!!
(µM) 0.16 (0.56) 
!"#$(µM) 0.22 (0.44) 
Table 20, Pearson’s linear correlation coefficient (R) and corresponding p-value for 
the relationship between cerebral hemodynamic changes and the transfusion volume 
(cc/kg).  Significant relations (p < 0.05) between changes in these parameters and 
transfusion amount were not observed.   
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dramatically with transfusion.  In 3 patients, for example, CBF increased more than 50%, 
and in 3 other patients CBF decreased more than 30%.  These results differ slightly from 
previously published work done on preterm infants using transcranial Doppler ultrasound 
in the pericallosal [217] and internal carotid [220] arteries.  These groups found small but 
significant decreases in cerebral blood flow velocity (CBFV) in these large vessels 
following transfusion, potentially indicating a decrease in cerebral blood flow on the 
microvascular level as well.  Additionally, it is believed that hematocrit and cerebral 
blood flow are anti-correlated [222].  Thus, our cerebral blood flow results are puzzling.  
Our CBF results may be explained by the fact that we are considering the two-minute 
window immediately following transfusion and not capturing the longer-term effects on 
CBF. 
From this preliminary analysis, we did not find any predictive population-
averaged variables of the cerebral hemodynamic changes to transfusion.  Thus, in order 
for a clinician to determine the success or failure of a blood transfusion to improve 
oxygen content and delivery of blood in an individual patient, individualized bedside DOS 
and DCS monitoring is needed.   
When grouped according to either palliative or corrective CHDs (HLHS or TGA, 
respectively), patients with “normal” circulation (TGA’s) showed a greater response in 
oxy-hemoglobin concentration to transfusion.  Our work may lead to changes in clinical 
transfusion protocols for HLHS patients.  If transfusions do not improve cerebral 
oxygenation, other preferred interventions exist, such as saline boluses or albumin 
infusions that would also have the desired effect of increasing blood pressure, but would 
not impose transfusion-related complications.  
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The main caveat of interpreting these results is that we did not explore the long-
term (hours to days after transfusion) cerebral hemodynamic effects of transfusion.  Our 
averaging window was chosen in order to avoid confounding factors that often occurred 
after transfusion, such as ventilator changes, medication delivery, or optical probe 
adjustments, that would affect the optical signal and/or brain dynamics.  However, we do 
believe that our results, obtained immediately after transfusion, may still be indicative of 
long-term effects of transfusion, as other groups have observed oxygen saturations 
immediately after transfusion to be reflective of saturations 12 hours after transfusion 
[215].   
Optical data assumptions  
Due to limitations in the head size of the neonates we studied, we were restricted 
to a single source-detector separation for DOS measurements.  Thus, the modified 
Beer-Lambert law was used to quantify changes in the absorption coefficient and thus 
changes in oxy- and deoxy-hemoglobin.  However, many assumptions are required to 
employ the modified Beer-Lambert Law.  In particular, it is assumed that !!! is small 
relative to its baseline value, and we assume that !!
!  remains constant.  These 
assumptions may not be valid in the present study since it is unknown whether the 
scattering properties of the tissue will change significantly with the presence of additional 
red blood cells.  However, preliminary data obtained in our laboratory on piglets during 
transfusion (results not shown) indicate that the reduced scattering coefficient does 
indeed remain unchanged after transfusion.  Additionally, depending on the patient, the 
absorption coefficient can change substantially (greater than 50%) with transfusion.  
Thus, future work would benefit greatly from the use of multiple source detector DOS 
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amplitude and phase measurements used to continuously quantify !! and !!
! .   
To fit the DCS data for a blood flow index, we assumed initial values for the 
absorption and reduced scattering coefficients (!!  and !!
! ).  Because we are only 
interested in relative changes in the BFI, our choice of initial !! and !!
!  has little to no 
effect on the resulting value of rCBF.  However, changes from these initial values of !! 
and !!
!  that occur during the duration of the study may influence the magnitude of rCBF.  
Thus, we incorporated changes in !! obtained with DOS into our fitting procedure for 
BFI.  However, as mentioned in the previous paragraph, our DOS analysis assumed that 
the scattering coefficient remained constant during the duration of the study.  If this 
assumption is false, a 10% increase in the scattering coefficient could alter the 
magnitude of rCBF by approximately 20%.  Again, future work would benefit from 
continuously quantifying !! and !!
! .   
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These results are the first to investigate blood transfusions in CHD patients.  We have 
observed significant increases in total hemoglobin concentrations with transfusions, with varying 
effects on cerebral blood flow in this population.  Patient recruitment is ongoing in an attempt to 
recruit at least five more patients with each CHD diagnosis in order to achieve the desired 
statistical significance (p < 0.05, 90% power) for our population averaged response to blood 
transfusion.   
We are currently investigating a neonatal piglet model of transfusion in order to have 
normative data to compare our CHD population results.  Additionally, these animal studies will be 
used to further validate the optical techniques employed herein using both multi-separation 
diffusion theory and radiolabeled microspheres (to validate DOS and DCS, respectively).  Once a 
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“normal” response to transfusion is established, albeit in a neonatal animal model, and the optical 
techniques have been well validated as reliable during transfusion, this data will be well received 
in the clinical community.   
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7 Conclusions/Future 
Over the past few decades, significant advances have been made in improving the 
survival of premature neonates and neonates with congenital heart defects. With these 
advances in medical and surgical therapy, clinicians are now focusing their attention on 
reducing the morbidity associated with routine neonatal care.  A major area of focus has 
been the greater understanding of the factors that contribute to impaired neurological 
development.  Increasing our understanding of regulation of cerebral blood flow and the 
perturbations that occur during injury will allow us to further investigate the factors that 
contribute to central nervous system injury.  These critically ill neonates would benefit 
greatly from continuous bedside monitoring of cerebral hemodynamics to identify, treat, 
and/or potentially prevent detrimental cerebral events such as hypoxic ischemia, 
hemorrhage, stroke, etc.   
I believe that diffuse optical techniques (namely DOS and DCS) are well suited for 
this unique population.  At a given source-detector separation, NIR light penetrates 
deeper into the neonatal cortex compared with adult cortex because of the decreased 
thickness of the neonatal skull. Therefore, neonates are ideal candidates for DOS/DCS 
monitoring. Conversely, DOS/DCS are particularly attractive tools for monitoring cerebral 
physiology in neonates because of their high temporal resolution, bedside capabilities, 
minimal deposition of energy, and its non-invasiveness.  Additionally, DOS/DCS can 
easily be integrated with other monitoring techniques, such as MRI, transcranial Doppler 
ultrasound, electroencephalography, or positron emission tomography. Unlike some of 
these other modalities, namely MRI and positron emission tomography, DOS and DCS 
measurements are easily performed without the use of general anesthesia. 
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This dissertation focused on clinical data obtained with DOS and DCS in these 
neonates.  As DCS is a relatively new technique, I demonstrate successful validation of 
both absolute DCS measures of blood flow index as well as relative changes in the 
blood flow index as a measure of cerebral blood flow in children.  This validation is vital 
for further acceptance and integration of the technique into the clinical arena.   
The last chapter (Chapter 6) highlights the translation of the DOS/DCS techniques 
to the intensive care unit for bedside monitoring.  I focus on a collection of data obtained 
from infants with congenital heart defects.  I demonstrate a progression of tissue oxygen 
saturation and cerebral blood volume (represented by total hemoglobin concentration) in 
the 12-hour period following cardiac surgery.  Preliminary data suggests that prolonged 
periods of low tissue oxygen saturation may be indicative of brain injury.  Additionally, 
chapter 6 quantifies the cerebral effects of various interventions, namely hypercapnia, 
blood transfusion, and sodium bicarbonate infusion.  Patient recruitment for these 
studies is ongoing in order to increase our numbers and improve our statistics.  We hope 
to get at least 20 more patients.   
Our laboratory’s collaborations with researchers at CHOP have grown by leaps 
and bounds in the four years that I have been working over there.  In this past year alone 
our optics team has been approached to facilitate understanding of cerebral 
hemodynamics during anesthesia induction/maintenance, extracorporeal membrane 
oxygenation (ECMO, which is essentially a bedside cardiopulmonary bypass machine), 
pulmonary hypertension treatment, and blood transfusions in preterm infants.  
In the near future, I envision DOS/DCS as a tool used primarily to study small 
subsets of pediatric patients to discover population-averaged patterns of cerebral 
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hemodynamic changes occurring with various clinical interventions, as well to gain 
insight into the predictors and risk factors for brain injury.  However, due to the low cost 
and high information content of combining DOS and DCS, these techniques may 
become standard bedside care in many pediatric populations within the next 20 years.   I 
quote this fairly long time frame because I believe there is still a substantial amount of 
work to be done for the techniques to gain widespread acceptance.  The first major 
hurdle will be to establish a “user-friendly” interface for a hybrid DOS/DCS device that 
provides reliable real time data.  The next hurdle will be to develop a way to obtain DCS 
signals through hair so that measurements can be made over regions other than the 
frontal cortex.  Finally, we must fully understand the origin of the DCS signal in order to 
assess absolute cerebral blood flow (as opposed to just relative changes) and to isolate 
the contribution of the CBF signal that arises from the brain itself from that which arises 
from extracerebral layers. 
The future looks bright for DOS and DCS monitoring in neonates.  Unlike adult 
patients, much is still completely unknown about cerebral hemodynamics, brain injury, 
and subsequent neurodevelopment of infants.  These optical techniques will help shed 
light on these unknowns, and may be the ideal cerebral monitor that is needed for these 
infants due to its non-invasive nature.  Yet there is a mountain of development, 
education, exploration, and integration to be done, and this dissertation is just part of the 
beginning.      
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